id	sid	tid	token	lemma	pos
bjos-8647123	1	1	braz	braz	PROPN
bjos-8647123	1	2	j	j	PROPN
bjos-8647123	1	3	oral	oral	PROPN
bjos-8647123	1	4	sci	sci	PROPN
bjos-8647123	1	5	.	.	PUNCT
bjos-8647123	2	1	15(1):51	15(1):51	NUM
bjos-8647123	2	2	-	-	SYM
bjos-8647123	2	3	56	56	NUM
bjos-8647123	2	4	original	original	ADJ
bjos-8647123	2	5	article	article	NOUN
bjos-8647123	2	6	braz	braz	PROPN
bjos-8647123	2	7	j	j	PROPN
bjos-8647123	2	8	oral	oral	PROPN
bjos-8647123	2	9	sci	sci	PROPN
bjos-8647123	2	10	.	.	PUNCT
bjos-8647123	3	1	january	january	PROPN
bjos-8647123	4	1	|	|	ADV
bjos-8647123	4	2	march	march	PROPN
bjos-8647123	4	3	2016	2016	NUM
bjos-8647123	4	4	volume	volume	NOUN
bjos-8647123	4	5	15	15	NUM
bjos-8647123	4	6	,	,	PUNCT
bjos-8647123	4	7	number	number	NOUN
bjos-8647123	4	8	1	1	NUM
bjos-8647123	4	9	expression	expression	NOUN
bjos-8647123	4	10	of	of	ADP
bjos-8647123	4	11	timp-2	timp-2	NUM
bjos-8647123	4	12	in	in	ADP
bjos-8647123	4	13	hpv-16	hpv-16	NUM
bjos-8647123	4	14	infected	infect	VERB
bjos-8647123	4	15	oral	oral	ADJ
bjos-8647123	4	16	squamous	squamous	ADJ
bjos-8647123	4	17	cell	cell	NOUN
bjos-8647123	4	18	carcinoma	carcinoma	NOUN
bjos-8647123	4	19	in	in	ADP
bjos-8647123	4	20	patients	patient	NOUN
bjos-8647123	4	21	in	in	ADP
bjos-8647123	4	22	iraq	iraq	PROPN
bjos-8647123	4	23	habib	habib	PROPN
bjos-8647123	4	24	a	a	DET
bjos-8647123	4	25	manal1	manal1	PROPN
bjos-8647123	4	26	,	,	PUNCT
bjos-8647123	4	27	habib	habib	PROPN
bjos-8647123	4	28	a	a	DET
bjos-8647123	4	29	huda2	huda2	NOUN
bjos-8647123	4	30	,	,	PUNCT
bjos-8647123	4	31	hussain	hussain	PROPN
bjos-8647123	4	32	a	a	DET
bjos-8647123	4	33	israa1	israa1	PROPN
bjos-8647123	4	34	,	,	PUNCT
bjos-8647123	4	35	karima	karima	PROPN
bjos-8647123	4	36	al	al	PROPN
bjos-8647123	4	37	-	-	PROPN
bjos-8647123	4	38	salihi3	salihi3	PROPN
bjos-8647123	4	39	1university	1university	NUM
bjos-8647123	4	40	of	of	ADP
bjos-8647123	4	41	baghdad	baghdad	PROPN
bjos-8647123	4	42	,	,	PUNCT
bjos-8647123	4	43	baghdad	baghdad	PROPN
bjos-8647123	4	44	college	college	PROPN
bjos-8647123	4	45	of	of	ADP
bjos-8647123	4	46	medicine	medicine	NOUN
bjos-8647123	4	47	,	,	PUNCT
bjos-8647123	4	48	department	department	NOUN
bjos-8647123	4	49	of	of	ADP
bjos-8647123	4	50	pathology	pathology	PROPN
bjos-8647123	4	51	,	,	PUNCT
bjos-8647123	4	52	iraq	iraq	PROPN
bjos-8647123	4	53	2university	2university	NUM
bjos-8647123	4	54	of	of	ADP
bjos-8647123	4	55	baghdad	baghdad	PROPN
bjos-8647123	4	56	,	,	PUNCT
bjos-8647123	4	57	al	al	PROPN
bjos-8647123	4	58	-	-	PUNCT
bjos-8647123	4	59	kindy	kindy	PROPN
bjos-8647123	4	60	college	college	PROPN
bjos-8647123	4	61	of	of	ADP
bjos-8647123	4	62	medicine	medicine	NOUN
bjos-8647123	4	63	,	,	PUNCT
bjos-8647123	4	64	department	department	NOUN
bjos-8647123	4	65	of	of	ADP
bjos-8647123	4	66	community	community	NOUN
bjos-8647123	4	67	,	,	PUNCT
bjos-8647123	4	68	iraq	iraq	PROPN
bjos-8647123	4	69	3the	3the	DET
bjos-8647123	4	70	university	university	NOUN
bjos-8647123	4	71	of	of	ADP
bjos-8647123	4	72	nottingham	nottingham	PROPN
bjos-8647123	4	73	,	,	PUNCT
bjos-8647123	4	74	school	school	NOUN
bjos-8647123	4	75	of	of	ADP
bjos-8647123	4	76	veterinary	veterinary	ADJ
bjos-8647123	4	77	medicine	medicine	NOUN
bjos-8647123	4	78	and	and	CCONJ
bjos-8647123	4	79	science	science	NOUN
bjos-8647123	4	80	,	,	PUNCT
bjos-8647123	4	81	loughborough	loughborough	PROPN
bjos-8647123	4	82	,	,	PUNCT
bjos-8647123	4	83	leicestershire	leicestershire	NOUN
bjos-8647123	4	84	,	,	PUNCT
bjos-8647123	4	85	uk	uk	PROPN
bjos-8647123	4	86	correspondence	correspondence	NOUN
bjos-8647123	4	87	to	to	ADP
bjos-8647123	4	88	:	:	PUNCT
bjos-8647123	4	89	karima	karima	PROPN
bjos-8647123	4	90	al	al	PROPN
bjos-8647123	4	91	-	-	PUNCT
bjos-8647123	4	92	salihi	salihi	PROPN
bjos-8647123	4	93	.	.	PUNCT
bjos-8647123	5	1	the	the	DET
bjos-8647123	5	2	university	university	PROPN
bjos-8647123	5	3	of	of	ADP
bjos-8647123	5	4	nottingham	nottingham	PROPN
bjos-8647123	5	5	,	,	PUNCT
bjos-8647123	5	6	school	school	NOUN
bjos-8647123	5	7	of	of	ADP
bjos-8647123	5	8	veterinary	veterinary	ADJ
bjos-8647123	5	9	medicine	medicine	NOUN
bjos-8647123	5	10	and	and	CCONJ
bjos-8647123	5	11	science	science	NOUN
bjos-8647123	5	12	,	,	PUNCT
bjos-8647123	5	13	college	college	NOUN
bjos-8647123	5	14	road	road	NOUN
bjos-8647123	5	15	,	,	PUNCT
bjos-8647123	5	16	sutton	sutton	PROPN
bjos-8647123	5	17	bonington	bonington	PROPN
bjos-8647123	5	18	,	,	PUNCT
bjos-8647123	5	19	loughborough	loughborough	PROPN
bjos-8647123	5	20	,	,	PUNCT
bjos-8647123	5	21	leicestershire	leicestershire	VERB
bjos-8647123	5	22	le12	le12	PROPN
bjos-8647123	5	23	5rd	5rd	PROPN
bjos-8647123	5	24	uk	uk	PROPN
bjos-8647123	5	25	e	e	NOUN
bjos-8647123	5	26	-	-	NOUN
bjos-8647123	5	27	mail	mail	NOUN
bjos-8647123	5	28	:	:	PUNCT
bjos-8647123	5	29	kareema.nasrullah@nottingham.ac.uk	kareema.nasrullah@nottingham.ac.uk	NUM
bjos-8647123	5	30	;	;	PUNCT
bjos-8647123	5	31	kama_akool18@yahoo.co.uk	kama_akool18@yahoo.co.uk	NOUN
bjos-8647123	5	32	;	;	PUNCT
bjos-8647123	5	33	mrvsa59@gmail.com	mrvsa59@gmail.com	X
bjos-8647123	5	34	abstract	abstract	ADV
bjos-8647123	5	35	aim	aim	VERB
bjos-8647123	5	36	:	:	PUNCT
bjos-8647123	5	37	to	to	PART
bjos-8647123	5	38	determine	determine	VERB
bjos-8647123	5	39	the	the	DET
bjos-8647123	5	40	expression	expression	NOUN
bjos-8647123	5	41	of	of	ADP
bjos-8647123	5	42	tissue	tissue	NOUN
bjos-8647123	5	43	inhibitors	inhibitor	NOUN
bjos-8647123	5	44	of	of	ADP
bjos-8647123	5	45	metalloproteinases	metalloproteinase	NOUN
bjos-8647123	5	46	(	(	PUNCT
bjos-8647123	5	47	timp-2	timp-2	NOUN
bjos-8647123	5	48	)	)	PUNCT
bjos-8647123	5	49	in	in	ADP
bjos-8647123	5	50	oral	oral	ADJ
bjos-8647123	5	51	squamous	squamous	ADJ
bjos-8647123	5	52	cell	cell	NOUN
bjos-8647123	5	53	carcinoma	carcinoma	NOUN
bjos-8647123	5	54	(	(	PUNCT
bjos-8647123	5	55	oscc	oscc	ADJ
bjos-8647123	5	56	)	)	PUNCT
bjos-8647123	5	57	and	and	CCONJ
bjos-8647123	5	58	the	the	DET
bjos-8647123	5	59	difference	difference	NOUN
bjos-8647123	5	60	in	in	ADP
bjos-8647123	5	61	its	its	PRON
bjos-8647123	5	62	expression	expression	NOUN
bjos-8647123	5	63	level	level	NOUN
bjos-8647123	5	64	between	between	ADP
bjos-8647123	5	65	positive	positive	ADJ
bjos-8647123	5	66	and	and	CCONJ
bjos-8647123	5	67	negative	negative	ADJ
bjos-8647123	5	68	hpv-16	hpv-16	PROPN
bjos-8647123	5	69	(	(	PUNCT
bjos-8647123	5	70	human	human	ADJ
bjos-8647123	5	71	papilloma	papilloma	NOUN
bjos-8647123	5	72	virus16	virus16	NOUN
bjos-8647123	5	73	)	)	PUNCT
bjos-8647123	5	74	oscc	oscc	ADJ
bjos-8647123	5	75	patients	patient	NOUN
bjos-8647123	5	76	.	.	PUNCT
bjos-8647123	6	1	methods	method	NOUN
bjos-8647123	6	2	:	:	PUNCT
bjos-8647123	6	3	this	this	DET
bjos-8647123	6	4	study	study	NOUN
bjos-8647123	6	5	was	be	AUX
bjos-8647123	6	6	conducted	conduct	VERB
bjos-8647123	6	7	on	on	ADP
bjos-8647123	6	8	33	33	NUM
bjos-8647123	6	9	biopsies	biopsy	NOUN
bjos-8647123	6	10	obtained	obtain	VERB
bjos-8647123	6	11	from	from	ADP
bjos-8647123	6	12	patients	patient	NOUN
bjos-8647123	6	13	with	with	ADP
bjos-8647123	6	14	oscc	oscc	NOUN
bjos-8647123	6	15	and	and	CCONJ
bjos-8647123	6	16	10	10	NUM
bjos-8647123	6	17	normal	normal	ADJ
bjos-8647123	6	18	oral	oral	ADJ
bjos-8647123	6	19	mucosa	mucosa	NOUN
bjos-8647123	6	20	as	as	ADP
bjos-8647123	6	21	controls	control	NOUN
bjos-8647123	6	22	.	.	PUNCT
bjos-8647123	7	1	in	in	ADP
bjos-8647123	7	2	situ	situ	ADJ
bjos-8647123	7	3	hybridization	hybridization	NOUN
bjos-8647123	7	4	(	(	PUNCT
bjos-8647123	7	5	ish	ish	AUX
bjos-8647123	7	6	)	)	PUNCT
bjos-8647123	7	7	was	be	AUX
bjos-8647123	7	8	used	use	VERB
bjos-8647123	7	9	to	to	PART
bjos-8647123	7	10	investigate	investigate	VERB
bjos-8647123	7	11	the	the	DET
bjos-8647123	7	12	presence	presence	NOUN
bjos-8647123	7	13	of	of	ADP
bjos-8647123	7	14	hpv-16	hpv-16	PROPN
bjos-8647123	7	15	,	,	PUNCT
bjos-8647123	7	16	while	while	SCONJ
bjos-8647123	7	17	immunohistochemistry	immunohistochemistry	NOUN
bjos-8647123	7	18	(	(	PUNCT
bjos-8647123	7	19	ihc	ihc	PROPN
bjos-8647123	7	20	)	)	PUNCT
bjos-8647123	7	21	was	be	AUX
bjos-8647123	7	22	used	use	VERB
bjos-8647123	7	23	to	to	PART
bjos-8647123	7	24	estimate	estimate	VERB
bjos-8647123	7	25	the	the	DET
bjos-8647123	7	26	expression	expression	NOUN
bjos-8647123	7	27	level	level	NOUN
bjos-8647123	7	28	of	of	ADP
bjos-8647123	7	29	timp-2	timp-2	PROPN
bjos-8647123	7	30	.	.	PUNCT
bjos-8647123	8	1	results	result	NOUN
bjos-8647123	8	2	:	:	PUNCT
bjos-8647123	8	3	the	the	DET
bjos-8647123	8	4	timp-2	timp-2	PROPN
bjos-8647123	8	5	was	be	AUX
bjos-8647123	8	6	expressed	express	VERB
bjos-8647123	8	7	in	in	ADP
bjos-8647123	8	8	27	27	NUM
bjos-8647123	8	9	(	(	PUNCT
bjos-8647123	8	10	81.8	81.8	NUM
bjos-8647123	8	11	%	%	NOUN
bjos-8647123	8	12	)	)	PUNCT
bjos-8647123	8	13	of	of	ADP
bjos-8647123	8	14	oscc	oscc	ADJ
bjos-8647123	8	15	sections	section	NOUN
bjos-8647123	8	16	with	with	ADP
bjos-8647123	8	17	no	no	DET
bjos-8647123	8	18	significant	significant	ADJ
bjos-8647123	8	19	difference	difference	NOUN
bjos-8647123	8	20	between	between	ADP
bjos-8647123	8	21	its	its	PRON
bjos-8647123	8	22	expression	expression	NOUN
bjos-8647123	8	23	level	level	NOUN
bjos-8647123	8	24	in	in	ADP
bjos-8647123	8	25	hpv-16	hpv-16	NUM
bjos-8647123	8	26	positive	positive	ADJ
bjos-8647123	8	27	and	and	CCONJ
bjos-8647123	9	1	hpv-16	hpv-16	NUM
bjos-8647123	9	2	negative	negative	ADJ
bjos-8647123	9	3	oscc	oscc	ADJ
bjos-8647123	9	4	cases	case	NOUN
bjos-8647123	9	5	(	(	PUNCT
bjos-8647123	9	6	p=0.058	p=0.058	NOUN
bjos-8647123	9	7	)	)	PUNCT
bjos-8647123	9	8	.	.	PUNCT
bjos-8647123	10	1	timp-2	timp-2	PROPN
bjos-8647123	10	2	was	be	AUX
bjos-8647123	10	3	found	find	VERB
bjos-8647123	10	4	to	to	PART
bjos-8647123	10	5	be	be	AUX
bjos-8647123	10	6	highly	highly	ADV
bjos-8647123	10	7	expressed	express	VERB
bjos-8647123	10	8	in	in	ADP
bjos-8647123	10	9	oscc	oscc	ADJ
bjos-8647123	10	10	sections	section	NOUN
bjos-8647123	10	11	,	,	PUNCT
bjos-8647123	10	12	and	and	CCONJ
bjos-8647123	10	13	the	the	DET
bjos-8647123	10	14	presence	presence	NOUN
bjos-8647123	10	15	of	of	ADP
bjos-8647123	10	16	hpv	hpv	NOUN
bjos-8647123	10	17	was	be	AUX
bjos-8647123	10	18	not	not	PART
bjos-8647123	10	19	related	relate	VERB
bjos-8647123	10	20	to	to	ADP
bjos-8647123	10	21	its	its	PRON
bjos-8647123	10	22	overexpression	overexpression	NOUN
bjos-8647123	10	23	.	.	PUNCT
bjos-8647123	11	1	conclusions	conclusion	NOUN
bjos-8647123	11	2	:	:	PUNCT
bjos-8647123	11	3	the	the	DET
bjos-8647123	11	4	percentage	percentage	NOUN
bjos-8647123	11	5	of	of	ADP
bjos-8647123	11	6	samples	sample	NOUN
bjos-8647123	11	7	that	that	PRON
bjos-8647123	11	8	appeared	appear	VERB
bjos-8647123	11	9	to	to	PART
bjos-8647123	11	10	accommodate	accommodate	VERB
bjos-8647123	11	11	detectable	detectable	ADJ
bjos-8647123	11	12	hpv-16	hpv-16	NUM
bjos-8647123	11	13	was	be	AUX
bjos-8647123	11	14	high	high	ADJ
bjos-8647123	11	15	,	,	PUNCT
bjos-8647123	11	16	but	but	CCONJ
bjos-8647123	11	17	no	no	DET
bjos-8647123	11	18	significant	significant	ADJ
bjos-8647123	11	19	difference	difference	NOUN
bjos-8647123	11	20	was	be	AUX
bjos-8647123	11	21	observed	observe	VERB
bjos-8647123	11	22	in	in	ADP
bjos-8647123	11	23	relation	relation	NOUN
bjos-8647123	11	24	to	to	ADP
bjos-8647123	11	25	timp-2	timp-2	NUM
bjos-8647123	11	26	expression	expression	NOUN
bjos-8647123	11	27	level	level	NOUN
bjos-8647123	11	28	.	.	PUNCT
bjos-8647123	12	1	future	future	ADJ
bjos-8647123	12	2	studies	study	NOUN
bjos-8647123	12	3	with	with	ADP
bjos-8647123	12	4	a	a	DET
bjos-8647123	12	5	larger	large	ADJ
bjos-8647123	12	6	number	number	NOUN
bjos-8647123	12	7	of	of	ADP
bjos-8647123	12	8	patients	patient	NOUN
bjos-8647123	12	9	are	be	AUX
bjos-8647123	12	10	highly	highly	ADV
bjos-8647123	12	11	recommended	recommend	VERB
bjos-8647123	12	12	to	to	PART
bjos-8647123	12	13	address	address	VERB
bjos-8647123	12	14	the	the	DET
bjos-8647123	12	15	possible	possible	ADJ
bjos-8647123	12	16	association	association	NOUN
bjos-8647123	12	17	between	between	ADP
bjos-8647123	12	18	timp-2	timp-2	PROPN
bjos-8647123	12	19	and	and	CCONJ
bjos-8647123	12	20	oscc	oscc	ADJ
bjos-8647123	12	21	positive	positive	ADJ
bjos-8647123	12	22	hpv-16	hpv-16	X
bjos-8647123	12	23	.	.	PUNCT
bjos-8647123	13	1	keywords	keyword	NOUN
bjos-8647123	13	2	:	:	PUNCT
bjos-8647123	14	1	timp-2	timp-2	PROPN
bjos-8647123	14	2	.	.	PUNCT
bjos-8647123	15	1	hpv	hpv	PROPN
bjos-8647123	15	2	.	.	PUNCT
bjos-8647123	16	1	iraq	iraq	PROPN
bjos-8647123	16	2	.	.	PUNCT
bjos-8647123	17	1	oral	oral	ADJ
bjos-8647123	17	2	cancer	cancer	NOUN
bjos-8647123	17	3	.	.	PUNCT
bjos-8647123	18	1	introduction	introduction	NOUN
bjos-8647123	18	2	the	the	DET
bjos-8647123	18	3	major	major	ADJ
bjos-8647123	18	4	neoplasm	neoplasm	NOUN
bjos-8647123	18	5	worldwide	worldwide	ADV
bjos-8647123	18	6	is	be	AUX
bjos-8647123	18	7	oral	oral	ADJ
bjos-8647123	18	8	cancer	cancer	NOUN
bjos-8647123	18	9	.	.	PUNCT
bjos-8647123	19	1	it	it	PRON
bjos-8647123	19	2	is	be	AUX
bjos-8647123	19	3	accompanied	accompany	VERB
bjos-8647123	19	4	with	with	ADP
bjos-8647123	19	5	high	high	ADJ
bjos-8647123	19	6	death	death	NOUN
bjos-8647123	19	7	rate	rate	NOUN
bjos-8647123	19	8	,	,	PUNCT
bjos-8647123	19	9	which	which	PRON
bjos-8647123	19	10	is	be	AUX
bjos-8647123	19	11	associated	associate	VERB
bjos-8647123	19	12	with	with	ADP
bjos-8647123	19	13	a	a	DET
bjos-8647123	19	14	routine	routine	ADJ
bjos-8647123	19	15	late	late	ADJ
bjos-8647123	19	16	discovery	discovery	NOUN
bjos-8647123	19	17	in	in	ADP
bjos-8647123	19	18	its	its	PRON
bjos-8647123	19	19	development	development	NOUN
bjos-8647123	19	20	.	.	PUNCT
bjos-8647123	20	1	the	the	DET
bjos-8647123	20	2	recurrence	recurrence	NOUN
bjos-8647123	20	3	is	be	AUX
bjos-8647123	20	4	a	a	DET
bjos-8647123	20	5	serious	serious	ADJ
bjos-8647123	20	6	prognostic	prognostic	ADJ
bjos-8647123	20	7	influence	influence	NOUN
bjos-8647123	20	8	in	in	ADP
bjos-8647123	20	9	patients	patient	NOUN
bjos-8647123	20	10	with	with	ADP
bjos-8647123	20	11	oral	oral	ADJ
bjos-8647123	20	12	squamous	squamous	ADJ
bjos-8647123	20	13	cell	cell	NOUN
bjos-8647123	20	14	carcinoma	carcinoma	NOUN
bjos-8647123	20	15	(	(	PUNCT
bjos-8647123	20	16	oscc)1	oscc)1	NOUN
bjos-8647123	20	17	-	-	SYM
bjos-8647123	20	18	3	3	NUM
bjos-8647123	20	19	.	.	PUNCT
bjos-8647123	21	1	according	accord	VERB
bjos-8647123	21	2	to	to	ADP
bjos-8647123	21	3	data	datum	NOUN
bjos-8647123	21	4	from	from	ADP
bjos-8647123	21	5	the	the	DET
bjos-8647123	21	6	american	american	ADJ
bjos-8647123	21	7	oral	oral	PROPN
bjos-8647123	21	8	cancer	cancer	NOUN
bjos-8647123	21	9	foundation	foundation	NOUN
bjos-8647123	21	10	published	publish	VERB
bjos-8647123	21	11	in	in	ADP
bjos-8647123	21	12	2014	2014	NUM
bjos-8647123	21	13	,	,	PUNCT
bjos-8647123	21	14	over	over	ADP
bjos-8647123	21	15	640,000	640,000	NUM
bjos-8647123	21	16	new	new	ADJ
bjos-8647123	21	17	cases	case	NOUN
bjos-8647123	21	18	are	be	AUX
bjos-8647123	21	19	found	find	VERB
bjos-8647123	21	20	every	every	DET
bjos-8647123	21	21	year4	year4	NOUN
bjos-8647123	21	22	,	,	PUNCT
bjos-8647123	21	23	whereas	whereas	SCONJ
bjos-8647123	21	24	there	there	PRON
bjos-8647123	21	25	were	be	VERB
bjos-8647123	21	26	128,000	128,000	NUM
bjos-8647123	21	27	deaths	death	NOUN
bjos-8647123	21	28	due	due	ADJ
bjos-8647123	21	29	to	to	ADP
bjos-8647123	21	30	oral	oral	ADJ
bjos-8647123	21	31	cancer	cancer	NOUN
bjos-8647123	21	32	worldwide	worldwide	ADV
bjos-8647123	21	33	in	in	ADP
bjos-8647123	21	34	2008	2008	NUM
bjos-8647123	21	35	according	accord	VERB
bjos-8647123	21	36	to	to	ADP
bjos-8647123	21	37	the	the	DET
bjos-8647123	21	38	international	international	ADJ
bjos-8647123	21	39	agency	agency	NOUN
bjos-8647123	21	40	for	for	ADP
bjos-8647123	21	41	research	research	NOUN
bjos-8647123	21	42	on	on	ADP
bjos-8647123	21	43	cancer	cancer	NOUN
bjos-8647123	21	44	(	(	PUNCT
bjos-8647123	21	45	iarc)5,6	iarc)5,6	NOUN
bjos-8647123	21	46	.	.	PROPN
bjos-8647123	22	1	in	in	ADP
bjos-8647123	22	2	iraq	iraq	PROPN
bjos-8647123	22	3	,	,	PUNCT
bjos-8647123	22	4	cancer	cancer	NOUN
bjos-8647123	22	5	made	make	VERB
bjos-8647123	22	6	up	up	ADP
bjos-8647123	22	7	10	10	NUM
bjos-8647123	22	8	%	%	NOUN
bjos-8647123	22	9	of	of	ADP
bjos-8647123	22	10	total	total	ADJ
bjos-8647123	22	11	deaths	death	NOUN
bjos-8647123	22	12	of	of	ADP
bjos-8647123	22	13	all	all	DET
bjos-8647123	22	14	ages	age	NOUN
bjos-8647123	22	15	.	.	PUNCT
bjos-8647123	23	1	oral	oral	ADJ
bjos-8647123	23	2	cancer	cancer	NOUN
bjos-8647123	23	3	constituted	constitute	VERB
bjos-8647123	23	4	approximately	approximately	ADV
bjos-8647123	23	5	4.5	4.5	NUM
bjos-8647123	23	6	%	%	NOUN
bjos-8647123	23	7	of	of	ADP
bjos-8647123	23	8	all	all	DET
bjos-8647123	23	9	cancer	cancer	NOUN
bjos-8647123	23	10	cases	case	NOUN
bjos-8647123	23	11	and	and	CCONJ
bjos-8647123	23	12	oscc	oscc	ADV
bjos-8647123	23	13	represents	represent	VERB
bjos-8647123	23	14	about	about	ADV
bjos-8647123	23	15	91.5	91.5	NUM
bjos-8647123	23	16	%	%	NOUN
bjos-8647123	23	17	of	of	ADP
bjos-8647123	23	18	all	all	DET
bjos-8647123	23	19	oral	oral	ADJ
bjos-8647123	23	20	cancer	cancer	NOUN
bjos-8647123	23	21	and	and	CCONJ
bjos-8647123	23	22	37	37	NUM
bjos-8647123	23	23	%	%	NOUN
bjos-8647123	23	24	of	of	ADP
bjos-8647123	23	25	head	head	NOUN
bjos-8647123	23	26	and	and	CCONJ
bjos-8647123	23	27	neck	neck	NOUN
bjos-8647123	23	28	cancer	cancer	NOUN
bjos-8647123	23	29	according	accord	VERB
bjos-8647123	23	30	to	to	ADP
bjos-8647123	23	31	iraqi	iraqi	ADJ
bjos-8647123	23	32	cancer	cancer	NOUN
bjos-8647123	23	33	registry7	registry7	PROPN
bjos-8647123	23	34	.	.	PUNCT
bjos-8647123	24	1	the	the	DET
bjos-8647123	24	2	prevalence	prevalence	NOUN
bjos-8647123	24	3	of	of	ADP
bjos-8647123	24	4	oral	oral	ADJ
bjos-8647123	24	5	cancer	cancer	NOUN
bjos-8647123	24	6	during	during	ADP
bjos-8647123	24	7	2003	2003	NUM
bjos-8647123	24	8	-	-	SYM
bjos-8647123	24	9	2006	2006	NUM
bjos-8647123	24	10	in	in	ADP
bjos-8647123	24	11	iraqi	iraqi	ADJ
bjos-8647123	24	12	governorates	governorate	NOUN
bjos-8647123	24	13	in	in	ADP
bjos-8647123	24	14	relation	relation	NOUN
bjos-8647123	24	15	to	to	ADP
bjos-8647123	24	16	sex	sex	NOUN
bjos-8647123	24	17	,	,	PUNCT
bjos-8647123	24	18	age	age	NOUN
bjos-8647123	24	19	and	and	CCONJ
bjos-8647123	24	20	site	site	NOUN
bjos-8647123	24	21	has	have	AUX
bjos-8647123	24	22	been	be	AUX
bjos-8647123	24	23	estimated	estimate	VERB
bjos-8647123	24	24	,	,	PUNCT
bjos-8647123	24	25	and	and	CCONJ
bjos-8647123	24	26	the	the	DET
bjos-8647123	24	27	study	study	NOUN
bjos-8647123	24	28	found	find	VERB
bjos-8647123	24	29	that	that	SCONJ
bjos-8647123	24	30	the	the	DET
bjos-8647123	24	31	highest	high	ADJ
bjos-8647123	24	32	prevalence	prevalence	NOUN
bjos-8647123	24	33	(	(	PUNCT
bjos-8647123	24	34	55.81	55.81	NUM
bjos-8647123	24	35	%	%	NOUN
bjos-8647123	24	36	)	)	PUNCT
bjos-8647123	24	37	was	be	AUX
bjos-8647123	24	38	observed	observe	VERB
bjos-8647123	24	39	in	in	ADP
bjos-8647123	24	40	tongue	tongue	NOUN
bjos-8647123	24	41	,	,	PUNCT
bjos-8647123	24	42	while	while	SCONJ
bjos-8647123	24	43	the	the	DET
bjos-8647123	24	44	lowest	low	ADJ
bjos-8647123	24	45	(	(	PUNCT
bjos-8647123	24	46	3.87	3.87	NUM
bjos-8647123	24	47	%	%	NOUN
bjos-8647123	24	48	)	)	PUNCT
bjos-8647123	24	49	was	be	AUX
bjos-8647123	24	50	found	find	VERB
bjos-8647123	24	51	in	in	ADP
bjos-8647123	24	52	the	the	DET
bjos-8647123	24	53	floor	floor	NOUN
bjos-8647123	24	54	of	of	ADP
bjos-8647123	24	55	the	the	DET
bjos-8647123	24	56	mouth	mouth	NOUN
bjos-8647123	24	57	(	(	PUNCT
bjos-8647123	24	58	al	al	PROPN
bjos-8647123	24	59	-	-	PUNCT
bjos-8647123	24	60	kawaz	kawaz	NOUN
bjos-8647123	24	61	,	,	PUNCT
bjos-8647123	24	62	2010)8	2010)8	NUM
bjos-8647123	24	63	.	.	PUNCT
bjos-8647123	25	1	moreover	moreover	ADV
bjos-8647123	25	2	,	,	PUNCT
bjos-8647123	25	3	baghdad	baghdad	PROPN
bjos-8647123	25	4	governorate	governorate	PROPN
bjos-8647123	25	5	was	be	AUX
bjos-8647123	25	6	found	find	VERB
bjos-8647123	25	7	to	to	PART
bjos-8647123	25	8	have	have	VERB
bjos-8647123	25	9	the	the	DET
bjos-8647123	25	10	highest	high	ADJ
bjos-8647123	25	11	prevalence	prevalence	NOUN
bjos-8647123	25	12	of	of	ADP
bjos-8647123	25	13	oscc	oscc	PROPN
bjos-8647123	25	14	(	(	PUNCT
bjos-8647123	25	15	41.08%)8	41.08%)8	NOUN
bjos-8647123	25	16	.	.	PUNCT
bjos-8647123	26	1	mohammed	mohammed	PROPN
bjos-8647123	26	2	et	et	PROPN
bjos-8647123	26	3	al	al	PROPN
bjos-8647123	26	4	.	.	PROPN
bjos-8647123	27	1	(	(	PUNCT
bjos-8647123	27	2	2015)9	2015)9	NUM
bjos-8647123	27	3	,	,	PUNCT
bjos-8647123	27	4	detected	detect	VERB
bjos-8647123	27	5	human	human	NOUN
bjos-8647123	27	6	herpesvirus-1	herpesvirus-1	ADP
bjos-8647123	27	7	antigen	antigen	NOUN
bjos-8647123	27	8	in	in	ADP
bjos-8647123	27	9	oscc	oscc	ADV
bjos-8647123	27	10	and	and	CCONJ
bjos-8647123	27	11	apparently	apparently	ADV
bjos-8647123	27	12	healthy	healthy	ADJ
bjos-8647123	27	13	control	control	NOUN
bjos-8647123	27	14	in	in	ADP
bjos-8647123	27	15	iraq	iraq	PROPN
bjos-8647123	27	16	.	.	PUNCT
bjos-8647123	28	1	the	the	DET
bjos-8647123	28	2	detection	detection	NOUN
bjos-8647123	28	3	of	of	ADP
bjos-8647123	28	4	hhv-1	hhv-1	PUNCT
bjos-8647123	28	5	antigen	antigen	PROPN
bjos-8647123	28	6	,	,	PUNCT
bjos-8647123	28	7	chemicals	chemical	NOUN
bjos-8647123	28	8	and	and	CCONJ
bjos-8647123	28	9	radiation	radiation	NOUN
bjos-8647123	28	10	,	,	PUNCT
bjos-8647123	28	11	found	find	VERB
bjos-8647123	28	12	to	to	PART
bjos-8647123	28	13	play	play	VERB
bjos-8647123	28	14	important	important	ADJ
bjos-8647123	28	15	role	role	NOUN
bjos-8647123	28	16	in	in	ADP
bjos-8647123	28	17	the	the	DET
bjos-8647123	28	18	development	development	NOUN
bjos-8647123	28	19	of	of	ADP
bjos-8647123	28	20	oral	oral	ADJ
bjos-8647123	28	21	cancers	cancer	NOUN
bjos-8647123	28	22	in	in	ADP
bjos-8647123	28	23	iraq	iraq	PROPN
bjos-8647123	28	24	.	.	PUNCT
bjos-8647123	29	1	http://dx.doi.org/10.20396/bjos.v15i1.8647123	http://dx.doi.org/10.20396/bjos.v15i1.8647123	PRON
bjos-8647123	29	2	received	receive	VERB
bjos-8647123	29	3	for	for	ADP
bjos-8647123	29	4	publication	publication	NOUN
bjos-8647123	29	5	:	:	PUNCT
bjos-8647123	29	6	april	april	PROPN
bjos-8647123	29	7	13	13	NUM
bjos-8647123	29	8	,	,	PUNCT
bjos-8647123	29	9	2016	2016	NUM
bjos-8647123	29	10	accepted	accept	VERB
bjos-8647123	29	11	:	:	PUNCT
bjos-8647123	29	12	july	july	PROPN
bjos-8647123	29	13	07	07	NUM
bjos-8647123	29	14	,	,	PUNCT
bjos-8647123	29	15	2016	2016	NUM
bjos-8647123	29	16	52	52	NUM
bjos-8647123	29	17	epidemiological	epidemiological	ADJ
bjos-8647123	29	18	and	and	CCONJ
bjos-8647123	29	19	molecular	molecular	ADJ
bjos-8647123	29	20	studies	study	NOUN
bjos-8647123	29	21	have	have	AUX
bjos-8647123	29	22	determined	determine	VERB
bjos-8647123	29	23	that	that	SCONJ
bjos-8647123	29	24	the	the	DET
bjos-8647123	29	25	persistence	persistence	NOUN
bjos-8647123	29	26	of	of	ADP
bjos-8647123	29	27	infection	infection	NOUN
bjos-8647123	29	28	with	with	ADP
bjos-8647123	29	29	high	high	ADJ
bjos-8647123	29	30	-	-	PUNCT
bjos-8647123	29	31	risk	risk	NOUN
bjos-8647123	29	32	human	human	ADJ
bjos-8647123	29	33	papillomaviruses	papillomaviruse	NOUN
bjos-8647123	29	34	(	(	PUNCT
bjos-8647123	29	35	hr	hr	NOUN
bjos-8647123	29	36	-	-	PUNCT
bjos-8647123	29	37	hpvs	hpvs	NOUN
bjos-8647123	29	38	)	)	PUNCT
bjos-8647123	29	39	types	type	NOUN
bjos-8647123	29	40	is	be	AUX
bjos-8647123	29	41	the	the	DET
bjos-8647123	29	42	most	most	ADV
bjos-8647123	29	43	common	common	ADJ
bjos-8647123	29	44	risk	risk	NOUN
bjos-8647123	29	45	factor	factor	NOUN
bjos-8647123	29	46	for	for	ADP
bjos-8647123	29	47	the	the	DET
bjos-8647123	29	48	development	development	NOUN
bjos-8647123	29	49	of	of	ADP
bjos-8647123	29	50	head	head	NOUN
bjos-8647123	29	51	and	and	CCONJ
bjos-8647123	29	52	neck	neck	NOUN
bjos-8647123	29	53	malignancies10	malignancies10	NOUN
bjos-8647123	29	54	-	-	PUNCT
bjos-8647123	29	55	12	12	NUM
bjos-8647123	29	56	.	.	PUNCT
bjos-8647123	30	1	hpvs	hpv	NOUN
bjos-8647123	30	2	are	be	AUX
bjos-8647123	30	3	small	small	ADJ
bjos-8647123	30	4	non	non	ADJ
bjos-8647123	30	5	-	-	ADJ
bjos-8647123	30	6	enveloped	envelop	VERB
bjos-8647123	30	7	,	,	PUNCT
bjos-8647123	30	8	double	double	ADJ
bjos-8647123	30	9	-	-	PUNCT
bjos-8647123	30	10	stranded	strand	VERB
bjos-8647123	30	11	,	,	PUNCT
bjos-8647123	30	12	circular	circular	ADJ
bjos-8647123	30	13	dna	dna	PROPN
bjos-8647123	30	14	viruses	virus	NOUN
bjos-8647123	30	15	that	that	PRON
bjos-8647123	30	16	encode	encode	VERB
bjos-8647123	30	17	two	two	NUM
bjos-8647123	30	18	viral	viral	ADJ
bjos-8647123	30	19	oncoproteins	oncoprotein	NOUN
bjos-8647123	30	20	,	,	PUNCT
bjos-8647123	30	21	e6	e6	NOUN
bjos-8647123	30	22	and	and	CCONJ
bjos-8647123	30	23	e7	e7	PROPN
bjos-8647123	30	24	.	.	PUNCT
bjos-8647123	31	1	the	the	DET
bjos-8647123	31	2	best	well	ADV
bjos-8647123	31	3	-	-	PUNCT
bjos-8647123	31	4	characteristic	characteristic	ADJ
bjos-8647123	31	5	properties	property	NOUN
bjos-8647123	31	6	of	of	ADP
bjos-8647123	31	7	e6	e6	PROPN
bjos-8647123	31	8	and	and	CCONJ
bjos-8647123	31	9	e7	e7	PROPN
bjos-8647123	31	10	proteins	protein	NOUN
bjos-8647123	31	11	from	from	ADP
bjos-8647123	31	12	hr	hr	NOUN
bjos-8647123	31	13	-	-	PUNCT
bjos-8647123	31	14	hpvs	hpvs	NOUN
bjos-8647123	31	15	are	be	AUX
bjos-8647123	31	16	their	their	PRON
bjos-8647123	31	17	ability	ability	NOUN
bjos-8647123	31	18	to	to	PART
bjos-8647123	31	19	mediate	mediate	VERB
bjos-8647123	31	20	the	the	DET
bjos-8647123	31	21	degradation	degradation	NOUN
bjos-8647123	31	22	of	of	ADP
bjos-8647123	31	23	p53	p53	NOUN
bjos-8647123	31	24	and	and	CCONJ
bjos-8647123	31	25	prb	prb	NOUN
bjos-8647123	31	26	,	,	PUNCT
bjos-8647123	31	27	respectively	respectively	ADV
bjos-8647123	31	28	.	.	PUNCT
bjos-8647123	32	1	these	these	DET
bjos-8647123	32	2	viral	viral	ADJ
bjos-8647123	32	3	proteins	protein	NOUN
bjos-8647123	32	4	also	also	ADV
bjos-8647123	32	5	interact	interact	VERB
bjos-8647123	32	6	with	with	ADP
bjos-8647123	32	7	other	other	ADJ
bjos-8647123	32	8	several	several	ADJ
bjos-8647123	32	9	cellular	cellular	ADJ
bjos-8647123	32	10	factors	factor	NOUN
bjos-8647123	32	11	and	and	CCONJ
bjos-8647123	32	12	lead	lead	VERB
bjos-8647123	32	13	to	to	PART
bjos-8647123	32	14	revoke	revoke	VERB
bjos-8647123	32	15	normal	normal	ADJ
bjos-8647123	32	16	cell	cell	NOUN
bjos-8647123	32	17	cycle	cycle	NOUN
bjos-8647123	32	18	checkpoint	checkpoint	NOUN
bjos-8647123	32	19	stand	stand	VERB
bjos-8647123	32	20	cell	cell	NOUN
bjos-8647123	32	21	death	death	NOUN
bjos-8647123	32	22	mechanisms13	mechanisms13	NOUN
bjos-8647123	32	23	.	.	PUNCT
bjos-8647123	33	1	a	a	DET
bjos-8647123	33	2	possible	possible	ADJ
bjos-8647123	33	3	malignant	malignant	ADJ
bjos-8647123	33	4	disorder	disorder	NOUN
bjos-8647123	33	5	is	be	AUX
bjos-8647123	33	6	the	the	DET
bjos-8647123	33	7	proliferative	proliferative	ADJ
bjos-8647123	33	8	verrucous	verrucous	ADJ
bjos-8647123	33	9	leukoplakia	leukoplakia	NOUN
bjos-8647123	33	10	(	(	PUNCT
bjos-8647123	33	11	pvl	pvl	NOUN
bjos-8647123	33	12	)	)	PUNCT
bjos-8647123	33	13	,	,	PUNCT
bjos-8647123	33	14	which	which	PRON
bjos-8647123	33	15	is	be	AUX
bjos-8647123	33	16	often	often	ADV
bjos-8647123	33	17	undergone	undergo	VERB
bjos-8647123	33	18	malignant	malignant	ADJ
bjos-8647123	33	19	transformation	transformation	NOUN
bjos-8647123	33	20	to	to	ADP
bjos-8647123	33	21	oscc14,15	oscc14,15	PROPN
bjos-8647123	33	22	.	.	PUNCT
bjos-8647123	34	1	akrish	akrish	PROPN
bjos-8647123	34	2	et	et	PROPN
bjos-8647123	34	3	al	al	PROPN
bjos-8647123	34	4	.	.	PROPN
bjos-8647123	34	5	,	,	PUNCT
bjos-8647123	34	6	(	(	PUNCT
bjos-8647123	34	7	2014)16	2014)16	NUM
bjos-8647123	34	8	reported	report	VERB
bjos-8647123	34	9	and	and	CCONJ
bjos-8647123	34	10	compared	compare	VERB
bjos-8647123	34	11	the	the	DET
bjos-8647123	34	12	histologic	histologic	ADJ
bjos-8647123	34	13	,	,	PUNCT
bjos-8647123	34	14	immunohistochemical	immunohistochemical	ADJ
bjos-8647123	34	15	and	and	CCONJ
bjos-8647123	34	16	clinical	clinical	ADJ
bjos-8647123	34	17	features	feature	NOUN
bjos-8647123	34	18	as	as	ADV
bjos-8647123	34	19	well	well	ADV
bjos-8647123	34	20	as	as	ADP
bjos-8647123	34	21	the	the	DET
bjos-8647123	34	22	survival	survival	NOUN
bjos-8647123	34	23	rates	rate	NOUN
bjos-8647123	34	24	of	of	ADP
bjos-8647123	34	25	carcinoma	carcinoma	NOUN
bjos-8647123	34	26	arising	arise	VERB
bjos-8647123	34	27	in	in	ADP
bjos-8647123	34	28	patients	patient	NOUN
bjos-8647123	34	29	with	with	ADP
bjos-8647123	34	30	pvl	pvl	PROPN
bjos-8647123	34	31	(	(	PUNCT
bjos-8647123	34	32	p	p	NOUN
bjos-8647123	34	33	-	-	PUNCT
bjos-8647123	34	34	scca	scca	NOUN
bjos-8647123	34	35	)	)	PUNCT
bjos-8647123	34	36	and	and	CCONJ
bjos-8647123	34	37	conventional	conventional	ADJ
bjos-8647123	34	38	squamous	squamous	ADJ
bjos-8647123	34	39	cell	cell	NOUN
bjos-8647123	34	40	carcinoma	carcinoma	NOUN
bjos-8647123	34	41	(	(	PUNCT
bjos-8647123	34	42	c	c	NOUN
bjos-8647123	34	43	-	-	PUNCT
bjos-8647123	34	44	scca	scca	NOUN
bjos-8647123	34	45	)	)	PUNCT
bjos-8647123	34	46	.	.	PUNCT
bjos-8647123	35	1	the	the	DET
bjos-8647123	35	2	authors	author	NOUN
bjos-8647123	35	3	found	find	VERB
bjos-8647123	35	4	that	that	SCONJ
bjos-8647123	35	5	p	p	PROPN
bjos-8647123	35	6	-	-	PUNCT
bjos-8647123	35	7	scca	scca	PROPN
bjos-8647123	35	8	revealed	reveal	VERB
bjos-8647123	35	9	considerably	considerably	ADV
bjos-8647123	35	10	better	well	ADJ
bjos-8647123	35	11	prognostic	prognostic	ADJ
bjos-8647123	35	12	factors	factor	NOUN
bjos-8647123	35	13	and	and	CCONJ
bjos-8647123	35	14	limited	limited	ADJ
bjos-8647123	35	15	survival	survival	NOUN
bjos-8647123	35	16	rates	rate	NOUN
bjos-8647123	35	17	and	and	CCONJ
bjos-8647123	35	18	longer	long	ADJ
bjos-8647123	35	19	duration	duration	NOUN
bjos-8647123	35	20	of	of	ADP
bjos-8647123	35	21	disease	disease	NOUN
bjos-8647123	35	22	in	in	ADP
bjos-8647123	35	23	compare	compare	NOUN
bjos-8647123	35	24	to	to	ADP
bjos-8647123	35	25	c	c	NOUN
bjos-8647123	35	26	-	-	PUNCT
bjos-8647123	35	27	scca	scca	NOUN
bjos-8647123	35	28	.	.	PUNCT
bjos-8647123	36	1	they	they	PRON
bjos-8647123	36	2	also	also	ADV
bjos-8647123	36	3	suggested	suggest	VERB
bjos-8647123	36	4	that	that	SCONJ
bjos-8647123	36	5	p	p	PROPN
bjos-8647123	36	6	-	-	PUNCT
bjos-8647123	36	7	scca	scca	PROPN
bjos-8647123	36	8	may	may	AUX
bjos-8647123	36	9	show	show	VERB
bjos-8647123	36	10	a	a	DET
bjos-8647123	36	11	distinct	distinct	ADJ
bjos-8647123	36	12	entity	entity	NOUN
bjos-8647123	36	13	,	,	PUNCT
bjos-8647123	36	14	which	which	PRON
bjos-8647123	36	15	may	may	AUX
bjos-8647123	36	16	have	have	VERB
bjos-8647123	36	17	clinical	clinical	ADJ
bjos-8647123	36	18	implications	implication	NOUN
bjos-8647123	36	19	on	on	ADP
bjos-8647123	36	20	treatment16	treatment16	NOUN
bjos-8647123	36	21	.	.	PUNCT
bjos-8647123	37	1	development	development	NOUN
bjos-8647123	37	2	of	of	ADP
bjos-8647123	37	3	most	most	ADJ
bjos-8647123	37	4	solid	solid	ADJ
bjos-8647123	37	5	tumors	tumor	NOUN
bjos-8647123	37	6	is	be	AUX
bjos-8647123	37	7	characterized	characterize	VERB
bjos-8647123	37	8	by	by	ADP
bjos-8647123	37	9	an	an	DET
bjos-8647123	37	10	increase	increase	NOUN
bjos-8647123	37	11	in	in	ADP
bjos-8647123	37	12	secretion	secretion	NOUN
bjos-8647123	37	13	and	and	CCONJ
bjos-8647123	37	14	activation	activation	NOUN
bjos-8647123	37	15	of	of	ADP
bjos-8647123	37	16	matrix	matrix	NOUN
bjos-8647123	37	17	metalloproteinases	metalloproteinase	NOUN
bjos-8647123	37	18	(	(	PUNCT
bjos-8647123	37	19	mmps	mmp	NOUN
bjos-8647123	37	20	)	)	PUNCT
bjos-8647123	37	21	produced	produce	VERB
bjos-8647123	37	22	by	by	ADP
bjos-8647123	37	23	either	either	CCONJ
bjos-8647123	37	24	the	the	DET
bjos-8647123	37	25	tumor	tumor	NOUN
bjos-8647123	37	26	cells	cell	NOUN
bjos-8647123	37	27	or	or	CCONJ
bjos-8647123	37	28	tumor	tumor	NOUN
bjos-8647123	37	29	-	-	PUNCT
bjos-8647123	37	30	associated	associate	VERB
bjos-8647123	37	31	fibroblasts	fibroblast	NOUN
bjos-8647123	37	32	.	.	PUNCT
bjos-8647123	38	1	these	these	DET
bjos-8647123	38	2	proteins	protein	NOUN
bjos-8647123	38	3	play	play	VERB
bjos-8647123	38	4	a	a	DET
bjos-8647123	38	5	master	master	NOUN
bjos-8647123	38	6	role	role	NOUN
bjos-8647123	38	7	in	in	ADP
bjos-8647123	38	8	diverse	diverse	ADJ
bjos-8647123	38	9	physiological	physiological	ADJ
bjos-8647123	38	10	processes	process	NOUN
bjos-8647123	38	11	and	and	CCONJ
bjos-8647123	38	12	diseases	disease	NOUN
bjos-8647123	38	13	such	such	ADJ
bjos-8647123	38	14	as	as	ADP
bjos-8647123	38	15	the	the	DET
bjos-8647123	38	16	homeostatic	homeostatic	ADJ
bjos-8647123	38	17	tissue	tissue	NOUN
bjos-8647123	38	18	remodeling	remodeling	NOUN
bjos-8647123	38	19	and	and	CCONJ
bjos-8647123	38	20	cancer17	cancer17	ADJ
bjos-8647123	38	21	.	.	PUNCT
bjos-8647123	39	1	proteolytic	proteolytic	ADJ
bjos-8647123	39	2	activity	activity	NOUN
bjos-8647123	39	3	of	of	ADP
bjos-8647123	39	4	mmps	mmp	NOUN
bjos-8647123	39	5	can	can	AUX
bjos-8647123	39	6	be	be	AUX
bjos-8647123	39	7	regulated	regulate	VERB
bjos-8647123	39	8	at	at	ADP
bjos-8647123	39	9	different	different	ADJ
bjos-8647123	39	10	levels	level	NOUN
bjos-8647123	39	11	including	include	VERB
bjos-8647123	39	12	gene	gene	NOUN
bjos-8647123	39	13	expression	expression	NOUN
bjos-8647123	39	14	,	,	PUNCT
bjos-8647123	39	15	protein	protein	NOUN
bjos-8647123	39	16	compartmentalization	compartmentalization	NOUN
bjos-8647123	39	17	zymogen	zymogen	NOUN
bjos-8647123	39	18	to	to	ADP
bjos-8647123	39	19	active	active	ADJ
bjos-8647123	39	20	enzyme	enzyme	NOUN
bjos-8647123	39	21	conversion	conversion	NOUN
bjos-8647123	39	22	and	and	CCONJ
bjos-8647123	39	23	the	the	DET
bjos-8647123	39	24	presence	presence	NOUN
bjos-8647123	39	25	of	of	ADP
bjos-8647123	39	26	specific	specific	ADJ
bjos-8647123	39	27	inhibitors18	inhibitors18	NOUN
bjos-8647123	39	28	.	.	PUNCT
bjos-8647123	40	1	tissue	tissue	NOUN
bjos-8647123	40	2	or	or	CCONJ
bjos-8647123	40	3	extracellular	extracellular	ADJ
bjos-8647123	40	4	mmps	mmp	NOUN
bjos-8647123	40	5	are	be	AUX
bjos-8647123	40	6	regulated	regulate	VERB
bjos-8647123	40	7	by	by	ADP
bjos-8647123	40	8	endogenous	endogenous	ADJ
bjos-8647123	40	9	inhibitors	inhibitor	NOUN
bjos-8647123	40	10	named	name	VERB
bjos-8647123	40	11	tissue	tissue	NOUN
bjos-8647123	40	12	inhibitor	inhibitor	NOUN
bjos-8647123	40	13	metalloproteinase	metalloproteinase	NOUN
bjos-8647123	40	14	family	family	NOUN
bjos-8647123	40	15	1	1	NUM
bjos-8647123	40	16	to	to	ADP
bjos-8647123	40	17	4	4	NUM
bjos-8647123	40	18	(	(	PUNCT
bjos-8647123	40	19	timp-1	timp-1	NOUN
bjos-8647123	40	20	-	-	SYM
bjos-8647123	40	21	4	4	NUM
bjos-8647123	40	22	)	)	PUNCT
bjos-8647123	40	23	.	.	PUNCT
bjos-8647123	41	1	among	among	ADP
bjos-8647123	41	2	them	they	PRON
bjos-8647123	41	3	,	,	PUNCT
bjos-8647123	41	4	timp-2	timp-2	PROPN
bjos-8647123	41	5	is	be	AUX
bjos-8647123	41	6	unique	unique	ADJ
bjos-8647123	41	7	because	because	SCONJ
bjos-8647123	41	8	it	it	PRON
bjos-8647123	41	9	may	may	AUX
bjos-8647123	41	10	function	function	VERB
bjos-8647123	41	11	both	both	PRON
bjos-8647123	41	12	as	as	ADP
bjos-8647123	41	13	an	an	DET
bjos-8647123	41	14	mmp	mmp	NOUN
bjos-8647123	41	15	activator	activator	NOUN
bjos-8647123	41	16	and	and	CCONJ
bjos-8647123	41	17	inhibitor17	inhibitor17	NOUN
bjos-8647123	41	18	.	.	PUNCT
bjos-8647123	42	1	although	although	SCONJ
bjos-8647123	42	2	timps	timp	NOUN
bjos-8647123	42	3	are	be	AUX
bjos-8647123	42	4	known	know	VERB
bjos-8647123	42	5	to	to	PART
bjos-8647123	42	6	act	act	VERB
bjos-8647123	42	7	as	as	ADP
bjos-8647123	42	8	inhibitors	inhibitor	NOUN
bjos-8647123	42	9	of	of	ADP
bjos-8647123	42	10	mmps	mmp	NOUN
bjos-8647123	42	11	,	,	PUNCT
bjos-8647123	42	12	they	they	PRON
bjos-8647123	42	13	exhibit	exhibit	VERB
bjos-8647123	42	14	other	other	ADJ
bjos-8647123	42	15	biological	biological	ADJ
bjos-8647123	42	16	functions	function	NOUN
bjos-8647123	42	17	.	.	PUNCT
bjos-8647123	43	1	indeed	indeed	ADV
bjos-8647123	43	2	,	,	PUNCT
bjos-8647123	43	3	timps	timp	NOUN
bjos-8647123	43	4	play	play	VERB
bjos-8647123	43	5	complex	complex	ADJ
bjos-8647123	43	6	divergent	divergent	ADJ
bjos-8647123	43	7	roles	role	NOUN
bjos-8647123	43	8	in	in	ADP
bjos-8647123	43	9	metastasis	metastasis	NOUN
bjos-8647123	43	10	,	,	PUNCT
bjos-8647123	43	11	functioning	function	VERB
bjos-8647123	43	12	both	both	PRON
bjos-8647123	43	13	as	as	ADP
bjos-8647123	43	14	anti	anti	ADJ
bjos-8647123	43	15	-	-	ADJ
bjos-8647123	43	16	invasive	invasive	ADJ
bjos-8647123	43	17	agents	agent	NOUN
bjos-8647123	43	18	and	and	CCONJ
bjos-8647123	43	19	as	as	ADP
bjos-8647123	43	20	prognostic	prognostic	ADJ
bjos-8647123	43	21	indicators	indicator	NOUN
bjos-8647123	43	22	.	.	PUNCT
bjos-8647123	44	1	another	another	DET
bjos-8647123	44	2	study	study	NOUN
bjos-8647123	44	3	suggested	suggest	VERB
bjos-8647123	44	4	that	that	SCONJ
bjos-8647123	44	5	the	the	DET
bjos-8647123	44	6	overexpression	overexpression	NOUN
bjos-8647123	44	7	of	of	ADP
bjos-8647123	44	8	timps	timp	NOUN
bjos-8647123	44	9	is	be	AUX
bjos-8647123	44	10	correlated	correlate	VERB
bjos-8647123	44	11	with	with	ADP
bjos-8647123	44	12	poor	poor	ADJ
bjos-8647123	44	13	outcome	outcome	NOUN
bjos-8647123	44	14	in	in	ADP
bjos-8647123	44	15	colorectal	colorectal	ADJ
bjos-8647123	44	16	and	and	CCONJ
bjos-8647123	44	17	breast	breast	NOUN
bjos-8647123	44	18	carcinomas18	carcinomas18	NOUN
bjos-8647123	44	19	.	.	PUNCT
bjos-8647123	45	1	in	in	ADP
bjos-8647123	45	2	oscc	oscc	ADJ
bjos-8647123	45	3	,	,	PUNCT
bjos-8647123	45	4	mmp-9	mmp-9	NOUN
bjos-8647123	45	5	and	and	CCONJ
bjos-8647123	45	6	timp-2	timp-2	NUM
bjos-8647123	45	7	expressions	expression	NOUN
bjos-8647123	45	8	have	have	AUX
bjos-8647123	45	9	shown	show	VERB
bjos-8647123	45	10	a	a	DET
bjos-8647123	45	11	predictive	predictive	ADJ
bjos-8647123	45	12	value	value	NOUN
bjos-8647123	45	13	for	for	ADP
bjos-8647123	45	14	tumor	tumor	NOUN
bjos-8647123	45	15	metastases	metastasis	NOUN
bjos-8647123	45	16	and	and	CCONJ
bjos-8647123	45	17	cause	cause	NOUN
bjos-8647123	45	18	-	-	PUNCT
bjos-8647123	45	19	specific	specific	ADJ
bjos-8647123	45	20	survival	survival	NOUN
bjos-8647123	45	21	.	.	PUNCT
bjos-8647123	46	1	as	as	ADP
bjos-8647123	46	2	in	in	ADP
bjos-8647123	46	3	other	other	ADJ
bjos-8647123	46	4	tissue	tissue	NOUN
bjos-8647123	46	5	carcinomas	carcinoma	NOUN
bjos-8647123	46	6	,	,	PUNCT
bjos-8647123	46	7	high	high	ADJ
bjos-8647123	46	8	expression	expression	NOUN
bjos-8647123	46	9	of	of	ADP
bjos-8647123	46	10	timp-2	timp-2	PROPN
bjos-8647123	46	11	is	be	AUX
bjos-8647123	46	12	the	the	DET
bjos-8647123	46	13	most	most	ADV
bjos-8647123	46	14	independent	independent	ADJ
bjos-8647123	46	15	factor	factor	NOUN
bjos-8647123	46	16	for	for	ADP
bjos-8647123	46	17	worse	bad	ADJ
bjos-8647123	46	18	prognosis	prognosis	NOUN
bjos-8647123	46	19	in	in	ADP
bjos-8647123	46	20	early	early	ADJ
bjos-8647123	46	21	-	-	PUNCT
bjos-8647123	46	22	stage	stage	NOUN
bjos-8647123	46	23	oral	oral	ADJ
bjos-8647123	46	24	scc10,12,17	scc10,12,17	NOUN
bjos-8647123	46	25	.	.	PUNCT
bjos-8647123	47	1	however	however	ADV
bjos-8647123	47	2	,	,	PUNCT
bjos-8647123	47	3	expression	expression	NOUN
bjos-8647123	47	4	of	of	ADP
bjos-8647123	47	5	timp-2	timp-2	PROPN
bjos-8647123	47	6	(	(	PUNCT
bjos-8647123	47	7	mmp	mmp	PROPN
bjos-8647123	47	8	)	)	PUNCT
bjos-8647123	47	9	in	in	ADP
bjos-8647123	47	10	hpv-16	hpv-16	NUM
bjos-8647123	47	11	infected	infect	VERB
bjos-8647123	47	12	oscc	oscc	ADJ
bjos-8647123	47	13	patients	patient	NOUN
bjos-8647123	47	14	is	be	AUX
bjos-8647123	47	15	still	still	ADV
bjos-8647123	47	16	incomplete	incomplete	ADJ
bjos-8647123	47	17	and	and	CCONJ
bjos-8647123	47	18	needs	need	VERB
bjos-8647123	47	19	further	further	ADJ
bjos-8647123	47	20	investigations14	investigations14	NOUN
bjos-8647123	47	21	,	,	PUNCT
bjos-8647123	47	22	whereas	whereas	SCONJ
bjos-8647123	47	23	,	,	PUNCT
bjos-8647123	47	24	the	the	DET
bjos-8647123	47	25	reliable	reliable	ADJ
bjos-8647123	47	26	markers	marker	NOUN
bjos-8647123	47	27	for	for	ADP
bjos-8647123	47	28	progression	progression	NOUN
bjos-8647123	47	29	of	of	ADP
bjos-8647123	47	30	high	high	ADJ
bjos-8647123	47	31	-	-	PUNCT
bjos-8647123	47	32	risk	risk	NOUN
bjos-8647123	47	33	hpvinfected	hpvinfecte	VERB
bjos-8647123	47	34	epithelium	epithelium	NOUN
bjos-8647123	47	35	to	to	ADP
bjos-8647123	47	36	malignancy	malignancy	NOUN
bjos-8647123	47	37	are	be	AUX
bjos-8647123	47	38	not	not	PART
bjos-8647123	47	39	yet	yet	ADV
bjos-8647123	47	40	available19	available19	NOUN
bjos-8647123	47	41	.	.	PUNCT
bjos-8647123	48	1	chandolia	chandolia	PROPN
bjos-8647123	48	2	et	et	PROPN
bjos-8647123	48	3	al	al	PROPN
bjos-8647123	48	4	.	.	PROPN
bjos-8647123	48	5	,	,	PUNCT
bjos-8647123	48	6	(	(	PUNCT
bjos-8647123	48	7	2016)20	2016)20	NUM
bjos-8647123	48	8	also	also	ADV
bjos-8647123	48	9	approved	approve	VERB
bjos-8647123	48	10	that	that	SCONJ
bjos-8647123	48	11	oscc	oscc	PROPN
bjos-8647123	48	12	shows	show	VERB
bjos-8647123	48	13	higher	high	ADJ
bjos-8647123	48	14	mmp-9	mmp-9	NOUN
bjos-8647123	48	15	expression	expression	NOUN
bjos-8647123	48	16	as	as	SCONJ
bjos-8647123	48	17	compared	compare	VERB
bjos-8647123	48	18	to	to	ADP
bjos-8647123	48	19	oral	oral	ADJ
bjos-8647123	48	20	epithelial	epithelial	ADJ
bjos-8647123	48	21	dysplasia	dysplasia	NOUN
bjos-8647123	48	22	followed	follow	VERB
bjos-8647123	48	23	by	by	ADP
bjos-8647123	48	24	epithelium	epithelium	NOUN
bjos-8647123	48	25	from	from	ADP
bjos-8647123	48	26	normal	normal	ADJ
bjos-8647123	48	27	oral	oral	ADJ
bjos-8647123	48	28	mucosa	mucosa	NOUN
bjos-8647123	48	29	.	.	PUNCT
bjos-8647123	49	1	however	however	ADV
bjos-8647123	49	2	,	,	PUNCT
bjos-8647123	49	3	no	no	DET
bjos-8647123	49	4	correlation	correlation	NOUN
bjos-8647123	49	5	was	be	AUX
bjos-8647123	49	6	found	find	VERB
bjos-8647123	49	7	between	between	ADP
bjos-8647123	49	8	the	the	DET
bjos-8647123	49	9	histological	histological	ADJ
bjos-8647123	49	10	grades	grade	NOUN
bjos-8647123	49	11	of	of	ADP
bjos-8647123	49	12	oscc	oscc	ADJ
bjos-8647123	49	13	.	.	PUNCT
bjos-8647123	50	1	a	a	DET
bjos-8647123	50	2	previous	previous	ADJ
bjos-8647123	50	3	immunohistochemical	immunohistochemical	ADJ
bjos-8647123	50	4	study	study	NOUN
bjos-8647123	50	5	reported	report	VERB
bjos-8647123	50	6	the	the	DET
bjos-8647123	50	7	presence	presence	NOUN
bjos-8647123	50	8	of	of	ADP
bjos-8647123	50	9	hpv	hpv	ADJ
bjos-8647123	50	10	type	type	NOUN
bjos-8647123	50	11	16	16	NUM
bjos-8647123	50	12	infected	infect	VERB
bjos-8647123	50	13	patients	patient	NOUN
bjos-8647123	50	14	with	with	ADP
bjos-8647123	50	15	oscc	oscc	NOUN
bjos-8647123	50	16	in	in	ADP
bjos-8647123	50	17	iraq21	iraq21	NOUN
bjos-8647123	50	18	.	.	PUNCT
bjos-8647123	51	1	overexpression	overexpression	NOUN
bjos-8647123	51	2	of	of	ADP
bjos-8647123	51	3	p53	p53	NOUN
bjos-8647123	51	4	tumor	tumor	NOUN
bjos-8647123	51	5	suppressor	suppressor	NOUN
bjos-8647123	51	6	gene	gene	NOUN
bjos-8647123	51	7	showed	show	VERB
bjos-8647123	51	8	significant	significant	ADJ
bjos-8647123	51	9	prevalence	prevalence	NOUN
bjos-8647123	51	10	of	of	ADP
bjos-8647123	51	11	high	high	ADJ
bjos-8647123	51	12	oncogenic	oncogenic	ADJ
bjos-8647123	51	13	hpv	hpv	ADJ
bjos-8647123	51	14	genotypes	genotype	NOUN
bjos-8647123	51	15	in	in	ADP
bjos-8647123	51	16	patients	patient	NOUN
bjos-8647123	51	17	with	with	ADP
bjos-8647123	51	18	oscc	oscc	NOUN
bjos-8647123	51	19	in	in	ADP
bjos-8647123	51	20	iraq	iraq	PROPN
bjos-8647123	51	21	.	.	PUNCT
bjos-8647123	52	1	they	they	PRON
bjos-8647123	52	2	found	find	VERB
bjos-8647123	52	3	herald	herald	NOUN
bjos-8647123	52	4	marks	mark	NOUN
bjos-8647123	52	5	for	for	ADP
bjos-8647123	52	6	the	the	DET
bjos-8647123	52	7	spread	spread	NOUN
bjos-8647123	52	8	of	of	ADP
bjos-8647123	52	9	hpv	hpv	NOUN
bjos-8647123	52	10	among	among	ADP
bjos-8647123	52	11	iraqi	iraqi	ADJ
bjos-8647123	52	12	general	general	ADJ
bjos-8647123	52	13	population	population	NOUN
bjos-8647123	52	14	,	,	PUNCT
bjos-8647123	52	15	which	which	PRON
bjos-8647123	52	16	played	play	VERB
bjos-8647123	52	17	an	an	DET
bjos-8647123	52	18	important	important	ADJ
bjos-8647123	52	19	role	role	NOUN
bjos-8647123	52	20	in	in	ADP
bjos-8647123	52	21	oral	oral	ADJ
bjos-8647123	52	22	carcinogenesis21	carcinogenesis21	NOUN
bjos-8647123	52	23	.	.	PUNCT
bjos-8647123	53	1	the	the	DET
bjos-8647123	53	2	expressions	expression	NOUN
bjos-8647123	53	3	of	of	ADP
bjos-8647123	53	4	p53	p53	NOUN
bjos-8647123	53	5	and	and	CCONJ
bjos-8647123	53	6	its	its	PRON
bjos-8647123	53	7	related	related	ADJ
bjos-8647123	53	8	gene	gene	NOUN
bjos-8647123	53	9	expression	expression	NOUN
bjos-8647123	53	10	of	of	ADP
bjos-8647123	53	11	timp-2	timp-2	NUM
bjos-8647123	53	12	in	in	ADP
bjos-8647123	53	13	hpv-16	hpv-16	NUM
bjos-8647123	53	14	infected	infect	VERB
bjos-8647123	53	15	oral	oral	ADJ
bjos-8647123	53	16	squamous	squamous	ADJ
bjos-8647123	53	17	cell	cell	NOUN
bjos-8647123	53	18	carcinoma	carcinoma	NOUN
bjos-8647123	53	19	in	in	ADP
bjos-8647123	53	20	patients	patient	NOUN
bjos-8647123	53	21	in	in	ADP
bjos-8647123	53	22	iraq	iraq	PROPN
bjos-8647123	53	23	braz	braz	PROPN
bjos-8647123	53	24	j	j	PROPN
bjos-8647123	53	25	oral	oral	PROPN
bjos-8647123	53	26	sci	sci	PROPN
bjos-8647123	53	27	.	.	PUNCT
bjos-8647123	54	1	15(1):51	15(1):51	NUM
bjos-8647123	54	2	-	-	SYM
bjos-8647123	54	3	56	56	NUM
bjos-8647123	54	4	mdm4	mdm4	NOUN
bjos-8647123	54	5	in	in	ADP
bjos-8647123	54	6	oral	oral	ADJ
bjos-8647123	54	7	,	,	PUNCT
bjos-8647123	54	8	laryngeal	laryngeal	ADJ
bjos-8647123	54	9	and	and	CCONJ
bjos-8647123	54	10	cutaneous	cutaneous	ADJ
bjos-8647123	54	11	squamous	squamous	ADJ
bjos-8647123	54	12	cell	cell	NOUN
bjos-8647123	54	13	carcinoma	carcinoma	NOUN
bjos-8647123	54	14	have	have	AUX
bjos-8647123	54	15	also	also	ADV
bjos-8647123	54	16	been	be	AUX
bjos-8647123	54	17	investigated	investigate	VERB
bjos-8647123	54	18	using	use	VERB
bjos-8647123	54	19	tissue	tissue	NOUN
bjos-8647123	54	20	microarray	microarray	NOUN
bjos-8647123	54	21	in	in	ADP
bjos-8647123	54	22	iraq22	iraq22	ADJ
bjos-8647123	54	23	.	.	PUNCT
bjos-8647123	55	1	it	it	PRON
bjos-8647123	55	2	was	be	AUX
bjos-8647123	55	3	found	find	VERB
bjos-8647123	55	4	that	that	SCONJ
bjos-8647123	55	5	p53	p53	NOUN
bjos-8647123	55	6	and	and	CCONJ
bjos-8647123	55	7	mdm4	mdm4	PROPN
bjos-8647123	55	8	were	be	AUX
bjos-8647123	55	9	frequently	frequently	ADV
bjos-8647123	55	10	overexpressed	overexpresse	VERB
bjos-8647123	55	11	in	in	ADP
bjos-8647123	55	12	scc	scc	NOUN
bjos-8647123	55	13	cases	case	NOUN
bjos-8647123	55	14	with	with	ADP
bjos-8647123	55	15	significant	significant	ADJ
bjos-8647123	55	16	correlation	correlation	NOUN
bjos-8647123	55	17	between	between	ADP
bjos-8647123	55	18	these	these	DET
bjos-8647123	55	19	markers	marker	NOUN
bjos-8647123	55	20	,	,	PUNCT
bjos-8647123	55	21	which	which	PRON
bjos-8647123	55	22	was	be	AUX
bjos-8647123	55	23	considered	consider	VERB
bjos-8647123	55	24	as	as	ADP
bjos-8647123	55	25	an	an	DET
bjos-8647123	55	26	indicator	indicator	NOUN
bjos-8647123	55	27	for	for	ADP
bjos-8647123	55	28	prognostic	prognostic	ADJ
bjos-8647123	55	29	factor	factor	NOUN
bjos-8647123	55	30	in	in	ADP
bjos-8647123	55	31	regard	regard	NOUN
bjos-8647123	55	32	to	to	ADP
bjos-8647123	55	33	tumor	tumor	NOUN
bjos-8647123	55	34	grading22	grading22	NOUN
bjos-8647123	55	35	.	.	PUNCT
bjos-8647123	56	1	several	several	ADJ
bjos-8647123	56	2	molecular	molecular	ADJ
bjos-8647123	56	3	markers	marker	NOUN
bjos-8647123	56	4	have	have	AUX
bjos-8647123	56	5	been	be	AUX
bjos-8647123	56	6	suggested	suggest	VERB
bjos-8647123	56	7	as	as	ADP
bjos-8647123	56	8	reliable	reliable	ADJ
bjos-8647123	56	9	prognostic	prognostic	ADJ
bjos-8647123	56	10	cancer	cancer	NOUN
bjos-8647123	56	11	biomarkers	biomarker	NOUN
bjos-8647123	56	12	for	for	ADP
bjos-8647123	56	13	the	the	DET
bjos-8647123	56	14	classification	classification	NOUN
bjos-8647123	56	15	of	of	ADP
bjos-8647123	56	16	oscc19,21	oscc19,21	NOUN
bjos-8647123	56	17	-	-	PUNCT
bjos-8647123	56	18	26	26	NUM
bjos-8647123	56	19	.	.	PUNCT
bjos-8647123	57	1	considering	consider	VERB
bjos-8647123	57	2	all	all	DET
bjos-8647123	57	3	the	the	DET
bjos-8647123	57	4	previous	previous	ADJ
bjos-8647123	57	5	facts	fact	NOUN
bjos-8647123	57	6	regarding	regard	VERB
bjos-8647123	57	7	ossc	ossc	NOUN
bjos-8647123	57	8	in	in	ADP
bjos-8647123	57	9	iraq	iraq	PROPN
bjos-8647123	57	10	,	,	PUNCT
bjos-8647123	57	11	this	this	DET
bjos-8647123	57	12	study	study	NOUN
bjos-8647123	57	13	intended	intend	VERB
bjos-8647123	57	14	to	to	PART
bjos-8647123	57	15	investigate	investigate	VERB
bjos-8647123	57	16	the	the	DET
bjos-8647123	57	17	expression	expression	NOUN
bjos-8647123	57	18	of	of	ADP
bjos-8647123	57	19	timp-2	timp-2	PROPN
bjos-8647123	57	20	,	,	PUNCT
bjos-8647123	57	21	and	and	CCONJ
bjos-8647123	57	22	the	the	DET
bjos-8647123	57	23	difference	difference	NOUN
bjos-8647123	57	24	in	in	ADP
bjos-8647123	57	25	its	its	PRON
bjos-8647123	57	26	expression	expression	NOUN
bjos-8647123	57	27	level	level	NOUN
bjos-8647123	57	28	between	between	ADP
bjos-8647123	57	29	positive	positive	ADJ
bjos-8647123	57	30	and	and	CCONJ
bjos-8647123	57	31	negative	negative	ADJ
bjos-8647123	57	32	hpv-16	hpv-16	NUM
bjos-8647123	57	33	oscc	oscc	ADJ
bjos-8647123	57	34	cases	case	NOUN
bjos-8647123	57	35	.	.	PUNCT
bjos-8647123	58	1	material	material	NOUN
bjos-8647123	58	2	and	and	CCONJ
bjos-8647123	58	3	methods	method	NOUN
bjos-8647123	58	4	sample	sample	NOUN
bjos-8647123	58	5	collection	collection	NOUN
bjos-8647123	58	6	the	the	DET
bjos-8647123	58	7	study	study	NOUN
bjos-8647123	58	8	was	be	AUX
bjos-8647123	58	9	conducted	conduct	VERB
bjos-8647123	58	10	on	on	ADP
bjos-8647123	58	11	33	33	NUM
bjos-8647123	58	12	retrospective	retrospective	ADJ
bjos-8647123	58	13	cases	case	NOUN
bjos-8647123	58	14	of	of	ADP
bjos-8647123	58	15	ossc	ossc	NOUN
bjos-8647123	58	16	taken	take	VERB
bjos-8647123	58	17	from	from	ADP
bjos-8647123	58	18	the	the	DET
bjos-8647123	58	19	maxillofacial	maxillofacial	ADJ
bjos-8647123	58	20	center	center	NOUN
bjos-8647123	58	21	in	in	ADP
bjos-8647123	58	22	surgical	surgical	ADJ
bjos-8647123	58	23	specialty	specialty	NOUN
bjos-8647123	58	24	hospital	hospital	NOUN
bjos-8647123	58	25	in	in	ADP
bjos-8647123	58	26	baghdad	baghdad	PROPN
bjos-8647123	58	27	between	between	ADP
bjos-8647123	58	28	2007	2007	NUM
bjos-8647123	58	29	and	and	CCONJ
bjos-8647123	58	30	2009	2009	NUM
bjos-8647123	58	31	.	.	PUNCT
bjos-8647123	59	1	the	the	DET
bjos-8647123	59	2	age	age	NOUN
bjos-8647123	59	3	of	of	ADP
bjos-8647123	59	4	patients	patient	NOUN
bjos-8647123	59	5	ranged	range	VERB
bjos-8647123	59	6	between	between	ADP
bjos-8647123	59	7	30	30	NUM
bjos-8647123	59	8	and	and	CCONJ
bjos-8647123	59	9	95	95	NUM
bjos-8647123	59	10	years	year	NOUN
bjos-8647123	59	11	.	.	PUNCT
bjos-8647123	60	1	none	none	NOUN
bjos-8647123	60	2	of	of	ADP
bjos-8647123	60	3	the	the	DET
bjos-8647123	60	4	cases	case	NOUN
bjos-8647123	60	5	had	have	AUX
bjos-8647123	60	6	received	receive	VERB
bjos-8647123	60	7	radiotherapy	radiotherapy	NOUN
bjos-8647123	60	8	or	or	CCONJ
bjos-8647123	60	9	chemotherapy	chemotherapy	NOUN
bjos-8647123	60	10	.	.	PUNCT
bjos-8647123	61	1	as	as	ADP
bjos-8647123	61	2	negative	negative	ADJ
bjos-8647123	61	3	controls	control	NOUN
bjos-8647123	61	4	,	,	PUNCT
bjos-8647123	61	5	ten	ten	NUM
bjos-8647123	61	6	normal	normal	ADJ
bjos-8647123	61	7	oral	oral	ADJ
bjos-8647123	61	8	tissues	tissue	NOUN
bjos-8647123	61	9	,	,	PUNCT
bjos-8647123	61	10	were	be	AUX
bjos-8647123	61	11	obtained	obtain	VERB
bjos-8647123	61	12	from	from	ADP
bjos-8647123	61	13	a	a	DET
bjos-8647123	61	14	buccal	buccal	ADJ
bjos-8647123	61	15	mucosa	mucosa	NOUN
bjos-8647123	61	16	of	of	ADP
bjos-8647123	61	17	individuals	individual	NOUN
bjos-8647123	61	18	underwent	undergo	VERB
bjos-8647123	61	19	plastic	plastic	ADJ
bjos-8647123	61	20	surgery	surgery	NOUN
bjos-8647123	61	21	at	at	ADP
bjos-8647123	61	22	the	the	DET
bjos-8647123	61	23	same	same	ADJ
bjos-8647123	61	24	hospital	hospital	NOUN
bjos-8647123	61	25	.	.	PUNCT
bjos-8647123	62	1	this	this	DET
bjos-8647123	62	2	study	study	NOUN
bjos-8647123	62	3	was	be	AUX
bjos-8647123	62	4	approved	approve	VERB
bjos-8647123	62	5	by	by	ADP
bjos-8647123	62	6	the	the	DET
bjos-8647123	62	7	ethical	ethical	PROPN
bjos-8647123	62	8	committee	committee	PROPN
bjos-8647123	62	9	/	/	SYM
bjos-8647123	62	10	college	college	NOUN
bjos-8647123	62	11	of	of	ADP
bjos-8647123	62	12	the	the	DET
bjos-8647123	62	13	medicine/	medicine/	NUM
bjos-8647123	62	14	university	university	NOUN
bjos-8647123	62	15	of	of	ADP
bjos-8647123	62	16	baghdad	baghdad	PROPN
bjos-8647123	62	17	(	(	PUNCT
bjos-8647123	62	18	no.2012	no.2012	PROPN
bjos-8647123	62	19	,	,	PUNCT
bjos-8647123	62	20	11	11	NUM
bjos-8647123	62	21	-	-	SYM
bjos-8647123	62	22	12	12	NUM
bjos-8647123	62	23	ar	ar	NOUN
bjos-8647123	62	24	)	)	PUNCT
bjos-8647123	62	25	.	.	PUNCT
bjos-8647123	63	1	the	the	DET
bjos-8647123	63	2	expression	expression	NOUN
bjos-8647123	63	3	of	of	ADP
bjos-8647123	63	4	hpv-16	hpv-16	PRON
bjos-8647123	63	5	and	and	CCONJ
bjos-8647123	63	6	timp-2	timp-2	PROPN
bjos-8647123	63	7	were	be	AUX
bjos-8647123	63	8	investigated	investigate	VERB
bjos-8647123	63	9	using	use	VERB
bjos-8647123	63	10	in	in	ADP
bjos-8647123	63	11	situ	situ	ADJ
bjos-8647123	63	12	hybridization	hybridization	NOUN
bjos-8647123	63	13	(	(	PUNCT
bjos-8647123	63	14	ish	ish	PROPN
bjos-8647123	63	15	)	)	PUNCT
bjos-8647123	63	16	and	and	CCONJ
bjos-8647123	63	17	immunohistochemistry	immunohistochemistry	NOUN
bjos-8647123	63	18	(	(	PUNCT
bjos-8647123	63	19	ihc	ihc	PROPN
bjos-8647123	63	20	)	)	PUNCT
bjos-8647123	63	21	respectively	respectively	ADV
bjos-8647123	63	22	.	.	PUNCT
bjos-8647123	64	1	immunohistochemistry	immunohistochemistry	NOUN
bjos-8647123	64	2	fixed	fix	VERB
bjos-8647123	64	3	paraffin	paraffin	NOUN
bjos-8647123	64	4	tumor	tumor	NOUN
bjos-8647123	64	5	and	and	CCONJ
bjos-8647123	64	6	control	control	NOUN
bjos-8647123	64	7	tissues	tissue	NOUN
bjos-8647123	64	8	were	be	AUX
bjos-8647123	64	9	sectioned	section	VERB
bjos-8647123	64	10	into	into	ADP
bjos-8647123	64	11	5	5	NUM
bjos-8647123	64	12	µm	µm	ADP
bjos-8647123	64	13	thickness	thickness	NOUN
bjos-8647123	64	14	and	and	CCONJ
bjos-8647123	64	15	stained	stain	VERB
bjos-8647123	64	16	according	accord	VERB
bjos-8647123	64	17	to	to	ADP
bjos-8647123	64	18	the	the	DET
bjos-8647123	64	19	timp-2	timp-2	PROPN
bjos-8647123	64	20	kit	kit	NOUN
bjos-8647123	64	21	manufacture	manufacture	NOUN
bjos-8647123	64	22	’s	’s	PART
bjos-8647123	64	23	protocol	protocol	NOUN
bjos-8647123	64	24	(	(	PUNCT
bjos-8647123	64	25	chemicon	chemicon	PROPN
bjos-8647123	64	26	international	international	PROPN
bjos-8647123	64	27	,	,	PUNCT
bjos-8647123	64	28	usa	usa	PROPN
bjos-8647123	64	29	)	)	PUNCT
bjos-8647123	64	30	.	.	PUNCT
bjos-8647123	65	1	the	the	DET
bjos-8647123	65	2	slides	slide	NOUN
bjos-8647123	65	3	were	be	AUX
bjos-8647123	65	4	placed	place	VERB
bjos-8647123	65	5	in	in	ADP
bjos-8647123	65	6	10	10	NUM
bjos-8647123	65	7	mm	mm	PROPN
bjos-8647123	65	8	citric	citric	ADJ
bjos-8647123	65	9	acid	acid	NOUN
bjos-8647123	65	10	buffer	buffer	NOUN
bjos-8647123	65	11	at	at	ADP
bjos-8647123	65	12	ph	ph	PROPN
bjos-8647123	65	13	6.0	6.0	NUM
bjos-8647123	65	14	and	and	CCONJ
bjos-8647123	65	15	underwent	undergo	VERB
bjos-8647123	65	16	antigen	antigen	ADJ
bjos-8647123	65	17	retrieval	retrieval	NOUN
bjos-8647123	65	18	for	for	ADP
bjos-8647123	65	19	10	10	NUM
bjos-8647123	65	20	min	min	NOUN
bjos-8647123	65	21	at	at	ADP
bjos-8647123	65	22	680	680	NUM
bjos-8647123	65	23	w	w	NOUN
bjos-8647123	65	24	in	in	ADP
bjos-8647123	65	25	a	a	DET
bjos-8647123	65	26	microwave	microwave	NOUN
bjos-8647123	65	27	oven	oven	VERB
bjos-8647123	65	28	.	.	PUNCT
bjos-8647123	66	1	mouse	mouse	NOUN
bjos-8647123	66	2	monoclonal	monoclonal	NOUN
bjos-8647123	66	3	antibody	antibody	NOUN
bjos-8647123	66	4	against	against	ADP
bjos-8647123	66	5	timp-2	timp-2	PRON
bjos-8647123	66	6	in	in	ADP
bjos-8647123	66	7	5ug	5ug	NOUN
bjos-8647123	66	8	/	/	SYM
bjos-8647123	66	9	ml	ml	PROPN
bjos-8647123	66	10	(	(	PUNCT
bjos-8647123	66	11	chemicon	chemicon	PROPN
bjos-8647123	66	12	international	international	PROPN
bjos-8647123	66	13	,	,	PUNCT
bjos-8647123	66	14	usa	usa	PROPN
bjos-8647123	66	15	)	)	PUNCT
bjos-8647123	66	16	was	be	AUX
bjos-8647123	66	17	then	then	ADV
bjos-8647123	66	18	added	add	VERB
bjos-8647123	66	19	and	and	CCONJ
bjos-8647123	66	20	kept	keep	VERB
bjos-8647123	66	21	overnight	overnight	ADV
bjos-8647123	66	22	at	at	ADP
bjos-8647123	66	23	room	room	NOUN
bjos-8647123	66	24	temperature	temperature	NOUN
bjos-8647123	66	25	.	.	PUNCT
bjos-8647123	67	1	after	after	ADP
bjos-8647123	67	2	application	application	NOUN
bjos-8647123	67	3	of	of	ADP
bjos-8647123	67	4	peroxidase	peroxidase	NOUN
bjos-8647123	67	5	labeled	label	VERB
bjos-8647123	67	6	secondary	secondary	ADJ
bjos-8647123	67	7	antibody	antibody	NOUN
bjos-8647123	67	8	and	and	CCONJ
bjos-8647123	67	9	the	the	DET
bjos-8647123	67	10	dab	dab	NOUN
bjos-8647123	67	11	,	,	PUNCT
bjos-8647123	67	12	the	the	DET
bjos-8647123	67	13	sections	section	NOUN
bjos-8647123	67	14	were	be	AUX
bjos-8647123	67	15	finally	finally	ADV
bjos-8647123	67	16	counterstained	counterstaine	VERB
bjos-8647123	67	17	and	and	CCONJ
bjos-8647123	67	18	mounted	mount	VERB
bjos-8647123	67	19	.	.	PUNCT
bjos-8647123	68	1	about	about	ADV
bjos-8647123	68	2	10	10	NUM
bjos-8647123	68	3	representative	representative	ADJ
bjos-8647123	68	4	areas	area	NOUN
bjos-8647123	68	5	containing	contain	VERB
bjos-8647123	68	6	100	100	NUM
bjos-8647123	68	7	scc	scc	ADJ
bjos-8647123	68	8	cells	cell	NOUN
bjos-8647123	68	9	were	be	AUX
bjos-8647123	68	10	analyzed	analyze	VERB
bjos-8647123	68	11	.	.	PUNCT
bjos-8647123	69	1	immunostaining	immunostaine	VERB
bjos-8647123	69	2	was	be	AUX
bjos-8647123	69	3	scored	score	VERB
bjos-8647123	69	4	using	use	VERB
bjos-8647123	69	5	combined	combine	VERB
bjos-8647123	69	6	quantitative	quantitative	ADJ
bjos-8647123	69	7	(	(	PUNCT
bjos-8647123	69	8	percentage	percentage	NOUN
bjos-8647123	69	9	of	of	ADP
bjos-8647123	69	10	tumor	tumor	NOUN
bjos-8647123	69	11	cells	cell	NOUN
bjos-8647123	69	12	with	with	ADP
bjos-8647123	69	13	immunoreactivity	immunoreactivity	NOUN
bjos-8647123	69	14	)	)	PUNCT
bjos-8647123	69	15	and	and	CCONJ
bjos-8647123	69	16	qualitative	qualitative	ADJ
bjos-8647123	69	17	criteria	criterion	NOUN
bjos-8647123	69	18	(	(	PUNCT
bjos-8647123	69	19	intensity	intensity	NOUN
bjos-8647123	69	20	of	of	ADP
bjos-8647123	69	21	staining	stain	VERB
bjos-8647123	69	22	:	:	PUNCT
bjos-8647123	69	23	none	none	NOUN
bjos-8647123	69	24	,	,	PUNCT
bjos-8647123	69	25	weak	weak	ADJ
bjos-8647123	69	26	,	,	PUNCT
bjos-8647123	69	27	or	or	CCONJ
bjos-8647123	69	28	strong	strong	ADJ
bjos-8647123	69	29	)	)	PUNCT
bjos-8647123	69	30	.	.	PUNCT
bjos-8647123	70	1	these	these	DET
bjos-8647123	70	2	parameters	parameter	NOUN
bjos-8647123	70	3	were	be	AUX
bjos-8647123	70	4	then	then	ADV
bjos-8647123	70	5	combined	combine	VERB
bjos-8647123	70	6	as	as	ADP
bjos-8647123	70	7	:	:	PUNCT
bjos-8647123	70	8	0=	0=	NOUN
bjos-8647123	70	9	no	no	DET
bjos-8647123	70	10	staining	staining	NOUN
bjos-8647123	70	11	;	;	PUNCT
bjos-8647123	70	12	1=	1=	X
bjos-8647123	70	13	weak	weak	ADJ
bjos-8647123	70	14	(	(	PUNCT
bjos-8647123	70	15	<	<	X
bjos-8647123	70	16	10	10	NUM
bjos-8647123	70	17	%	%	NOUN
bjos-8647123	70	18	of	of	ADP
bjos-8647123	70	19	tumor	tumor	NOUN
bjos-8647123	70	20	cells	cell	NOUN
bjos-8647123	70	21	)	)	PUNCT
bjos-8647123	70	22	;	;	PUNCT
bjos-8647123	70	23	2=	2=	NUM
bjos-8647123	70	24	weak	weak	ADJ
bjos-8647123	70	25	(	(	PUNCT
bjos-8647123	70	26	≥10	≥10	ADP
bjos-8647123	70	27	%	%	NOUN
bjos-8647123	70	28	of	of	ADP
bjos-8647123	70	29	tumor	tumor	NOUN
bjos-8647123	70	30	cells	cell	NOUN
bjos-8647123	70	31	)	)	PUNCT
bjos-8647123	70	32	,	,	PUNCT
bjos-8647123	70	33	and	and	CCONJ
bjos-8647123	70	34	3	3	NUM
bjos-8647123	70	35	=	=	NOUN
bjos-8647123	70	36	strong	strong	ADJ
bjos-8647123	70	37	(	(	PUNCT
bjos-8647123	70	38	≥10	≥10	ADP
bjos-8647123	70	39	%	%	NOUN
bjos-8647123	70	40	of	of	ADP
bjos-8647123	70	41	tumor	tumor	NOUN
bjos-8647123	70	42	cells)27	cells)27	PROPN
bjos-8647123	70	43	.	.	PUNCT
bjos-8647123	71	1	paraffin	paraffin	NOUN
bjos-8647123	71	2	-	-	PUNCT
bjos-8647123	71	3	embedded	embed	VERB
bjos-8647123	71	4	sections	section	NOUN
bjos-8647123	71	5	of	of	ADP
bjos-8647123	71	6	colon	colon	NOUN
bjos-8647123	71	7	cancer	cancer	NOUN
bjos-8647123	71	8	were	be	AUX
bjos-8647123	71	9	immunostained	immunostaine	VERB
bjos-8647123	71	10	as	as	ADP
bjos-8647123	71	11	positive	positive	ADJ
bjos-8647123	71	12	control	control	NOUN
bjos-8647123	71	13	.	.	PUNCT
bjos-8647123	72	1	in	in	ADP
bjos-8647123	72	2	situ	situ	ADJ
bjos-8647123	72	3	hybridization	hybridization	NOUN
bjos-8647123	72	4	(	(	PUNCT
bjos-8647123	72	5	ish	ish	NOUN
bjos-8647123	72	6	)	)	PUNCT
bjos-8647123	72	7	ish	ish	NOUN
bjos-8647123	72	8	procedure	procedure	NOUN
bjos-8647123	72	9	was	be	AUX
bjos-8647123	72	10	done	do	VERB
bjos-8647123	72	11	using	use	VERB
bjos-8647123	72	12	dna	dna	PROPN
bjos-8647123	72	13	probe	probe	NOUN
bjos-8647123	72	14	hybridization/	hybridization/	NUM
bjos-8647123	72	15	detection	detection	NOUN
bjos-8647123	72	16	system	system	NOUN
bjos-8647123	72	17	in	in	ADP
bjos-8647123	72	18	situ	situ	ADJ
bjos-8647123	72	19	kit	kit	NOUN
bjos-8647123	72	20	(	(	PUNCT
bjos-8647123	72	21	maxim	maxim	NOUN
bjos-8647123	72	22	biotech	biotech	NOUN
bjos-8647123	72	23	,	,	PUNCT
bjos-8647123	72	24	usa	usa	PROPN
bjos-8647123	72	25	)	)	PUNCT
bjos-8647123	72	26	,	,	PUNCT
bjos-8647123	72	27	according	accord	VERB
bjos-8647123	72	28	to	to	ADP
bjos-8647123	72	29	manufacturer	manufacturer	PROPN
bjos-8647123	72	30	’s	’s	PART
bjos-8647123	72	31	protocol	protocol	NOUN
bjos-8647123	72	32	.	.	PUNCT
bjos-8647123	73	1	the	the	DET
bjos-8647123	73	2	biotinylated	biotinylate	VERB
bjos-8647123	73	3	cdna	cdna	PROPN
bjos-8647123	73	4	probe	probe	NOUN
bjos-8647123	73	5	for	for	ADP
bjos-8647123	73	6	hpv16	hpv16	NOUN
bjos-8647123	73	7	(	(	PUNCT
bjos-8647123	73	8	maxim	maxim	NOUN
bjos-8647123	73	9	biotech	biotech	NOUN
bjos-8647123	73	10	,	,	PUNCT
bjos-8647123	73	11	usa	usa	PROPN
bjos-8647123	73	12	)	)	PUNCT
bjos-8647123	73	13	was	be	AUX
bjos-8647123	73	14	diluted	dilute	VERB
bjos-8647123	73	15	to	to	ADP
bjos-8647123	73	16	7	7	NUM
bjos-8647123	73	17	%	%	NOUN
bjos-8647123	73	18	(	(	PUNCT
bjos-8647123	73	19	0.7	0.7	NUM
bjos-8647123	73	20	µl	µl	NOUN
bjos-8647123	73	21	of	of	ADP
bjos-8647123	73	22	the	the	DET
bjos-8647123	73	23	probe	probe	NOUN
bjos-8647123	73	24	diluted	dilute	VERB
bjos-8647123	73	25	in	in	ADP
bjos-8647123	73	26	9.3	9.3	NUM
bjos-8647123	73	27	µl	µl	NOUN
bjos-8647123	73	28	of	of	ADP
bjos-8647123	73	29	hybridization	hybridization	NOUN
bjos-8647123	73	30	solution	solution	NOUN
bjos-8647123	73	31	)	)	PUNCT
bjos-8647123	73	32	.	.	PUNCT
bjos-8647123	74	1	positive	positive	ADJ
bjos-8647123	74	2	control	control	NOUN
bjos-8647123	74	3	was	be	AUX
bjos-8647123	74	4	made	make	VERB
bjos-8647123	74	5	with	with	ADP
bjos-8647123	74	6	housekeeping	housekeeping	NOUN
bjos-8647123	74	7	gene	gene	NOUN
bjos-8647123	74	8	probe	probe	NOUN
bjos-8647123	74	9	,	,	PUNCT
bjos-8647123	74	10	while	while	SCONJ
bjos-8647123	74	11	the	the	DET
bjos-8647123	74	12	negative	negative	ADJ
bjos-8647123	74	13	control	control	NOUN
bjos-8647123	74	14	made	make	VERB
bjos-8647123	74	15	with	with	ADP
bjos-8647123	74	16	hybridization	hybridization	NOUN
bjos-8647123	74	17	solution	solution	NOUN
bjos-8647123	74	18	without	without	ADP
bjos-8647123	74	19	probe	probe	NOUN
bjos-8647123	74	20	.	.	PUNCT
bjos-8647123	75	1	determination	determination	NOUN
bjos-8647123	75	2	of	of	ADP
bjos-8647123	75	3	positive	positive	ADJ
bjos-8647123	75	4	reaction	reaction	NOUN
bjos-8647123	75	5	was	be	AUX
bjos-8647123	75	6	made	make	VERB
bjos-8647123	75	7	with	with	ADP
bjos-8647123	75	8	nuclear	nuclear	ADJ
bjos-8647123	75	9	and/or	and/or	CCONJ
bjos-8647123	75	10	cytoplasmic	cytoplasmic	ADJ
bjos-8647123	75	11	blue	blue	ADJ
bjos-8647123	75	12	staining	staining	NOUN
bjos-8647123	75	13	of	of	ADP
bjos-8647123	75	14	cells28	cells28	PROPN
bjos-8647123	75	15	.	.	PUNCT
bjos-8647123	76	1	53expression	53expression	NOUN
bjos-8647123	76	2	of	of	ADP
bjos-8647123	76	3	timp-2	timp-2	NUM
bjos-8647123	76	4	in	in	ADP
bjos-8647123	76	5	hpv-16	hpv-16	NUM
bjos-8647123	76	6	infected	infect	VERB
bjos-8647123	76	7	oral	oral	ADJ
bjos-8647123	76	8	squamous	squamous	ADJ
bjos-8647123	76	9	cell	cell	NOUN
bjos-8647123	76	10	carcinoma	carcinoma	NOUN
bjos-8647123	76	11	in	in	ADP
bjos-8647123	76	12	patients	patient	NOUN
bjos-8647123	76	13	in	in	ADP
bjos-8647123	76	14	iraq	iraq	PROPN
bjos-8647123	76	15	braz	braz	PROPN
bjos-8647123	76	16	j	j	PROPN
bjos-8647123	76	17	oral	oral	PROPN
bjos-8647123	76	18	sci	sci	PROPN
bjos-8647123	76	19	.	.	PUNCT
bjos-8647123	77	1	15(1):51	15(1):51	NUM
bjos-8647123	77	2	-	-	SYM
bjos-8647123	77	3	56	56	NUM
bjos-8647123	77	4	statistical	statistical	ADJ
bjos-8647123	77	5	analysis	analysis	NOUN
bjos-8647123	77	6	statistical	statistical	ADJ
bjos-8647123	77	7	analysis	analysis	NOUN
bjos-8647123	77	8	of	of	ADP
bjos-8647123	77	9	observed	observed	ADJ
bjos-8647123	77	10	data	datum	NOUN
bjos-8647123	77	11	was	be	AUX
bjos-8647123	77	12	performed	perform	VERB
bjos-8647123	77	13	by	by	ADP
bjos-8647123	77	14	utilizing	utilize	VERB
bjos-8647123	77	15	spss	spss	PROPN
bjos-8647123	77	16	22.0	22.0	NUM
bjos-8647123	77	17	(	(	PUNCT
bjos-8647123	77	18	spss	spss	PROPN
bjos-8647123	77	19	inc	inc	PROPN
bjos-8647123	77	20	.	.	PROPN
bjos-8647123	77	21	,	,	PUNCT
bjos-8647123	77	22	chicago	chicago	PROPN
bjos-8647123	77	23	,	,	PUNCT
bjos-8647123	77	24	il	il	PROPN
bjos-8647123	77	25	,	,	PUNCT
bjos-8647123	77	26	usa	usa	PROPN
bjos-8647123	77	27	)	)	PUNCT
bjos-8647123	77	28	with	with	ADP
bjos-8647123	77	29	the	the	DET
bjos-8647123	77	30	application	application	NOUN
bjos-8647123	77	31	of	of	ADP
bjos-8647123	77	32	chi	chi	ADJ
bjos-8647123	77	33	-	-	PUNCT
bjos-8647123	77	34	square	square	ADJ
bjos-8647123	77	35	and	and	CCONJ
bjos-8647123	77	36	fisher	fisher	PROPN
bjos-8647123	77	37	exact	exact	ADJ
bjos-8647123	77	38	tests	test	NOUN
bjos-8647123	77	39	.	.	PUNCT
bjos-8647123	78	1	results	result	VERB
bjos-8647123	78	2	the	the	DET
bjos-8647123	78	3	median	median	ADJ
bjos-8647123	78	4	age	age	NOUN
bjos-8647123	78	5	of	of	ADP
bjos-8647123	78	6	the	the	DET
bjos-8647123	78	7	patients	patient	NOUN
bjos-8647123	78	8	was	be	AUX
bjos-8647123	78	9	55	55	NUM
bjos-8647123	78	10	years	year	NOUN
bjos-8647123	78	11	with	with	ADP
bjos-8647123	78	12	a	a	DET
bjos-8647123	78	13	mean	mean	ADJ
bjos-8647123	78	14	±	±	NUM
bjos-8647123	78	15	s.	s.	PROPN
bjos-8647123	78	16	d.	d.	PROPN
bjos-8647123	78	17	of	of	ADP
bjos-8647123	78	18	54.5	54.5	NUM
bjos-8647123	78	19	±	±	NUM
bjos-8647123	78	20	12.9	12.9	NUM
bjos-8647123	78	21	years	year	NOUN
bjos-8647123	78	22	.	.	PUNCT
bjos-8647123	79	1	twenty	twenty	NUM
bjos-8647123	79	2	-	-	PUNCT
bjos-8647123	79	3	five	five	NUM
bjos-8647123	79	4	of	of	ADP
bjos-8647123	79	5	patients	patient	NOUN
bjos-8647123	79	6	were	be	AUX
bjos-8647123	79	7	males	male	NOUN
bjos-8647123	79	8	(	(	PUNCT
bjos-8647123	79	9	75.8	75.8	NUM
bjos-8647123	79	10	%	%	NOUN
bjos-8647123	79	11	)	)	PUNCT
bjos-8647123	79	12	and	and	CCONJ
bjos-8647123	79	13	eight	eight	NUM
bjos-8647123	79	14	(	(	PUNCT
bjos-8647123	79	15	24.2	24.2	NUM
bjos-8647123	79	16	%	%	NOUN
bjos-8647123	79	17	)	)	PUNCT
bjos-8647123	79	18	were	be	AUX
bjos-8647123	79	19	females	female	NOUN
bjos-8647123	79	20	.	.	PUNCT
bjos-8647123	80	1	the	the	DET
bjos-8647123	80	2	majority	majority	NOUN
bjos-8647123	80	3	of	of	ADP
bjos-8647123	80	4	cases	case	NOUN
bjos-8647123	80	5	(	(	PUNCT
bjos-8647123	80	6	27	27	NUM
bjos-8647123	80	7	,	,	PUNCT
bjos-8647123	80	8	81.8	81.8	NUM
bjos-8647123	80	9	%	%	NOUN
bjos-8647123	80	10	)	)	PUNCT
bjos-8647123	80	11	were	be	AUX
bjos-8647123	80	12	of	of	ADP
bjos-8647123	80	13	stage	stage	NOUN
bjos-8647123	80	14	4	4	NUM
bjos-8647123	80	15	(	(	PUNCT
bjos-8647123	80	16	according	accord	VERB
bjos-8647123	80	17	to	to	ADP
bjos-8647123	80	18	tnm	tnm	NUM
bjos-8647123	80	19	staging	staging	NOUN
bjos-8647123	80	20	system	system	NOUN
bjos-8647123	80	21	)	)	PUNCT
bjos-8647123	80	22	;	;	PUNCT
bjos-8647123	80	23	4	4	NUM
bjos-8647123	80	24	cases	case	NOUN
bjos-8647123	80	25	(	(	PUNCT
bjos-8647123	80	26	12.1	12.1	NUM
bjos-8647123	80	27	%	%	NOUN
bjos-8647123	80	28	)	)	PUNCT
bjos-8647123	80	29	were	be	AUX
bjos-8647123	80	30	stage	stage	NOUN
bjos-8647123	80	31	2	2	NUM
bjos-8647123	80	32	and	and	CCONJ
bjos-8647123	80	33	2	2	NUM
bjos-8647123	80	34	cases	case	NOUN
bjos-8647123	80	35	were	be	AUX
bjos-8647123	80	36	stage	stage	NOUN
bjos-8647123	80	37	1	1	NUM
bjos-8647123	80	38	(	(	PUNCT
bjos-8647123	80	39	6.1	6.1	NUM
bjos-8647123	80	40	%	%	NOUN
bjos-8647123	80	41	)	)	PUNCT
bjos-8647123	80	42	.	.	PUNCT
bjos-8647123	81	1	the	the	DET
bjos-8647123	81	2	grades	grade	NOUN
bjos-8647123	81	3	(	(	PUNCT
bjos-8647123	81	4	using	use	VERB
bjos-8647123	81	5	border	border	NOUN
bjos-8647123	81	6	’s	’s	PART
bjos-8647123	81	7	system	system	NOUN
bjos-8647123	81	8	)	)	PUNCT
bjos-8647123	81	9	of	of	ADP
bjos-8647123	81	10	the	the	DET
bjos-8647123	81	11	tumor	tumor	NOUN
bjos-8647123	81	12	were	be	AUX
bjos-8647123	81	13	as	as	SCONJ
bjos-8647123	81	14	follows	follow	VERB
bjos-8647123	81	15	:	:	PUNCT
bjos-8647123	81	16	low	low	ADJ
bjos-8647123	81	17	,	,	PUNCT
bjos-8647123	81	18	4	4	NUM
bjos-8647123	81	19	(	(	PUNCT
bjos-8647123	81	20	12.1	12.1	NUM
bjos-8647123	81	21	%	%	NOUN
bjos-8647123	81	22	)	)	PUNCT
bjos-8647123	81	23	;	;	PUNCT
bjos-8647123	81	24	intermediate	intermediate	ADJ
bjos-8647123	81	25	,	,	PUNCT
bjos-8647123	81	26	26	26	NUM
bjos-8647123	81	27	(	(	PUNCT
bjos-8647123	81	28	78.8	78.8	NUM
bjos-8647123	81	29	%	%	NOUN
bjos-8647123	81	30	)	)	PUNCT
bjos-8647123	81	31	and	and	CCONJ
bjos-8647123	81	32	high	high	ADJ
bjos-8647123	81	33	,	,	PUNCT
bjos-8647123	81	34	3	3	NUM
bjos-8647123	81	35	(	(	PUNCT
bjos-8647123	81	36	9.1	9.1	NUM
bjos-8647123	81	37	%	%	NOUN
bjos-8647123	81	38	)	)	PUNCT
bjos-8647123	81	39	.	.	PUNCT
bjos-8647123	82	1	lymph	lymph	NOUN
bjos-8647123	82	2	nodes	node	NOUN
bjos-8647123	82	3	involvements	involvement	NOUN
bjos-8647123	82	4	were	be	AUX
bjos-8647123	82	5	positive	positive	ADJ
bjos-8647123	82	6	in	in	ADP
bjos-8647123	82	7	23	23	NUM
bjos-8647123	82	8	(	(	PUNCT
bjos-8647123	82	9	85.2	85.2	NUM
bjos-8647123	82	10	%	%	NOUN
bjos-8647123	82	11	)	)	PUNCT
bjos-8647123	82	12	cases	case	NOUN
bjos-8647123	82	13	.	.	PUNCT
bjos-8647123	83	1	nuclear	nuclear	ADJ
bjos-8647123	83	2	hybridization	hybridization	NOUN
bjos-8647123	83	3	signals	signal	NOUN
bjos-8647123	83	4	for	for	ADP
bjos-8647123	83	5	hpv-16	hpv-16	PRON
bjos-8647123	83	6	were	be	AUX
bjos-8647123	83	7	observed	observe	VERB
bjos-8647123	83	8	in	in	ADP
bjos-8647123	83	9	24	24	NUM
bjos-8647123	83	10	(	(	PUNCT
bjos-8647123	83	11	72.7	72.7	NUM
bjos-8647123	83	12	%	%	NOUN
bjos-8647123	83	13	)	)	PUNCT
bjos-8647123	83	14	of	of	ADP
bjos-8647123	83	15	oscc	oscc	ADJ
bjos-8647123	83	16	paraffin	paraffin	NOUN
bjos-8647123	83	17	-	-	PUNCT
bjos-8647123	83	18	embedded	embed	VERB
bjos-8647123	83	19	tissues	tissue	NOUN
bjos-8647123	83	20	,	,	PUNCT
bjos-8647123	83	21	while	while	SCONJ
bjos-8647123	83	22	6	6	NUM
bjos-8647123	83	23	(	(	PUNCT
bjos-8647123	83	24	18.2	18.2	NUM
bjos-8647123	83	25	%	%	NOUN
bjos-8647123	83	26	)	)	PUNCT
bjos-8647123	83	27	cases	case	NOUN
bjos-8647123	83	28	appeared	appear	VERB
bjos-8647123	83	29	negative	negative	ADJ
bjos-8647123	83	30	(	(	PUNCT
bjos-8647123	83	31	table	table	NOUN
bjos-8647123	83	32	1	1	NUM
bjos-8647123	83	33	)	)	PUNCT
bjos-8647123	83	34	.	.	PUNCT
bjos-8647123	84	1	no	no	DET
bjos-8647123	84	2	detectable	detectable	ADJ
bjos-8647123	84	3	signals	signal	NOUN
bjos-8647123	84	4	were	be	AUX
bjos-8647123	84	5	seen	see	VERB
bjos-8647123	84	6	in	in	ADP
bjos-8647123	84	7	the	the	DET
bjos-8647123	84	8	sections	section	NOUN
bjos-8647123	84	9	from	from	ADP
bjos-8647123	84	10	the	the	DET
bjos-8647123	84	11	control	control	NOUN
bjos-8647123	84	12	group	group	NOUN
bjos-8647123	84	13	.	.	PUNCT
bjos-8647123	85	1	the	the	DET
bjos-8647123	85	2	immunoreactivity	immunoreactivity	NOUN
bjos-8647123	85	3	of	of	ADP
bjos-8647123	85	4	timp-2	timp-2	PRON
bjos-8647123	85	5	observed	observe	VERB
bjos-8647123	85	6	in	in	ADP
bjos-8647123	85	7	24	24	NUM
bjos-8647123	85	8	(	(	PUNCT
bjos-8647123	85	9	72.7	72.7	NUM
bjos-8647123	85	10	%	%	NOUN
bjos-8647123	85	11	)	)	PUNCT
bjos-8647123	85	12	and	and	CCONJ
bjos-8647123	85	13	3	3	NUM
bjos-8647123	85	14	(	(	PUNCT
bjos-8647123	85	15	9.1	9.1	NUM
bjos-8647123	85	16	%	%	NOUN
bjos-8647123	85	17	)	)	PUNCT
bjos-8647123	85	18	of	of	ADP
bjos-8647123	85	19	positive	positive	ADJ
bjos-8647123	85	20	and	and	CCONJ
bjos-8647123	85	21	negative	negative	ADJ
bjos-8647123	85	22	hpv-16	hpv-16	NUM
bjos-8647123	85	23	oscc	oscc	ADJ
bjos-8647123	85	24	cases	case	NOUN
bjos-8647123	85	25	,	,	PUNCT
bjos-8647123	85	26	respectively	respectively	ADV
bjos-8647123	85	27	(	(	PUNCT
bjos-8647123	85	28	table	table	NOUN
bjos-8647123	85	29	1	1	NUM
bjos-8647123	85	30	)	)	PUNCT
bjos-8647123	85	31	.	.	PUNCT
bjos-8647123	86	1	immunoreactivity	immunoreactivity	NOUN
bjos-8647123	86	2	to	to	ADP
bjos-8647123	86	3	timp-2	timp-2	PROPN
bjos-8647123	86	4	was	be	AUX
bjos-8647123	86	5	localized	localize	VERB
bjos-8647123	86	6	mainly	mainly	ADV
bjos-8647123	86	7	on	on	ADP
bjos-8647123	86	8	the	the	DET
bjos-8647123	86	9	cell	cell	NOUN
bjos-8647123	86	10	membrane	membrane	NOUN
bjos-8647123	86	11	and	and	CCONJ
bjos-8647123	86	12	the	the	DET
bjos-8647123	86	13	cytoplasm	cytoplasm	NOUN
bjos-8647123	86	14	of	of	ADP
bjos-8647123	86	15	tumor	tumor	NOUN
bjos-8647123	86	16	cells	cell	NOUN
bjos-8647123	86	17	(	(	PUNCT
bjos-8647123	86	18	figure	figure	NOUN
bjos-8647123	86	19	1	1	NUM
bjos-8647123	86	20	.	.	PUNCT
bjos-8647123	87	1	a	a	DET
bjos-8647123	87	2	,	,	PUNCT
bjos-8647123	87	3	b	b	NOUN
bjos-8647123	87	4	)	)	PUNCT
bjos-8647123	87	5	.	.	PUNCT
bjos-8647123	88	1	it	it	PRON
bjos-8647123	88	2	was	be	AUX
bjos-8647123	88	3	also	also	ADV
bjos-8647123	88	4	detected	detect	VERB
bjos-8647123	88	5	on	on	ADP
bjos-8647123	88	6	some	some	DET
bjos-8647123	88	7	stromal	stromal	ADJ
bjos-8647123	88	8	cells	cell	NOUN
bjos-8647123	88	9	surrounding	surround	VERB
bjos-8647123	88	10	the	the	DET
bjos-8647123	88	11	tumor	tumor	NOUN
bjos-8647123	88	12	cells	cell	NOUN
bjos-8647123	88	13	.	.	PUNCT
bjos-8647123	89	1	no	no	DET
bjos-8647123	89	2	detectable	detectable	ADJ
bjos-8647123	89	3	signals	signal	NOUN
bjos-8647123	89	4	were	be	AUX
bjos-8647123	89	5	observed	observe	VERB
bjos-8647123	89	6	in	in	ADP
bjos-8647123	89	7	the	the	DET
bjos-8647123	89	8	sections	section	NOUN
bjos-8647123	89	9	from	from	ADP
bjos-8647123	89	10	the	the	DET
bjos-8647123	89	11	control	control	NOUN
bjos-8647123	89	12	group	group	NOUN
bjos-8647123	89	13	(	(	PUNCT
bjos-8647123	89	14	figure	figure	NOUN
bjos-8647123	89	15	2	2	NUM
bjos-8647123	89	16	)	)	PUNCT
bjos-8647123	89	17	.	.	PUNCT
bjos-8647123	90	1	the	the	DET
bjos-8647123	90	2	total	total	ADJ
bjos-8647123	90	3	expression	expression	NOUN
bjos-8647123	90	4	of	of	ADP
bjos-8647123	90	5	timp-2	timp-2	PROPN
bjos-8647123	90	6	was	be	AUX
bjos-8647123	90	7	detected	detect	VERB
bjos-8647123	90	8	in	in	ADP
bjos-8647123	90	9	27	27	NUM
bjos-8647123	90	10	(	(	PUNCT
bjos-8647123	90	11	81.8	81.8	NUM
bjos-8647123	90	12	%	%	NOUN
bjos-8647123	90	13	)	)	PUNCT
bjos-8647123	90	14	of	of	ADP
bjos-8647123	90	15	oscc	oscc	ADJ
bjos-8647123	90	16	cases	case	NOUN
bjos-8647123	90	17	(	(	PUNCT
bjos-8647123	90	18	table	table	NOUN
bjos-8647123	90	19	1	1	NUM
bjos-8647123	90	20	)	)	PUNCT
bjos-8647123	90	21	and	and	CCONJ
bjos-8647123	90	22	its	its	PRON
bjos-8647123	90	23	expression	expression	NOUN
bjos-8647123	90	24	scores	score	NOUN
bjos-8647123	90	25	are	be	AUX
bjos-8647123	90	26	illustrated	illustrate	VERB
bjos-8647123	90	27	in	in	ADP
bjos-8647123	90	28	table	table	NOUN
bjos-8647123	90	29	2	2	NUM
bjos-8647123	90	30	.	.	PUNCT
bjos-8647123	91	1	there	there	PRON
bjos-8647123	91	2	was	be	VERB
bjos-8647123	91	3	no	no	DET
bjos-8647123	91	4	significant	significant	ADJ
bjos-8647123	91	5	difference	difference	NOUN
bjos-8647123	91	6	in	in	ADP
bjos-8647123	91	7	timp2	timp2	NOUN
bjos-8647123	91	8	expression	expression	NOUN
bjos-8647123	91	9	between	between	ADP
bjos-8647123	91	10	hpv-16	hpv-16	NUM
bjos-8647123	91	11	infected	infected	ADJ
bjos-8647123	91	12	and	and	CCONJ
bjos-8647123	91	13	non	non	ADJ
bjos-8647123	91	14	-	-	ADJ
bjos-8647123	91	15	infected	infected	ADJ
bjos-8647123	91	16	cases	case	NOUN
bjos-8647123	91	17	(	(	PUNCT
bjos-8647123	91	18	p=0.058	p=0.058	NOUN
bjos-8647123	91	19	)	)	PUNCT
bjos-8647123	91	20	.	.	PUNCT
bjos-8647123	92	1	in	in	ADP
bjos-8647123	92	2	addition	addition	NOUN
bjos-8647123	92	3	,	,	PUNCT
bjos-8647123	92	4	the	the	DET
bjos-8647123	92	5	expression	expression	NOUN
bjos-8647123	92	6	score	score	NOUN
bjos-8647123	92	7	of	of	ADP
bjos-8647123	92	8	timp-2	timp-2	PRON
bjos-8647123	92	9	revealed	reveal	VERB
bjos-8647123	92	10	no	no	DET
bjos-8647123	92	11	significant	significant	ADJ
bjos-8647123	92	12	difference	difference	NOUN
bjos-8647123	92	13	between	between	ADP
bjos-8647123	92	14	cases	case	NOUN
bjos-8647123	92	15	with	with	ADP
bjos-8647123	92	16	and	and	CCONJ
bjos-8647123	92	17	without	without	ADP
bjos-8647123	92	18	lymph	lymph	NOUN
bjos-8647123	92	19	node	node	NOUN
bjos-8647123	92	20	metastases	metastasis	NOUN
bjos-8647123	92	21	,	,	PUNCT
bjos-8647123	92	22	p	p	NOUN
bjos-8647123	92	23	=	=	X
bjos-8647123	92	24	0.176	0.176	NUM
bjos-8647123	92	25	(	(	PUNCT
bjos-8647123	92	26	table	table	NOUN
bjos-8647123	92	27	3	3	NUM
bjos-8647123	92	28	)	)	PUNCT
bjos-8647123	92	29	,	,	PUNCT
bjos-8647123	92	30	whereas	whereas	SCONJ
bjos-8647123	92	31	,	,	PUNCT
bjos-8647123	92	32	its	its	PRON
bjos-8647123	92	33	expression	expression	NOUN
bjos-8647123	92	34	showed	show	VERB
bjos-8647123	92	35	no	no	DET
bjos-8647123	92	36	significant	significant	ADJ
bjos-8647123	92	37	difference	difference	NOUN
bjos-8647123	92	38	considering	consider	VERB
bjos-8647123	92	39	the	the	DET
bjos-8647123	92	40	tumor	tumor	NOUN
bjos-8647123	92	41	grade	grade	NOUN
bjos-8647123	92	42	and	and	CCONJ
bjos-8647123	92	43	stage	stage	NOUN
bjos-8647123	92	44	,	,	PUNCT
bjos-8647123	92	45	p	p	NOUN
bjos-8647123	92	46	=	=	PROPN
bjos-8647123	92	47	0.838	0.838	NUM
bjos-8647123	92	48	and	and	CCONJ
bjos-8647123	92	49	p	p	NOUN
bjos-8647123	92	50	=	=	NOUN
bjos-8647123	92	51	0.169	0.169	NUM
bjos-8647123	92	52	,	,	PUNCT
bjos-8647123	92	53	respectively	respectively	ADV
bjos-8647123	92	54	(	(	PUNCT
bjos-8647123	92	55	table	table	NOUN
bjos-8647123	92	56	4	4	NUM
bjos-8647123	92	57	)	)	PUNCT
bjos-8647123	92	58	.	.	PUNCT
bjos-8647123	93	1	discussion	discussion	NOUN
bjos-8647123	93	2	according	accord	VERB
bjos-8647123	93	3	to	to	ADP
bjos-8647123	93	4	a	a	DET
bjos-8647123	93	5	recent	recent	ADJ
bjos-8647123	93	6	review	review	NOUN
bjos-8647123	93	7	article6	article6	ADV
bjos-8647123	93	8	,	,	PUNCT
bjos-8647123	93	9	there	there	PRON
bjos-8647123	93	10	are	be	VERB
bjos-8647123	93	11	shortage	shortage	NOUN
bjos-8647123	93	12	in	in	ADP
bjos-8647123	93	13	the	the	DET
bjos-8647123	93	14	studies	study	NOUN
bjos-8647123	93	15	regarding	regard	VERB
bjos-8647123	93	16	the	the	DET
bjos-8647123	93	17	correlation	correlation	NOUN
bjos-8647123	93	18	between	between	ADP
bjos-8647123	93	19	oscc	oscc	ADJ
bjos-8647123	93	20	,	,	PUNCT
bjos-8647123	93	21	detection	detection	NOUN
bjos-8647123	93	22	of	of	ADP
bjos-8647123	93	23	hpv	hpv	NOUN
bjos-8647123	93	24	and	and	CCONJ
bjos-8647123	93	25	expression	expression	NOUN
bjos-8647123	93	26	of	of	ADP
bjos-8647123	93	27	strictly	strictly	ADV
bjos-8647123	93	28	related	relate	VERB
bjos-8647123	93	29	tumor	tumor	NOUN
bjos-8647123	93	30	markers	marker	NOUN
bjos-8647123	93	31	.	.	PUNCT
bjos-8647123	94	1	however	however	ADV
bjos-8647123	94	2	,	,	PUNCT
bjos-8647123	94	3	published	publish	VERB
bjos-8647123	94	4	articles	article	NOUN
bjos-8647123	94	5	have	have	AUX
bjos-8647123	94	6	shown	show	VERB
bjos-8647123	94	7	that	that	SCONJ
bjos-8647123	94	8	high	high	ADJ
bjos-8647123	94	9	oncogenic	oncogenic	ADJ
bjos-8647123	94	10	hpv	hpv	ADJ
bjos-8647123	94	11	genotypes	genotype	NOUN
bjos-8647123	94	12	have	have	VERB
bjos-8647123	94	13	an	an	DET
bjos-8647123	94	14	essential	essential	ADJ
bjos-8647123	94	15	etiologic	etiologic	ADJ
bjos-8647123	94	16	role	role	NOUN
bjos-8647123	94	17	in	in	ADP
bjos-8647123	94	18	the	the	DET
bjos-8647123	94	19	development	development	NOUN
bjos-8647123	94	20	of	of	ADP
bjos-8647123	94	21	oscc	oscc	ADJ
bjos-8647123	94	22	worldwide17,28	worldwide17,28	NOUN
bjos-8647123	94	23	-	-	SYM
bjos-8647123	94	24	36	36	NUM
bjos-8647123	94	25	.	.	PUNCT
bjos-8647123	95	1	the	the	DET
bjos-8647123	95	2	correlation	correlation	NOUN
bjos-8647123	95	3	between	between	ADP
bjos-8647123	95	4	hpv	hpv	NOUN
bjos-8647123	95	5	and	and	CCONJ
bjos-8647123	95	6	oscc	oscc	ADJ
bjos-8647123	95	7	was	be	AUX
bjos-8647123	95	8	first	first	ADV
bjos-8647123	95	9	suggested	suggest	VERB
bjos-8647123	95	10	by	by	ADP
bjos-8647123	95	11	syrjänen	syrjänen	PROPN
bjos-8647123	95	12	et	et	PROPN
bjos-8647123	95	13	al	al	PROPN
bjos-8647123	95	14	.	.	PROPN
bjos-8647123	95	15	,	,	PUNCT
bjos-8647123	95	16	(	(	PUNCT
bjos-8647123	95	17	1983)14	1983)14	NUM
bjos-8647123	95	18	,	,	PUNCT
bjos-8647123	95	19	who	who	PRON
bjos-8647123	95	20	detected	detect	VERB
bjos-8647123	95	21	koilocytotic	koilocytotic	ADJ
bjos-8647123	95	22	atypias	atypia	NOUN
bjos-8647123	95	23	in	in	ADP
bjos-8647123	95	24	malignant	malignant	ADJ
bjos-8647123	95	25	oral	oral	ADJ
bjos-8647123	95	26	lesions	lesion	NOUN
bjos-8647123	95	27	by	by	ADP
bjos-8647123	95	28	optical	optical	ADJ
bjos-8647123	95	29	microscopy	microscopy	NOUN
bjos-8647123	95	30	and	and	CCONJ
bjos-8647123	95	31	the	the	DET
bjos-8647123	95	32	presence	presence	NOUN
bjos-8647123	95	33	of	of	ADP
bjos-8647123	95	34	viral	viral	ADJ
bjos-8647123	95	35	dna	dna	NOUN
bjos-8647123	95	36	by	by	ADP
bjos-8647123	95	37	means	mean	NOUN
bjos-8647123	95	38	of	of	ADP
bjos-8647123	95	39	ish14	ish14	NOUN
bjos-8647123	95	40	.	.	PUNCT
bjos-8647123	96	1	the	the	DET
bjos-8647123	96	2	current	current	ADJ
bjos-8647123	96	3	study	study	NOUN
bjos-8647123	96	4	revealed	reveal	VERB
bjos-8647123	96	5	positive	positive	ADJ
bjos-8647123	96	6	nuclear	nuclear	ADJ
bjos-8647123	96	7	hybridization	hybridization	NOUN
bjos-8647123	96	8	signals	signal	NOUN
bjos-8647123	96	9	for	for	ADP
bjos-8647123	96	10	hpv-16	hpv-16	PROPN
bjos-8647123	96	11	in	in	ADP
bjos-8647123	96	12	24	24	NUM
bjos-8647123	96	13	(	(	PUNCT
bjos-8647123	96	14	72.7	72.7	NUM
bjos-8647123	96	15	%	%	NOUN
bjos-8647123	96	16	)	)	PUNCT
bjos-8647123	96	17	of	of	ADP
bjos-8647123	96	18	oscc	oscc	ADJ
bjos-8647123	96	19	cases	case	NOUN
bjos-8647123	96	20	.	.	PUNCT
bjos-8647123	97	1	this	this	DET
bjos-8647123	97	2	result	result	NOUN
bjos-8647123	97	3	is	be	AUX
bjos-8647123	97	4	in	in	ADP
bjos-8647123	97	5	accordance	accordance	NOUN
bjos-8647123	97	6	with	with	ADP
bjos-8647123	97	7	those	those	PRON
bjos-8647123	97	8	of	of	ADP
bjos-8647123	97	9	previous	previous	ADJ
bjos-8647123	97	10	studies	study	NOUN
bjos-8647123	97	11	,	,	PUNCT
bjos-8647123	97	12	which	which	PRON
bjos-8647123	97	13	reported	report	VERB
bjos-8647123	97	14	a	a	DET
bjos-8647123	97	15	similar	similar	ADJ
bjos-8647123	97	16	detection	detection	NOUN
bjos-8647123	97	17	rate	rate	NOUN
bjos-8647123	97	18	among	among	ADP
bjos-8647123	97	19	hnscc	hnscc	NOUN
bjos-8647123	97	20	tumors	tumor	NOUN
bjos-8647123	97	21	with	with	ADP
bjos-8647123	97	22	90	90	NUM
bjos-8647123	97	23	%	%	NOUN
bjos-8647123	97	24	of	of	ADP
bjos-8647123	97	25	the	the	DET
bjos-8647123	97	26	hpv	hpv	ADJ
bjos-8647123	97	27	types	type	NOUN
bjos-8647123	97	28	identified	identify	VERB
bjos-8647123	97	29	as	as	ADP
bjos-8647123	97	30	hpv-1634,35	hpv-1634,35	NOUN
bjos-8647123	97	31	.	.	PUNCT
bjos-8647123	98	1	a	a	DET
bjos-8647123	98	2	previous	previous	ADJ
bjos-8647123	98	3	study	study	NOUN
bjos-8647123	98	4	also	also	ADV
bjos-8647123	98	5	confirmed	confirm	VERB
bjos-8647123	98	6	that	that	SCONJ
bjos-8647123	98	7	oral	oral	ADJ
bjos-8647123	98	8	infection	infection	NOUN
bjos-8647123	98	9	with	with	ADP
bjos-8647123	98	10	hpv	hpv	NOUN
bjos-8647123	98	11	increased	increase	VERB
bjos-8647123	98	12	the	the	DET
bjos-8647123	98	13	risk	risk	NOUN
bjos-8647123	98	14	of	of	ADP
bjos-8647123	98	15	tumorigenesis	tumorigenesis	NOUN
bjos-8647123	98	16	of	of	ADP
bjos-8647123	98	17	oropharyngeal	oropharyngeal	ADJ
bjos-8647123	98	18	cancer	cancer	NOUN
bjos-8647123	98	19	independent	independent	ADJ
bjos-8647123	98	20	of	of	ADP
bjos-8647123	98	21	tobacco	tobacco	NOUN
bjos-8647123	98	22	use35	use35	NOUN
bjos-8647123	98	23	.	.	PUNCT
bjos-8647123	99	1	the	the	DET
bjos-8647123	99	2	result	result	NOUN
bjos-8647123	99	3	of	of	ADP
bjos-8647123	99	4	the	the	DET
bjos-8647123	99	5	present	present	ADJ
bjos-8647123	99	6	study	study	NOUN
bjos-8647123	99	7	is	be	AUX
bjos-8647123	99	8	also	also	ADV
bjos-8647123	99	9	in	in	ADP
bjos-8647123	99	10	agreement	agreement	NOUN
bjos-8647123	99	11	with	with	ADP
bjos-8647123	99	12	a	a	DET
bjos-8647123	99	13	previous	previous	ADJ
bjos-8647123	99	14	study	study	NOUN
bjos-8647123	99	15	in	in	ADP
bjos-8647123	99	16	iraq	iraq	PROPN
bjos-8647123	99	17	,	,	PUNCT
bjos-8647123	99	18	which	which	PRON
bjos-8647123	99	19	reported	report	VERB
bjos-8647123	99	20	the	the	DET
bjos-8647123	99	21	significant	significant	ADJ
bjos-8647123	99	22	prevalence	prevalence	NOUN
bjos-8647123	99	23	of	of	ADP
bjos-8647123	99	24	high	high	ADJ
bjos-8647123	99	25	oncogenic	oncogenic	ADJ
bjos-8647123	99	26	hpv	hpv	ADJ
bjos-8647123	99	27	genotypes	genotype	NOUN
bjos-8647123	99	28	in	in	ADP
bjos-8647123	99	29	oscc	oscc	PROPN
bjos-8647123	99	30	patients21	patients21	NOUN
bjos-8647123	99	31	.	.	PUNCT
bjos-8647123	100	1	the	the	DET
bjos-8647123	100	2	high	high	ADJ
bjos-8647123	100	3	-	-	PUNCT
bjos-8647123	100	4	risk	risk	NOUN
bjos-8647123	100	5	hpv	hpv	NOUN
bjos-8647123	100	6	adopts	adopt	VERB
bjos-8647123	100	7	mechanism	mechanism	NOUN
bjos-8647123	100	8	to	to	PART
bjos-8647123	100	9	generate	generate	VERB
bjos-8647123	100	10	the	the	DET
bjos-8647123	100	11	malignant	malignant	ADJ
bjos-8647123	100	12	progression	progression	NOUN
bjos-8647123	100	13	of	of	ADP
bjos-8647123	100	14	previously	previously	ADV
bjos-8647123	100	15	benign	benign	ADJ
bjos-8647123	100	16	lesions	lesion	NOUN
bjos-8647123	100	17	.	.	PUNCT
bjos-8647123	101	1	earlier	early	ADJ
bjos-8647123	101	2	investigations	investigation	NOUN
bjos-8647123	101	3	have	have	AUX
bjos-8647123	101	4	proved	prove	VERB
bjos-8647123	101	5	that	that	SCONJ
bjos-8647123	101	6	high	high	ADJ
bjos-8647123	101	7	-	-	PUNCT
bjos-8647123	101	8	risk	risk	NOUN
bjos-8647123	101	9	hpvs	hpvs	NOUN
bjos-8647123	101	10	and	and	CCONJ
bjos-8647123	101	11	the	the	DET
bjos-8647123	101	12	two	two	NUM
bjos-8647123	101	13	hpv	hpv	ADJ
bjos-8647123	101	14	-	-	PUNCT
bjos-8647123	101	15	related	relate	VERB
bjos-8647123	101	16	oncoproteins	oncoprotein	NOUN
bjos-8647123	101	17	e6	e6	NOUN
bjos-8647123	101	18	and	and	CCONJ
bjos-8647123	101	19	e7	e7	PROPN
bjos-8647123	101	20	can	can	AUX
bjos-8647123	101	21	immortalize	immortalize	VERB
bjos-8647123	101	22	and	and	CCONJ
bjos-8647123	101	23	transform	transform	VERB
bjos-8647123	101	24	oral	oral	ADJ
bjos-8647123	101	25	keratinocytes	keratinocyte	NOUN
bjos-8647123	101	26	in	in	ADP
bjos-8647123	101	27	vitro34,35	vitro34,35	PROPN
bjos-8647123	101	28	.	.	PUNCT
bjos-8647123	102	1	pérez	pérez	NOUN
bjos-8647123	102	2	-	-	PUNCT
bjos-8647123	102	3	sayáns	sayáns	NOUN
bjos-8647123	102	4	garcía	garcía	NOUN
bjos-8647123	102	5	et	et	PROPN
bjos-8647123	102	6	al	al	PROPN
bjos-8647123	102	7	.	.	PUNCT
bjos-8647123	103	1	(	(	PUNCT
bjos-8647123	103	2	2012)32	2012)32	NUM
bjos-8647123	103	3	stated	state	VERB
bjos-8647123	103	4	that	that	SCONJ
bjos-8647123	103	5	“	"	PUNCT
bjos-8647123	103	6	the	the	DET
bjos-8647123	103	7	expression	expression	NOUN
bjos-8647123	103	8	of	of	ADP
bjos-8647123	103	9	timps	timp	NOUN
bjos-8647123	103	10	in	in	ADP
bjos-8647123	103	11	oscc	oscc	ADV
bjos-8647123	103	12	is	be	AUX
bjos-8647123	103	13	higher	high	ADJ
bjos-8647123	103	14	in	in	ADP
bjos-8647123	103	15	tumors	tumor	NOUN
bjos-8647123	103	16	than	than	ADP
bjos-8647123	103	17	in	in	ADP
bjos-8647123	103	18	normal	normal	ADJ
bjos-8647123	103	19	tissue	tissue	NOUN
bjos-8647123	103	20	,	,	PUNCT
bjos-8647123	103	21	which	which	PRON
bjos-8647123	103	22	correlates	correlate	VERB
bjos-8647123	103	23	with	with	ADP
bjos-8647123	103	24	an	an	DET
bjos-8647123	103	25	increase	increase	NOUN
bjos-8647123	103	26	of	of	ADP
bjos-8647123	103	27	metastatic	metastatic	ADJ
bjos-8647123	103	28	risk	risk	NOUN
bjos-8647123	103	29	and	and	CCONJ
bjos-8647123	103	30	regional	regional	ADJ
bjos-8647123	103	31	lymph	lymph	NOUN
bjos-8647123	103	32	node	node	NOUN
bjos-8647123	103	33	affectation	affectation	NOUN
bjos-8647123	103	34	”	"	PUNCT
bjos-8647123	103	35	.	.	PUNCT
bjos-8647123	104	1	however	however	ADV
bjos-8647123	104	2	,	,	PUNCT
bjos-8647123	104	3	the	the	DET
bjos-8647123	104	4	role	role	NOUN
bjos-8647123	104	5	of	of	ADP
bjos-8647123	104	6	timp-2	timp-2	PROPN
bjos-8647123	104	7	in	in	ADP
bjos-8647123	104	8	cervical	cervical	ADJ
bjos-8647123	104	9	carcinoma	carcinoma	NOUN
bjos-8647123	104	10	has	have	AUX
bjos-8647123	104	11	been	be	AUX
bjos-8647123	104	12	approved	approve	VERB
bjos-8647123	104	13	to	to	PART
bjos-8647123	104	14	be	be	AUX
bjos-8647123	104	15	down	down	ADV
bjos-8647123	104	16	-	-	PUNCT
bjos-8647123	104	17	regulated	regulate	VERB
bjos-8647123	104	18	by	by	ADP
bjos-8647123	104	19	acute	acute	ADJ
bjos-8647123	104	20	expression	expression	NOUN
bjos-8647123	104	21	of	of	ADP
bjos-8647123	104	22	hpv	hpv	NOUN
bjos-8647123	104	23	oncoproteins	oncoprotein	NOUN
bjos-8647123	104	24	that	that	PRON
bjos-8647123	104	25	may	may	AUX
bjos-8647123	104	26	favor	favor	VERB
bjos-8647123	104	27	deregulated	deregulate	VERB
bjos-8647123	104	28	mmp	mmp	PROPN
bjos-8647123	104	29	activity	activity	NOUN
bjos-8647123	104	30	in	in	ADP
bjos-8647123	104	31	the	the	DET
bjos-8647123	104	32	context	context	NOUN
bjos-8647123	104	33	of	of	ADP
bjos-8647123	104	34	hpv	hpv	NOUN
bjos-8647123	104	35	infection15,30	infection15,30	PROPN
bjos-8647123	104	36	.	.	PUNCT
bjos-8647123	105	1	fig.1	fig.1	PROPN
bjos-8647123	105	2	.	.	PUNCT
bjos-8647123	105	3	immunohistochemical	immunohistochemical	ADJ
bjos-8647123	105	4	expression	expression	NOUN
bjos-8647123	105	5	of	of	ADP
bjos-8647123	105	6	timp-2	timp-2	PROPN
bjos-8647123	105	7	in	in	ADP
bjos-8647123	105	8	a	a	DET
bjos-8647123	105	9	:	:	PUNCT
bjos-8647123	105	10	colon	colon	NOUN
bjos-8647123	105	11	cancer	cancer	NOUN
bjos-8647123	105	12	(	(	PUNCT
bjos-8647123	105	13	positive	positive	ADJ
bjos-8647123	105	14	control	control	NOUN
bjos-8647123	105	15	)	)	PUNCT
bjos-8647123	105	16	,	,	PUNCT
bjos-8647123	105	17	b	b	X
bjos-8647123	105	18	:	:	PUNCT
bjos-8647123	105	19	oscc	oscc	ADJ
bjos-8647123	105	20	brown	brown	ADJ
bjos-8647123	105	21	cytoplasmic	cytoplasmic	ADJ
bjos-8647123	105	22	granular	granular	ADJ
bjos-8647123	105	23	staining	staining	NOUN
bjos-8647123	105	24	in	in	ADP
bjos-8647123	105	25	poor	poor	ADJ
bjos-8647123	105	26	differentiated	differentiated	ADJ
bjos-8647123	105	27	oral	oral	ADJ
bjos-8647123	105	28	squamous	squamous	ADJ
bjos-8647123	105	29	cell	cell	NOUN
bjos-8647123	105	30	cancer	cancer	NOUN
bjos-8647123	105	31	,	,	PUNCT
bjos-8647123	105	32	strong	strong	ADJ
bjos-8647123	105	33	immunostaining	immunostaine	VERB
bjos-8647123	105	34	(	(	PUNCT
bjos-8647123	105	35	score	score	NOUN
bjos-8647123	105	36	3	3	NUM
bjos-8647123	105	37	)	)	PUNCT
bjos-8647123	105	38	,	,	PUNCT
bjos-8647123	105	39	(	(	PUNCT
bjos-8647123	105	40	x	x	NOUN
bjos-8647123	105	41	200	200	NUM
bjos-8647123	105	42	)	)	PUNCT
bjos-8647123	105	43	.	.	PUNCT
bjos-8647123	106	1	in	in	ADP
bjos-8647123	106	2	this	this	DET
bjos-8647123	106	3	study	study	NOUN
bjos-8647123	106	4	,	,	PUNCT
bjos-8647123	106	5	immunoreactivity	immunoreactivity	NOUN
bjos-8647123	106	6	to	to	ADP
bjos-8647123	106	7	timp-2	timp-2	PROPN
bjos-8647123	106	8	was	be	AUX
bjos-8647123	106	9	observed	observe	VERB
bjos-8647123	106	10	in	in	ADP
bjos-8647123	106	11	27	27	NUM
bjos-8647123	106	12	(	(	PUNCT
bjos-8647123	106	13	81.8	81.8	NUM
bjos-8647123	106	14	%	%	NOUN
bjos-8647123	106	15	)	)	PUNCT
bjos-8647123	106	16	of	of	ADP
bjos-8647123	106	17	oscc	oscc	ADJ
bjos-8647123	106	18	cases	case	NOUN
bjos-8647123	106	19	.	.	PUNCT
bjos-8647123	107	1	this	this	DET
bjos-8647123	107	2	result	result	NOUN
bjos-8647123	107	3	is	be	AUX
bjos-8647123	107	4	in	in	ADP
bjos-8647123	107	5	accordance	accordance	NOUN
bjos-8647123	107	6	with	with	ADP
bjos-8647123	107	7	previous	previous	ADJ
bjos-8647123	107	8	studies	study	NOUN
bjos-8647123	107	9	,	,	PUNCT
bjos-8647123	107	10	and	and	CCONJ
bjos-8647123	107	11	reflect	reflect	VERB
bjos-8647123	107	12	a	a	DET
bjos-8647123	107	13	pathological	pathological	ADJ
bjos-8647123	107	14	role	role	NOUN
bjos-8647123	107	15	of	of	ADP
bjos-8647123	107	16	timp-2	timp-2	PROPN
bjos-8647123	107	17	in	in	ADP
bjos-8647123	107	18	oscc17,18,3639	oscc17,18,3639	PROPN
bjos-8647123	107	19	.	.	PUNCT
bjos-8647123	108	1	the	the	DET
bjos-8647123	108	2	finding	finding	NOUN
bjos-8647123	108	3	of	of	ADP
bjos-8647123	108	4	increased	increase	VERB
bjos-8647123	108	5	timp-2	timp-2	NUM
bjos-8647123	108	6	expression	expression	NOUN
bjos-8647123	108	7	in	in	ADP
bjos-8647123	108	8	oral	oral	ADJ
bjos-8647123	108	9	cancer	cancer	NOUN
bjos-8647123	108	10	might	might	AUX
bjos-8647123	108	11	be	be	AUX
bjos-8647123	108	12	explained	explain	VERB
bjos-8647123	108	13	by	by	ADP
bjos-8647123	108	14	the	the	DET
bjos-8647123	108	15	growth	growth	NOUN
bjos-8647123	108	16	-	-	PUNCT
bjos-8647123	108	17	promoting	promote	VERB
bjos-8647123	108	18	activity	activity	NOUN
bjos-8647123	108	19	of	of	ADP
bjos-8647123	108	20	timps	timp	NOUN
bjos-8647123	108	21	on	on	ADP
bjos-8647123	108	22	a	a	DET
bjos-8647123	108	23	variety	variety	NOUN
bjos-8647123	108	24	of	of	ADP
bjos-8647123	108	25	cell	cell	NOUN
bjos-8647123	108	26	types	type	NOUN
bjos-8647123	108	27	,	,	PUNCT
bjos-8647123	108	28	or	or	CCONJ
bjos-8647123	108	29	the	the	DET
bjos-8647123	108	30	induction	induction	NOUN
bjos-8647123	108	31	of	of	ADP
bjos-8647123	108	32	timps	timp	NOUN
bjos-8647123	108	33	by	by	ADP
bjos-8647123	108	34	secreted	secrete	VERB
bjos-8647123	108	35	mmps	mmp	NOUN
bjos-8647123	108	36	from	from	ADP
bjos-8647123	108	37	tumor	tumor	NOUN
bjos-8647123	108	38	–	–	PUNCT
bjos-8647123	108	39	host	host	NOUN
bjos-8647123	108	40	interaction	interaction	NOUN
bjos-8647123	108	41	in	in	ADP
bjos-8647123	108	42	the	the	DET
bjos-8647123	108	43	extracellular	extracellular	ADJ
bjos-8647123	108	44	milieu39	milieu39	NOUN
bjos-8647123	108	45	.	.	PUNCT
bjos-8647123	109	1	in	in	ADP
bjos-8647123	109	2	addition	addition	NOUN
bjos-8647123	109	3	,	,	PUNCT
bjos-8647123	109	4	many	many	ADJ
bjos-8647123	109	5	immunohistochemical	immunohistochemical	ADJ
bjos-8647123	109	6	studies	study	NOUN
bjos-8647123	109	7	addressed	address	VERB
bjos-8647123	109	8	the	the	DET
bjos-8647123	109	9	positive	positive	ADJ
bjos-8647123	109	10	role	role	NOUN
bjos-8647123	109	11	for	for	ADP
bjos-8647123	109	12	timp-2	timp-2	PROPN
bjos-8647123	109	13	in	in	ADP
bjos-8647123	109	14	tumor	tumor	NOUN
bjos-8647123	109	15	progression	progression	NOUN
bjos-8647123	109	16	and	and	CCONJ
bjos-8647123	109	17	metastasis3,16,18,21	metastasis3,16,18,21	NOUN
bjos-8647123	109	18	-	-	NOUN
bjos-8647123	109	19	23,26	23,26	NOUN
bjos-8647123	109	20	.	.	PUNCT
bjos-8647123	110	1	it	it	PRON
bjos-8647123	110	2	is	be	AUX
bjos-8647123	110	3	believed	believe	VERB
bjos-8647123	110	4	that	that	SCONJ
bjos-8647123	110	5	timp-2	timp-2	PRON
bjos-8647123	110	6	suppresses	suppress	VERB
bjos-8647123	110	7	the	the	DET
bjos-8647123	110	8	tumor	tumor	NOUN
bjos-8647123	110	9	invasion	invasion	NOUN
bjos-8647123	110	10	and	and	CCONJ
bjos-8647123	110	11	metastases	metastasis	NOUN
bjos-8647123	110	12	by	by	ADP
bjos-8647123	110	13	inhibiting	inhibit	VERB
bjos-8647123	110	14	mmp-2	mmp-2	NOUN
bjos-8647123	110	15	.	.	PUNCT
bjos-8647123	111	1	high	high	ADJ
bjos-8647123	111	2	activation	activation	NOUN
bjos-8647123	111	3	of	of	ADP
bjos-8647123	111	4	mmp-2	mmp-2	PUNCT
bjos-8647123	111	5	in	in	ADV
bjos-8647123	111	6	oscc	oscc	ADV
bjos-8647123	111	7	has	have	AUX
bjos-8647123	111	8	been	be	AUX
bjos-8647123	111	9	reported	report	VERB
bjos-8647123	111	10	to	to	PART
bjos-8647123	111	11	be	be	AUX
bjos-8647123	111	12	associated	associate	VERB
bjos-8647123	111	13	with	with	ADP
bjos-8647123	111	14	high	high	ADJ
bjos-8647123	111	15	expression	expression	NOUN
bjos-8647123	111	16	of	of	ADP
bjos-8647123	111	17	timp-2	timp-2	PROPN
bjos-8647123	111	18	in	in	ADP
bjos-8647123	111	19	tumor	tumor	NOUN
bjos-8647123	111	20	cells26,39,40	cells26,39,40	VERB
bjos-8647123	111	21	timp-2	timp-2	PROPN
bjos-8647123	111	22	over	over	ADP
bjos-8647123	111	23	-	-	PUNCT
bjos-8647123	111	24	expression	expression	NOUN
bjos-8647123	111	25	has	have	AUX
bjos-8647123	111	26	been	be	AUX
bjos-8647123	111	27	linked	link	VERB
bjos-8647123	111	28	with	with	ADP
bjos-8647123	111	29	local	local	ADJ
bjos-8647123	111	30	tumor	tumor	NOUN
bjos-8647123	111	31	invasion	invasion	NOUN
bjos-8647123	111	32	,	,	PUNCT
bjos-8647123	111	33	nodal	nodal	NOUN
bjos-8647123	111	34	status	status	NOUN
bjos-8647123	111	35	and	and	CCONJ
bjos-8647123	111	36	clinical	clinical	ADJ
bjos-8647123	111	37	stage	stage	NOUN
bjos-8647123	111	38	,	,	PUNCT
bjos-8647123	111	39	as	as	ADV
bjos-8647123	111	40	well	well	ADV
bjos-8647123	111	41	as	as	ADP
bjos-8647123	111	42	with	with	ADP
bjos-8647123	111	43	disease	disease	NOUN
bjos-8647123	111	44	-	-	PUNCT
bjos-8647123	111	45	free	free	ADJ
bjos-8647123	111	46	survival	survival	NOUN
bjos-8647123	111	47	in	in	ADP
bjos-8647123	111	48	oral	oral	ADJ
bjos-8647123	111	49	cancer	cancer	NOUN
bjos-8647123	111	50	,	,	PUNCT
bjos-8647123	111	51	especially	especially	ADV
bjos-8647123	111	52	in	in	ADP
bjos-8647123	111	53	tongue	tongue	PROPN
bjos-8647123	111	54	scc41	scc41	PROPN
bjos-8647123	111	55	.	.	PUNCT
bjos-8647123	112	1	in	in	ADP
bjos-8647123	112	2	this	this	DET
bjos-8647123	112	3	study	study	NOUN
bjos-8647123	112	4	,	,	PUNCT
bjos-8647123	112	5	72.7	72.7	NUM
bjos-8647123	112	6	%	%	NOUN
bjos-8647123	112	7	of	of	ADP
bjos-8647123	112	8	oscc	oscc	ADV
bjos-8647123	112	9	appeared	appear	VERB
bjos-8647123	112	10	to	to	PART
bjos-8647123	112	11	harbor	harbor	VERB
bjos-8647123	112	12	detectable	detectable	ADJ
bjos-8647123	112	13	hpv-16	hpv-16	NOUN
bjos-8647123	112	14	,	,	PUNCT
bjos-8647123	112	15	whereas	whereas	ADV
bjos-8647123	112	16	,	,	PUNCT
bjos-8647123	112	17	no	no	DET
bjos-8647123	112	18	significant	significant	ADJ
bjos-8647123	112	19	difference	difference	NOUN
bjos-8647123	112	20	was	be	AUX
bjos-8647123	112	21	observed	observe	VERB
bjos-8647123	112	22	in	in	ADP
bjos-8647123	112	23	relation	relation	NOUN
bjos-8647123	112	24	between	between	ADP
bjos-8647123	112	25	positive	positive	ADJ
bjos-8647123	112	26	hpv-16	hpv-16	NOUN
bjos-8647123	112	27	and	and	CCONJ
bjos-8647123	112	28	timp-2	timp-2	NUM
bjos-8647123	112	29	expression	expression	NOUN
bjos-8647123	112	30	level	level	NOUN
bjos-8647123	112	31	.	.	PUNCT
bjos-8647123	113	1	however	however	ADV
bjos-8647123	113	2	,	,	PUNCT
bjos-8647123	113	3	the	the	DET
bjos-8647123	113	4	p	p	NOUN
bjos-8647123	113	5	value	value	NOUN
bjos-8647123	113	6	was	be	AUX
bjos-8647123	113	7	borderline	borderline	NOUN
bjos-8647123	113	8	(	(	PUNCT
bjos-8647123	113	9	p	p	X
bjos-8647123	113	10	=	=	NOUN
bjos-8647123	113	11	0.058	0.058	NUM
bjos-8647123	113	12	)	)	PUNCT
bjos-8647123	113	13	.	.	PUNCT
bjos-8647123	114	1	the	the	DET
bjos-8647123	114	2	results	result	NOUN
bjos-8647123	114	3	of	of	ADP
bjos-8647123	114	4	this	this	DET
bjos-8647123	114	5	study	study	NOUN
bjos-8647123	114	6	also	also	ADV
bjos-8647123	114	7	revealed	reveal	VERB
bjos-8647123	114	8	no	no	DET
bjos-8647123	114	9	significant	significant	ADJ
bjos-8647123	114	10	association	association	NOUN
bjos-8647123	114	11	between	between	ADP
bjos-8647123	114	12	level	level	NOUN
bjos-8647123	114	13	of	of	ADP
bjos-8647123	114	14	timp-2	timp-2	NUM
bjos-8647123	114	15	expression	expression	NOUN
bjos-8647123	114	16	and	and	CCONJ
bjos-8647123	114	17	tumor	tumor	NOUN
bjos-8647123	114	18	stage	stage	NOUN
bjos-8647123	114	19	,	,	PUNCT
bjos-8647123	114	20	tumor	tumor	NOUN
bjos-8647123	114	21	grade	grade	NOUN
bjos-8647123	114	22	or	or	CCONJ
bjos-8647123	114	23	lymph	lymph	NOUN
bjos-8647123	114	24	node	node	ADJ
bjos-8647123	114	25	metastases	metastasis	NOUN
bjos-8647123	114	26	.	.	PUNCT
bjos-8647123	115	1	however	however	ADV
bjos-8647123	115	2	,	,	PUNCT
bjos-8647123	115	3	many	many	ADJ
bjos-8647123	115	4	other	other	ADJ
bjos-8647123	115	5	researchers	researcher	NOUN
bjos-8647123	115	6	found	find	VERB
bjos-8647123	115	7	significant	significant	ADJ
bjos-8647123	115	8	relationships	relationship	NOUN
bjos-8647123	115	9	,	,	PUNCT
bjos-8647123	115	10	and	and	CCONJ
bjos-8647123	115	11	such	such	ADJ
bjos-8647123	115	12	studies	study	NOUN
bjos-8647123	115	13	include	include	VERB
bjos-8647123	115	14	the	the	DET
bjos-8647123	115	15	following	follow	VERB
bjos-8647123	115	16	correlations	correlation	NOUN
bjos-8647123	115	17	between	between	ADP
bjos-8647123	115	18	:	:	PUNCT
bjos-8647123	115	19	a	a	X
bjos-8647123	115	20	)	)	PUNCT
bjos-8647123	115	21	the	the	DET
bjos-8647123	115	22	expression	expression	NOUN
bjos-8647123	115	23	of	of	ADP
bjos-8647123	115	24	timp-2	timp-2	PROPN
bjos-8647123	115	25	and	and	CCONJ
bjos-8647123	115	26	tumor	tumor	NOUN
bjos-8647123	115	27	size	size	NOUN
bjos-8647123	115	28	or	or	CCONJ
bjos-8647123	115	29	lymphatic	lymphatic	ADJ
bjos-8647123	115	30	metastasis9,41	metastasis9,41	PROPN
bjos-8647123	115	31	.	.	PUNCT
bjos-8647123	116	1	b	b	X
bjos-8647123	116	2	)	)	PUNCT
bjos-8647123	116	3	the	the	DET
bjos-8647123	116	4	expression	expression	NOUN
bjos-8647123	116	5	of	of	ADP
bjos-8647123	116	6	timp-1	timp-1	NUM
bjos-8647123	116	7	and	and	CCONJ
bjos-8647123	116	8	lymphatic	lymphatic	ADJ
bjos-8647123	116	9	metastasis9,41,42	metastasis9,41,42	NOUN
bjos-8647123	116	10	;	;	PUNCT
bjos-8647123	116	11	c	c	X
bjos-8647123	116	12	)	)	PUNCT
bjos-8647123	116	13	the	the	DET
bjos-8647123	116	14	expression	expression	NOUN
bjos-8647123	116	15	of	of	ADP
bjos-8647123	116	16	mmp-2	mmp-2	ADJ
bjos-8647123	116	17	and	and	CCONJ
bjos-8647123	116	18	histologic	histologic	ADJ
bjos-8647123	116	19	grade	grade	NOUN
bjos-8647123	116	20	or	or	CCONJ
bjos-8647123	116	21	lymphatic	lymphatic	ADJ
bjos-8647123	116	22	metastasis4,14,39,42	metastasis4,14,39,42	NOUN
bjos-8647123	116	23	-	-	PUNCT
bjos-8647123	116	24	45	45	NUM
bjos-8647123	116	25	.	.	PUNCT
bjos-8647123	117	1	in	in	ADP
bjos-8647123	117	2	conclusion	conclusion	NOUN
bjos-8647123	117	3	,	,	PUNCT
bjos-8647123	117	4	this	this	DET
bjos-8647123	117	5	study	study	NOUN
bjos-8647123	117	6	investigated	investigate	VERB
bjos-8647123	117	7	the	the	DET
bjos-8647123	117	8	expression	expression	NOUN
bjos-8647123	117	9	of	of	ADP
bjos-8647123	117	10	timp2	timp2	NOUN
bjos-8647123	117	11	in	in	ADP
bjos-8647123	117	12	hpv-16	hpv-16	NUM
bjos-8647123	117	13	infected	infect	VERB
bjos-8647123	117	14	tumor	tumor	NOUN
bjos-8647123	117	15	tissues	tissue	NOUN
bjos-8647123	117	16	of	of	ADP
bjos-8647123	117	17	oscc	oscc	NOUN
bjos-8647123	117	18	in	in	ADP
bjos-8647123	117	19	iraq	iraq	PROPN
bjos-8647123	117	20	,	,	PUNCT
bjos-8647123	117	21	and	and	CCONJ
bjos-8647123	117	22	found	find	VERB
bjos-8647123	117	23	that	that	SCONJ
bjos-8647123	117	24	the	the	DET
bjos-8647123	117	25	percentage	percentage	NOUN
bjos-8647123	117	26	of	of	ADP
bjos-8647123	117	27	samples	sample	NOUN
bjos-8647123	117	28	that	that	PRON
bjos-8647123	117	29	appeared	appear	VERB
bjos-8647123	117	30	to	to	PART
bjos-8647123	117	31	accommodate	accommodate	VERB
bjos-8647123	117	32	detectable	detectable	ADJ
bjos-8647123	117	33	hpv-16	hpv-16	PRON
bjos-8647123	117	34	reached	reach	VERB
bjos-8647123	117	35	up	up	ADP
bjos-8647123	117	36	to	to	PART
bjos-8647123	117	37	72.7	72.7	NUM
bjos-8647123	117	38	%	%	NOUN
bjos-8647123	117	39	.	.	PUNCT
bjos-8647123	118	1	however	however	ADV
bjos-8647123	118	2	,	,	PUNCT
bjos-8647123	118	3	no	no	DET
bjos-8647123	118	4	significant	significant	ADJ
bjos-8647123	118	5	difference	difference	NOUN
bjos-8647123	118	6	was	be	AUX
bjos-8647123	118	7	observed	observe	VERB
bjos-8647123	118	8	in	in	ADP
bjos-8647123	118	9	relation	relation	NOUN
bjos-8647123	118	10	to	to	ADP
bjos-8647123	118	11	timp-2	timp-2	NUM
bjos-8647123	118	12	expression	expression	NOUN
bjos-8647123	118	13	level	level	NOUN
bjos-8647123	118	14	.	.	PUNCT
bjos-8647123	119	1	future	future	ADJ
bjos-8647123	119	2	studies	study	NOUN
bjos-8647123	119	3	with	with	ADP
bjos-8647123	119	4	a	a	DET
bjos-8647123	119	5	larger	large	ADJ
bjos-8647123	119	6	number	number	NOUN
bjos-8647123	119	7	of	of	ADP
bjos-8647123	119	8	patients	patient	NOUN
bjos-8647123	119	9	are	be	AUX
bjos-8647123	119	10	highly	highly	ADV
bjos-8647123	119	11	recommended	recommend	VERB
bjos-8647123	119	12	to	to	PART
bjos-8647123	119	13	address	address	VERB
bjos-8647123	119	14	the	the	DET
bjos-8647123	119	15	possible	possible	ADJ
bjos-8647123	119	16	association	association	NOUN
bjos-8647123	119	17	between	between	ADP
bjos-8647123	119	18	timp-2	timp-2	PROPN
bjos-8647123	119	19	and	and	CCONJ
bjos-8647123	119	20	oscc	oscc	ADJ
bjos-8647123	119	21	positive	positive	ADJ
bjos-8647123	119	22	hpv-16	hpv-16	PROPN
bjos-8647123	119	23	.	.	PROPN
bjos-8647123	119	24	references	reference	NOUN
bjos-8647123	119	25	1	1	NUM
bjos-8647123	119	26	.	.	PUNCT
bjos-8647123	120	1	wang	wang	PROPN
bjos-8647123	120	2	b	b	PROPN
bjos-8647123	120	3	,	,	PUNCT
bjos-8647123	120	4	zhang	zhang	PROPN
bjos-8647123	120	5	s	s	PROPN
bjos-8647123	120	6	,	,	PUNCT
bjos-8647123	120	7	yue	yue	PROPN
bjos-8647123	120	8	k	k	PROPN
bjos-8647123	120	9	,	,	PUNCT
bjos-8647123	120	10	wang	wang	PROPN
bjos-8647123	120	11	xd	xd	PROPN
bjos-8647123	120	12	.	.	PUNCT
bjos-8647123	121	1	the	the	DET
bjos-8647123	121	2	recurrence	recurrence	NOUN
bjos-8647123	121	3	and	and	CCONJ
bjos-8647123	121	4	survival	survival	NOUN
bjos-8647123	121	5	of	of	ADP
bjos-8647123	121	6	oral	oral	ADJ
bjos-8647123	121	7	squamous	squamous	ADJ
bjos-8647123	121	8	cell	cell	NOUN
bjos-8647123	121	9	carcinoma	carcinoma	NOUN
bjos-8647123	121	10	:	:	PUNCT
bjos-8647123	121	11	a	a	DET
bjos-8647123	121	12	report	report	NOUN
bjos-8647123	121	13	of	of	ADP
bjos-8647123	121	14	275	275	NUM
bjos-8647123	121	15	cases	case	NOUN
bjos-8647123	121	16	.	.	PUNCT
bjos-8647123	122	1	chin	chin	PROPN
bjos-8647123	122	2	j	j	PROPN
bjos-8647123	122	3	cancer	cancer	NOUN
bjos-8647123	122	4	.	.	PUNCT
bjos-8647123	123	1	2013	2013	NUM
bjos-8647123	123	2	nov;32(11):614	nov;32(11):614	PROPN
bjos-8647123	123	3	-	-	X
bjos-8647123	123	4	8	8	NUM
bjos-8647123	123	5	.	.	PUNCT
bjos-8647123	124	1	doi	doi	NOUN
bjos-8647123	124	2	:	:	PUNCT
bjos-8647123	124	3	10.5732	10.5732	NUM
bjos-8647123	124	4	/	/	SYM
bjos-8647123	124	5	cjc.012.10219	cjc.012.10219	NOUN
bjos-8647123	124	6	.	.	PUNCT
bjos-8647123	125	1	2	2	NUM
bjos-8647123	125	2	.	.	X
bjos-8647123	125	3	scully	scully	PROPN
bjos-8647123	125	4	c	c	PROPN
bjos-8647123	125	5	,	,	PUNCT
bjos-8647123	125	6	kirby	kirby	PROPN
bjos-8647123	125	7	j.	j.	PROPN
bjos-8647123	125	8	statement	statement	PROPN
bjos-8647123	125	9	on	on	ADP
bjos-8647123	125	10	mouth	mouth	NOUN
bjos-8647123	125	11	cancer	cancer	NOUN
bjos-8647123	125	12	diagnosis	diagnosis	NOUN
bjos-8647123	125	13	and	and	CCONJ
bjos-8647123	125	14	prevention	prevention	NOUN
bjos-8647123	125	15	.	.	PUNCT
bjos-8647123	126	1	br	br	PROPN
bjos-8647123	126	2	dent	dent	NOUN
bjos-8647123	126	3	j.	j.	PROPN
bjos-8647123	126	4	2014	2014	NUM
bjos-8647123	126	5	jan;216(1):37	jan;216(1):37	PROPN
bjos-8647123	126	6	-	-	PUNCT
bjos-8647123	126	7	8	8	NUM
bjos-8647123	126	8	.	.	PUNCT
bjos-8647123	126	9	doi	doi	NOUN
bjos-8647123	126	10	:	:	PUNCT
bjos-8647123	126	11	10.1038	10.1038	NUM
bjos-8647123	126	12	/	/	SYM
bjos-8647123	126	13	sj.bdj.2013.1235	sj.bdj.2013.1235	PROPN
bjos-8647123	126	14	3	3	NUM
bjos-8647123	126	15	.	.	PROPN
bjos-8647123	126	16	sasahira	sasahira	PROPN
bjos-8647123	126	17	t	t	PROPN
bjos-8647123	126	18	,	,	PUNCT
bjos-8647123	126	19	kurihara	kurihara	VERB
bjos-8647123	126	20	m	m	PROPN
bjos-8647123	126	21	,	,	PUNCT
bjos-8647123	126	22	nishiguchi	nishiguchi	PROPN
bjos-8647123	126	23	y	y	PROPN
bjos-8647123	126	24	,	,	PUNCT
bjos-8647123	126	25	fujiwara	fujiwara	PROPN
bjos-8647123	126	26	r	r	PROPN
bjos-8647123	126	27	,	,	PUNCT
bjos-8647123	126	28	kirita	kirita	PROPN
bjos-8647123	126	29	t	t	PROPN
bjos-8647123	126	30	,	,	PUNCT
bjos-8647123	126	31	kuniyasu	kuniyasu	PROPN
bjos-8647123	126	32	h.	h.	PROPN
bjos-8647123	126	33	nedd	nedd	PROPN
bjos-8647123	126	34	4	4	NUM
bjos-8647123	126	35	binding	bind	VERB
bjos-8647123	126	36	protein	protein	NOUN
bjos-8647123	126	37	2	2	NUM
bjos-8647123	126	38	-	-	PUNCT
bjos-8647123	126	39	like	like	ADJ
bjos-8647123	126	40	1	1	NUM
bjos-8647123	126	41	promotes	promote	VERB
bjos-8647123	126	42	cancer	cancer	NOUN
bjos-8647123	126	43	cell	cell	NOUN
bjos-8647123	126	44	invasion	invasion	NOUN
bjos-8647123	126	45	in	in	ADP
bjos-8647123	126	46	oral	oral	ADJ
bjos-8647123	126	47	squamous	squamous	ADJ
bjos-8647123	126	48	cell	cell	NOUN
bjos-8647123	126	49	carcinoma	carcinoma	NOUN
bjos-8647123	126	50	.	.	PUNCT
bjos-8647123	127	1	virchows	virchow	VERB
bjos-8647123	127	2	archiv	archiv	PROPN
bjos-8647123	127	3	.	.	PUNCT
bjos-8647123	128	1	2016	2016	NUM
bjos-8647123	128	2	aug;469(2):163	aug;469(2):163	ADJ
bjos-8647123	128	3	-	-	NOUN
bjos-8647123	128	4	72	72	NUM
bjos-8647123	128	5	.	.	PUNCT
bjos-8647123	129	1	doi	doi	NOUN
bjos-8647123	129	2	:	:	PUNCT
bjos-8647123	129	3	10.1007	10.1007	NUM
bjos-8647123	129	4	/	/	SYM
bjos-8647123	129	5	s00428	s00428	PROPN
bjos-8647123	129	6	-	-	PUNCT
bjos-8647123	129	7	016	016	NUM
bjos-8647123	129	8	-	-	PUNCT
bjos-8647123	129	9	1955	1955	NUM
bjos-8647123	129	10	-	-	SYM
bjos-8647123	129	11	4	4	NUM
bjos-8647123	129	12	.	.	NOUN
bjos-8647123	129	13	4	4	NUM
bjos-8647123	129	14	.	.	NOUN
bjos-8647123	129	15	oral	oral	ADJ
bjos-8647123	129	16	cancer	cancer	NOUN
bjos-8647123	129	17	foundation	foundation	PROPN
bjos-8647123	129	18	.	.	PUNCT
bjos-8647123	130	1	oral	oral	ADJ
bjos-8647123	130	2	cancer	cancer	NOUN
bjos-8647123	130	3	facts	fact	NOUN
bjos-8647123	130	4	.	.	PUNCT
bjos-8647123	131	1	the	the	DET
bjos-8647123	131	2	oral	oral	ADJ
bjos-8647123	131	3	cancer	cancer	NOUN
bjos-8647123	131	4	foundation	foundation	PROPN
bjos-8647123	131	5	.	.	PUNCT
bjos-8647123	132	1	available	available	ADJ
bjos-8647123	132	2	from	from	ADP
bjos-8647123	132	3	:	:	PUNCT
bjos-8647123	132	4	http://www.oralcancerfoundation.org/facts	http://www.oralcancerfoundation.org/fact	NOUN
bjos-8647123	132	5	.	.	NOUN
bjos-8647123	133	1	5	5	NUM
bjos-8647123	133	2	.	.	X
bjos-8647123	133	3	jemal	jemal	PROPN
bjos-8647123	133	4	a	a	PRON
bjos-8647123	133	5	,	,	PUNCT
bjos-8647123	133	6	bray	bray	PROPN
bjos-8647123	133	7	f	f	PROPN
bjos-8647123	133	8	,	,	PUNCT
bjos-8647123	133	9	center	center	NOUN
bjos-8647123	133	10	mm	mm	PROPN
bjos-8647123	133	11	,	,	PUNCT
bjos-8647123	133	12	ferlay	ferlay	PROPN
bjos-8647123	133	13	j	j	PROPN
bjos-8647123	133	14	,	,	PUNCT
bjos-8647123	133	15	ward	ward	NOUN
bjos-8647123	133	16	e	e	NOUN
bjos-8647123	133	17	,	,	PUNCT
bjos-8647123	133	18	forman	forman	PROPN
bjos-8647123	133	19	d.	d.	PROPN
bjos-8647123	133	20	global	global	PROPN
bjos-8647123	133	21	cancer	cancer	PROPN
bjos-8647123	133	22	statistics	statistic	NOUN
bjos-8647123	133	23	.	.	PUNCT
bjos-8647123	134	1	ca	can	AUX
bjos-8647123	134	2	cancer	cancer	PROPN
bjos-8647123	134	3	j	j	PROPN
bjos-8647123	134	4	clin	clin	PROPN
bjos-8647123	134	5	.	.	PUNCT
bjos-8647123	135	1	2011	2011	NUM
bjos-8647123	135	2	mar	mar	PROPN
bjos-8647123	135	3	-	-	PUNCT
bjos-8647123	135	4	apr;61(2):69	apr;61(2):69	PROPN
bjos-8647123	135	5	-	-	PUNCT
bjos-8647123	135	6	90	90	NUM
bjos-8647123	135	7	.	.	PUNCT
bjos-8647123	135	8	doi	doi	NOUN
bjos-8647123	135	9	:	:	PUNCT
bjos-8647123	135	10	10.3322/	10.3322/	NUM
bjos-8647123	135	11	caac.20107	caac.20107	PROPN
bjos-8647123	135	12	6	6	NUM
bjos-8647123	135	13	.	.	PUNCT
bjos-8647123	135	14	lima	lima	PROPN
bjos-8647123	135	15	map	map	NOUN
bjos-8647123	135	16	,	,	PUNCT
bjos-8647123	135	17	silva	silva	PROPN
bjos-8647123	135	18	cgl	cgl	PROPN
bjos-8647123	135	19	,	,	PUNCT
bjos-8647123	135	20	rabenhorst	rabenhorst	ADJ
bjos-8647123	135	21	shb	shb	PROPN
bjos-8647123	135	22	.	.	PUNCT
bjos-8647123	136	1	association	association	NOUN
bjos-8647123	136	2	between	between	ADP
bjos-8647123	136	3	human	human	ADJ
bjos-8647123	136	4	papillomavirus	papillomavirus	NOUN
bjos-8647123	136	5	(	(	PUNCT
bjos-8647123	136	6	hpv	hpv	NOUN
bjos-8647123	136	7	)	)	PUNCT
bjos-8647123	136	8	and	and	CCONJ
bjos-8647123	136	9	the	the	DET
bjos-8647123	136	10	oral	oral	ADJ
bjos-8647123	136	11	squamous	squamous	ADJ
bjos-8647123	136	12	cell	cell	NOUN
bjos-8647123	136	13	carcinoma	carcinoma	NOUN
bjos-8647123	136	14	:	:	PUNCT
bjos-8647123	136	15	a	a	DET
bjos-8647123	136	16	systematic	systematic	ADJ
bjos-8647123	136	17	review	review	NOUN
bjos-8647123	136	18	.	.	PUNCT
bjos-8647123	137	1	j	j	PROPN
bjos-8647123	137	2	bras	bras	PROPN
bjos-8647123	137	3	patol	patol	VERB
bjos-8647123	137	4	med	med	ADJ
bjos-8647123	137	5	lab	lab	NOUN
bjos-8647123	137	6	.	.	PUNCT
bjos-8647123	138	1	2014	2014	NUM
bjos-8647123	138	2	feb	feb	NOUN
bjos-8647123	139	1	[	[	X
bjos-8647123	139	2	cited	cite	VERB
bjos-8647123	139	3	2014	2014	NUM
bjos-8647123	139	4	54	54	NUM
bjos-8647123	139	5	expression	expression	NOUN
bjos-8647123	139	6	of	of	ADP
bjos-8647123	139	7	timp-2	timp-2	NUM
bjos-8647123	139	8	in	in	ADP
bjos-8647123	139	9	hpv-16	hpv-16	NUM
bjos-8647123	139	10	infected	infect	VERB
bjos-8647123	139	11	oral	oral	ADJ
bjos-8647123	139	12	squamous	squamous	ADJ
bjos-8647123	139	13	cell	cell	NOUN
bjos-8647123	139	14	carcinoma	carcinoma	NOUN
bjos-8647123	139	15	in	in	ADP
bjos-8647123	139	16	patients	patient	NOUN
bjos-8647123	139	17	in	in	ADP
bjos-8647123	139	18	iraq	iraq	PROPN
bjos-8647123	139	19	fig.2	fig.2	PROPN
bjos-8647123	139	20	.	.	PUNCT
bjos-8647123	140	1	immunohistochemical	immunohistochemical	ADJ
bjos-8647123	140	2	expression	expression	NOUN
bjos-8647123	140	3	of	of	ADP
bjos-8647123	140	4	timp-2	timp-2	PROPN
bjos-8647123	140	5	/	/	SYM
bjos-8647123	140	6	oscc	oscc	ADJ
bjos-8647123	140	7	negative	negative	ADJ
bjos-8647123	140	8	control	control	NOUN
bjos-8647123	140	9	.	.	PUNCT
bjos-8647123	141	1	timp-2	timp-2	NUM
bjos-8647123	141	2	score	score	NOUN
bjos-8647123	141	3	0	0	NUM
bjos-8647123	141	4	score	score	NOUN
bjos-8647123	141	5	1	1	NUM
bjos-8647123	141	6	score	score	NOUN
bjos-8647123	141	7	2	2	NUM
bjos-8647123	141	8	score	score	NOUN
bjos-8647123	141	9	3	3	NUM
bjos-8647123	141	10	6	6	NUM
bjos-8647123	141	11	(	(	PUNCT
bjos-8647123	141	12	18,20	18,20	NOUN
bjos-8647123	141	13	%	%	NOUN
bjos-8647123	141	14	)	)	PUNCT
bjos-8647123	141	15	12	12	NUM
bjos-8647123	141	16	(	(	PUNCT
bjos-8647123	141	17	36.40	36.40	NUM
bjos-8647123	141	18	%	%	NOUN
bjos-8647123	141	19	)	)	PUNCT
bjos-8647123	141	20	11	11	NUM
bjos-8647123	141	21	(	(	PUNCT
bjos-8647123	141	22	33.30	33.30	NUM
bjos-8647123	141	23	%	%	NOUN
bjos-8647123	141	24	)	)	PUNCT
bjos-8647123	141	25	4	4	NUM
bjos-8647123	141	26	(	(	PUNCT
bjos-8647123	141	27	12.1	12.1	NUM
bjos-8647123	141	28	%	%	NOUN
bjos-8647123	141	29	)	)	PUNCT
bjos-8647123	141	30	table	table	NOUN
bjos-8647123	141	31	2	2	NUM
bjos-8647123	141	32	expression	expression	NOUN
bjos-8647123	141	33	score	score	NOUN
bjos-8647123	141	34	of	of	ADP
bjos-8647123	141	35	timp-2	timp-2	PROPN
bjos-8647123	141	36	in	in	ADP
bjos-8647123	141	37	oscc	oscc	ADV
bjos-8647123	141	38	.	.	PUNCT
bjos-8647123	142	1	timp-2	timp-2	NUM
bjos-8647123	142	2	score	score	NOUN
bjos-8647123	142	3	lymph	lymph	NOUN
bjos-8647123	142	4	node	node	PROPN
bjos-8647123	142	5	involvement	involvement	NOUN
bjos-8647123	142	6	score	score	NOUN
bjos-8647123	142	7	1	1	NUM
bjos-8647123	142	8	score	score	NOUN
bjos-8647123	142	9	2	2	NUM
bjos-8647123	142	10	score	score	NOUN
bjos-8647123	142	11	3	3	NUM
bjos-8647123	142	12	total	total	NOUN
bjos-8647123	142	13	positive	positive	ADJ
bjos-8647123	142	14	8	8	NUM
bjos-8647123	142	15	(	(	PUNCT
bjos-8647123	142	16	34.80	34.80	NUM
bjos-8647123	142	17	%	%	NOUN
bjos-8647123	142	18	)	)	PUNCT
bjos-8647123	142	19	12	12	NUM
bjos-8647123	142	20	(	(	PUNCT
bjos-8647123	142	21	36.40	36.40	NUM
bjos-8647123	142	22	%	%	NOUN
bjos-8647123	142	23	)	)	PUNCT
bjos-8647123	142	24	3	3	NUM
bjos-8647123	142	25	(	(	PUNCT
bjos-8647123	142	26	13.00	13.00	NUM
bjos-8647123	142	27	%	%	NOUN
bjos-8647123	142	28	)	)	PUNCT
bjos-8647123	142	29	23	23	NUM
bjos-8647123	142	30	(	(	PUNCT
bjos-8647123	142	31	85.20	85.20	NUM
bjos-8647123	142	32	%	%	NOUN
bjos-8647123	142	33	)	)	PUNCT
bjos-8647123	142	34	negative	negative	ADJ
bjos-8647123	142	35	3	3	NUM
bjos-8647123	142	36	(	(	PUNCT
bjos-8647123	142	37	75.00	75.00	NUM
bjos-8647123	142	38	%	%	NOUN
bjos-8647123	142	39	)	)	PUNCT
bjos-8647123	142	40	0	0	NUM
bjos-8647123	142	41	%	%	NOUN
bjos-8647123	142	42	1	1	NUM
bjos-8647123	142	43	(	(	PUNCT
bjos-8647123	142	44	25.00	25.00	NUM
bjos-8647123	142	45	%	%	NOUN
bjos-8647123	142	46	)	)	PUNCT
bjos-8647123	142	47	4	4	NUM
bjos-8647123	142	48	(	(	PUNCT
bjos-8647123	142	49	14.80	14.80	NUM
bjos-8647123	142	50	%	%	NOUN
bjos-8647123	142	51	)	)	PUNCT
bjos-8647123	142	52	total	total	NOUN
bjos-8647123	142	53	11	11	NUM
bjos-8647123	142	54	(	(	PUNCT
bjos-8647123	142	55	33.30	33.30	NUM
bjos-8647123	142	56	%	%	NOUN
bjos-8647123	142	57	)	)	PUNCT
bjos-8647123	142	58	12	12	NUM
bjos-8647123	142	59	(	(	PUNCT
bjos-8647123	142	60	36.40	36.40	NUM
bjos-8647123	142	61	%	%	NOUN
bjos-8647123	142	62	)	)	PUNCT
bjos-8647123	142	63	4	4	NUM
bjos-8647123	142	64	(	(	PUNCT
bjos-8647123	142	65	36.40	36.40	NUM
bjos-8647123	142	66	%	%	NOUN
bjos-8647123	142	67	)	)	PUNCT
bjos-8647123	142	68	27	27	NUM
bjos-8647123	142	69	table	table	NOUN
bjos-8647123	142	70	3	3	NUM
bjos-8647123	142	71	association	association	NOUN
bjos-8647123	142	72	of	of	ADP
bjos-8647123	142	73	timp-2	timp-2	NUM
bjos-8647123	142	74	expression	expression	NOUN
bjos-8647123	142	75	score	score	NOUN
bjos-8647123	142	76	and	and	CCONJ
bjos-8647123	142	77	lymph	lymph	VERB
bjos-8647123	142	78	node	node	ADJ
bjos-8647123	142	79	metastases	metastasis	NOUN
bjos-8647123	142	80	in	in	ADP
bjos-8647123	142	81	oscc	oscc	PROPN
bjos-8647123	142	82	(	(	PUNCT
bjos-8647123	142	83	p=	p=	NOUN
bjos-8647123	142	84	0.176	0.176	NUM
bjos-8647123	142	85	)	)	PUNCT
bjos-8647123	142	86	.	.	PUNCT
bjos-8647123	143	1	timp-2	timp-2	NUM
bjos-8647123	143	2	grade	grade	NOUN
bjos-8647123	143	3	*	*	PUNCT
bjos-8647123	143	4	positive	positive	ADJ
bjos-8647123	143	5	n	n	CCONJ
bjos-8647123	143	6	(	(	PUNCT
bjos-8647123	143	7	%	%	INTJ
bjos-8647123	143	8	)	)	PUNCT
bjos-8647123	143	9	negative	negative	ADJ
bjos-8647123	143	10	n	n	CCONJ
bjos-8647123	143	11	(	(	PUNCT
bjos-8647123	143	12	%	%	NOUN
bjos-8647123	143	13	)	)	PUNCT
bjos-8647123	143	14	total	total	NOUN
bjos-8647123	143	15	n	n	CCONJ
bjos-8647123	143	16	(	(	PUNCT
bjos-8647123	143	17	%	%	INTJ
bjos-8647123	143	18	)	)	PUNCT
bjos-8647123	143	19	low	low	ADJ
bjos-8647123	143	20	3	3	NUM
bjos-8647123	143	21	(	(	PUNCT
bjos-8647123	143	22	75	75	NUM
bjos-8647123	143	23	)	)	SYM
bjos-8647123	143	24	1	1	NUM
bjos-8647123	143	25	(	(	PUNCT
bjos-8647123	143	26	25	25	NUM
bjos-8647123	143	27	)	)	PUNCT
bjos-8647123	143	28	4	4	NUM
bjos-8647123	143	29	(	(	PUNCT
bjos-8647123	143	30	12.1	12.1	NUM
bjos-8647123	143	31	)	)	PUNCT
bjos-8647123	143	32	intermediate	intermediate	ADJ
bjos-8647123	143	33	21	21	NUM
bjos-8647123	143	34	(	(	PUNCT
bjos-8647123	143	35	80.8	80.8	NUM
bjos-8647123	143	36	)	)	SYM
bjos-8647123	143	37	5	5	NUM
bjos-8647123	143	38	(	(	PUNCT
bjos-8647123	143	39	19.2	19.2	NUM
bjos-8647123	143	40	)	)	PUNCT
bjos-8647123	143	41	26	26	NUM
bjos-8647123	143	42	(	(	PUNCT
bjos-8647123	143	43	78.8	78.8	NUM
bjos-8647123	143	44	)	)	PUNCT
bjos-8647123	143	45	high	high	ADJ
bjos-8647123	143	46	3	3	NUM
bjos-8647123	143	47	(	(	PUNCT
bjos-8647123	143	48	100	100	NUM
bjos-8647123	143	49	)	)	PUNCT
bjos-8647123	143	50	0	0	NUM
bjos-8647123	143	51	3	3	NUM
bjos-8647123	143	52	(	(	PUNCT
bjos-8647123	143	53	9.1	9.1	NUM
bjos-8647123	143	54	)	)	PUNCT
bjos-8647123	143	55	total	total	NOUN
bjos-8647123	143	56	27	27	NUM
bjos-8647123	143	57	(	(	PUNCT
bjos-8647123	143	58	81.8	81.8	NUM
bjos-8647123	143	59	)	)	PUNCT
bjos-8647123	143	60	6	6	NUM
bjos-8647123	143	61	(	(	PUNCT
bjos-8647123	143	62	18.2	18.2	NUM
bjos-8647123	143	63	)	)	PUNCT
bjos-8647123	143	64	33	33	NUM
bjos-8647123	143	65	stage	stage	NOUN
bjos-8647123	143	66	*	*	PUNCT
bjos-8647123	143	67	*	*	PUNCT
bjos-8647123	143	68	stage	stage	NOUN
bjos-8647123	143	69	i	i	PRON
bjos-8647123	143	70	2	2	NUM
bjos-8647123	143	71	(	(	PUNCT
bjos-8647123	143	72	100	100	NUM
bjos-8647123	143	73	)	)	PUNCT
bjos-8647123	143	74	0	0	NUM
bjos-8647123	143	75	2	2	NUM
bjos-8647123	143	76	(	(	PUNCT
bjos-8647123	143	77	6.1	6.1	NUM
bjos-8647123	143	78	)	)	PUNCT
bjos-8647123	143	79	stage	stage	NOUN
bjos-8647123	143	80	ii	ii	NOUN
bjos-8647123	143	81	2	2	NUM
bjos-8647123	143	82	(	(	PUNCT
bjos-8647123	143	83	50	50	NUM
bjos-8647123	143	84	)	)	SYM
bjos-8647123	143	85	2	2	NUM
bjos-8647123	143	86	(	(	PUNCT
bjos-8647123	143	87	50	50	NUM
bjos-8647123	143	88	)	)	PUNCT
bjos-8647123	143	89	4	4	NUM
bjos-8647123	143	90	(	(	PUNCT
bjos-8647123	143	91	12.1	12.1	NUM
bjos-8647123	143	92	)	)	PUNCT
bjos-8647123	143	93	stage	stage	NOUN
bjos-8647123	143	94	iv	iv	NUM
bjos-8647123	143	95	23	23	NUM
bjos-8647123	143	96	(	(	PUNCT
bjos-8647123	143	97	85.2	85.2	NUM
bjos-8647123	143	98	)	)	PUNCT
bjos-8647123	143	99	4	4	NUM
bjos-8647123	143	100	(	(	PUNCT
bjos-8647123	143	101	14.8	14.8	NUM
bjos-8647123	143	102	)	)	PUNCT
bjos-8647123	143	103	27	27	NUM
bjos-8647123	143	104	(	(	PUNCT
bjos-8647123	143	105	81.8	81.8	NUM
bjos-8647123	143	106	)	)	PUNCT
bjos-8647123	143	107	total	total	NOUN
bjos-8647123	143	108	27	27	NUM
bjos-8647123	143	109	(	(	PUNCT
bjos-8647123	143	110	81.8	81.8	NUM
bjos-8647123	143	111	)	)	PUNCT
bjos-8647123	143	112	6	6	NUM
bjos-8647123	143	113	(	(	PUNCT
bjos-8647123	143	114	18.2	18.2	NUM
bjos-8647123	143	115	)	)	PUNCT
bjos-8647123	143	116	33	33	NUM
bjos-8647123	143	117	table	table	NOUN
bjos-8647123	143	118	4	4	NUM
bjos-8647123	143	119	association	association	NOUN
bjos-8647123	143	120	of	of	ADP
bjos-8647123	143	121	timp-2	timp-2	NUM
bjos-8647123	143	122	expression	expression	NOUN
bjos-8647123	143	123	with	with	ADP
bjos-8647123	143	124	grade	grade	NOUN
bjos-8647123	143	125	and	and	CCONJ
bjos-8647123	143	126	stage	stage	NOUN
bjos-8647123	143	127	of	of	ADP
bjos-8647123	143	128	oscc	oscc	PROPN
bjos-8647123	143	129	(	(	PUNCT
bjos-8647123	143	130	*	*	PUNCT
bjos-8647123	143	131	p	p	X
bjos-8647123	143	132	=	=	NOUN
bjos-8647123	143	133	0.838	0.838	NUM
bjos-8647123	143	134	,	,	PUNCT
bjos-8647123	143	135	*	*	PUNCT
bjos-8647123	144	1	*	*	PUNCT
bjos-8647123	144	2	p	p	X
bjos-8647123	144	3	=	=	NOUN
bjos-8647123	144	4	0.169	0.169	NUM
bjos-8647123	144	5	)	)	PUNCT
bjos-8647123	144	6	.	.	PUNCT
bjos-8647123	145	1	timp-2	timp-2	PRON
bjos-8647123	145	2	positive	positive	ADJ
bjos-8647123	145	3	negative	negative	ADJ
bjos-8647123	145	4	positive	positive	ADJ
bjos-8647123	145	5	24	24	NUM
bjos-8647123	145	6	(	(	PUNCT
bjos-8647123	145	7	72.7	72.7	NUM
bjos-8647123	145	8	%	%	NOUN
bjos-8647123	145	9	)	)	PUNCT
bjos-8647123	145	10	3	3	NUM
bjos-8647123	145	11	(	(	PUNCT
bjos-8647123	145	12	9.1	9.1	NUM
bjos-8647123	145	13	%	%	NOUN
bjos-8647123	145	14	)	)	PUNCT
bjos-8647123	145	15	hpv	hpv	PROPN
bjos-8647123	145	16	negative	negative	ADJ
bjos-8647123	145	17	3	3	NUM
bjos-8647123	145	18	(	(	PUNCT
bjos-8647123	145	19	9.1	9.1	NUM
bjos-8647123	145	20	%	%	NOUN
bjos-8647123	145	21	)	)	PUNCT
bjos-8647123	145	22	3	3	NUM
bjos-8647123	145	23	(	(	PUNCT
bjos-8647123	145	24	9.1	9.1	NUM
bjos-8647123	145	25	%	%	NOUN
bjos-8647123	145	26	)	)	PUNCT
bjos-8647123	145	27	total	total	NOUN
bjos-8647123	145	28	27	27	NUM
bjos-8647123	145	29	(	(	PUNCT
bjos-8647123	145	30	81.8	81.8	NUM
bjos-8647123	145	31	%	%	NOUN
bjos-8647123	145	32	)	)	PUNCT
bjos-8647123	145	33	6	6	NUM
bjos-8647123	145	34	(	(	PUNCT
bjos-8647123	145	35	18.2	18.2	NUM
bjos-8647123	145	36	%	%	NOUN
bjos-8647123	145	37	)	)	PUNCT
bjos-8647123	145	38	table	table	NOUN
bjos-8647123	145	39	1	1	NUM
bjos-8647123	145	40	expression	expression	NOUN
bjos-8647123	145	41	of	of	ADP
bjos-8647123	145	42	timp-2	timp-2	NUM
bjos-8647123	145	43	in	in	ADP
bjos-8647123	145	44	hpv-16	hpv-16	NUM
bjos-8647123	145	45	positive	positive	ADJ
bjos-8647123	145	46	versus	versus	ADP
bjos-8647123	145	47	hpv16	hpv16	NOUN
bjos-8647123	145	48	negative	negative	ADJ
bjos-8647123	145	49	oscc	oscc	ADJ
bjos-8647123	145	50	cases	case	NOUN
bjos-8647123	145	51	(	(	PUNCT
bjos-8647123	145	52	p	p	X
bjos-8647123	145	53	=	=	NOUN
bjos-8647123	145	54	0.058	0.058	NUM
bjos-8647123	145	55	)	)	PUNCT
bjos-8647123	145	56	.	.	PUNCT
bjos-8647123	146	1	braz	braz	PROPN
bjos-8647123	146	2	j	j	PROPN
bjos-8647123	146	3	oral	oral	PROPN
bjos-8647123	146	4	sci	sci	PROPN
bjos-8647123	146	5	.	.	PUNCT
bjos-8647123	147	1	15(1):51	15(1):51	NUM
bjos-8647123	147	2	-	-	SYM
bjos-8647123	147	3	56	56	NUM
bjos-8647123	147	4	55	55	NUM
bjos-8647123	147	5	apr];50(1):75	apr];50(1):75	PROPN
bjos-8647123	147	6	-	-	PUNCT
bjos-8647123	147	7	84	84	NUM
bjos-8647123	147	8	.	.	PUNCT
bjos-8647123	148	1	available	available	ADJ
bjos-8647123	148	2	from	from	ADP
bjos-8647123	148	3	:	:	PUNCT
bjos-8647123	148	4	http://www.scielo.br/pdf/jbpml/	http://www.scielo.br/pdf/jbpml/	X
bjos-8647123	148	5	v50n1/1676	v50n1/1676	NOUN
bjos-8647123	148	6	-	-	PUNCT
bjos-8647123	148	7	2444	2444	NUM
bjos-8647123	148	8	-	-	PUNCT
bjos-8647123	148	9	jbpml-50	jbpml-50	ADV
bjos-8647123	148	10	-	-	PUNCT
bjos-8647123	148	11	01	01	NUM
bjos-8647123	148	12	-	-	PUNCT
bjos-8647123	148	13	0075.pdf	0075.pdf	NOUN
bjos-8647123	148	14	.	.	PUNCT
bjos-8647123	149	1	7	7	X
bjos-8647123	149	2	.	.	X
bjos-8647123	149	3	iraq	iraq	PROPN
bjos-8647123	149	4	.	.	PUNCT
bjos-8647123	150	1	world	world	PROPN
bjos-8647123	150	2	health	health	PROPN
bjos-8647123	150	3	organization	organization	NOUN
bjos-8647123	150	4	–	–	PUNCT
bjos-8647123	150	5	noncommunicable	noncommunicable	ADJ
bjos-8647123	150	6	diseases	disease	NOUN
bjos-8647123	150	7	(	(	PUNCT
bjos-8647123	150	8	ncd	ncd	PROPN
bjos-8647123	150	9	)	)	PUNCT
bjos-8647123	150	10	country	country	NOUN
bjos-8647123	150	11	profiles	profile	NOUN
bjos-8647123	150	12	,	,	PUNCT
bjos-8647123	150	13	2014	2014	NUM
bjos-8647123	150	14	.	.	PUNCT
bjos-8647123	151	1	8	8	NUM
bjos-8647123	151	2	.	.	PUNCT
bjos-8647123	152	1	al	al	PROPN
bjos-8647123	152	2	-	-	PUNCT
bjos-8647123	152	3	kawaz	kawaz	PROPN
bjos-8647123	152	4	ab	ab	PROPN
bjos-8647123	152	5	(	(	PUNCT
bjos-8647123	152	6	2010	2010	NUM
bjos-8647123	152	7	)	)	PUNCT
bjos-8647123	152	8	.	.	PUNCT
bjos-8647123	153	1	oral	oral	ADJ
bjos-8647123	153	2	squamous	squamous	ADJ
bjos-8647123	153	3	cell	cell	NOUN
bjos-8647123	153	4	carcinoma	carcinoma	NOUN
bjos-8647123	153	5	in	in	ADP
bjos-8647123	153	6	iraq	iraq	PROPN
bjos-8647123	153	7	:	:	PUNCT
bjos-8647123	153	8	clinical	clinical	ADJ
bjos-8647123	153	9	analysis	analysis	NOUN
bjos-8647123	153	10	.	.	PUNCT
bjos-8647123	154	1	mdj	mdj	PROPN
bjos-8647123	154	2	.	.	PROPN
bjos-8647123	155	1	2010;7(1):100	2010;7(1):100	NUM
bjos-8647123	155	2	-	-	SYM
bjos-8647123	155	3	5	5	NUM
bjos-8647123	155	4	.	.	NOUN
bjos-8647123	156	1	9	9	NUM
bjos-8647123	156	2	.	.	PUNCT
bjos-8647123	157	1	mohammed	mohammed	PROPN
bjos-8647123	157	2	na	na	PROPN
bjos-8647123	157	3	,	,	PUNCT
bjos-8647123	157	4	hussein	hussein	PROPN
bjos-8647123	157	5	aa	aa	PROPN
bjos-8647123	157	6	,	,	PUNCT
bjos-8647123	157	7	majeed	majeed	PROPN
bjos-8647123	157	8	ah	ah	INTJ
bjos-8647123	157	9	.	.	PUNCT
bjos-8647123	158	1	detection	detection	NOUN
bjos-8647123	158	2	of	of	ADP
bjos-8647123	158	3	human	human	ADJ
bjos-8647123	158	4	herpesvirus	herpesvirus	NOUN
bjos-8647123	158	5	type-1	type-1	NUM
bjos-8647123	158	6	antigen	antigen	ADJ
bjos-8647123	158	7	in	in	ADP
bjos-8647123	158	8	tissues	tissue	NOUN
bjos-8647123	158	9	of	of	ADP
bjos-8647123	158	10	oral	oral	ADJ
bjos-8647123	158	11	squamous	squamous	ADJ
bjos-8647123	158	12	cell	cell	NOUN
bjos-8647123	158	13	carcinoma	carcinoma	NOUN
bjos-8647123	158	14	by	by	ADP
bjos-8647123	158	15	direct	direct	ADJ
bjos-8647123	158	16	immunofluorecent	immunofluorecent	NOUN
bjos-8647123	158	17	assay	assay	VERB
bjos-8647123	158	18	.	.	PUNCT
bjos-8647123	159	1	diyala	diyala	PROPN
bjos-8647123	159	2	j	j	PROPN
bjos-8647123	159	3	med	med	PROPN
bjos-8647123	159	4	.	.	PROPN
bjos-8647123	159	5	2015	2015	NUM
bjos-8647123	159	6	jun;8(2):38	jun;8(2):38	PROPN
bjos-8647123	159	7	-	-	PUNCT
bjos-8647123	159	8	45	45	NUM
bjos-8647123	159	9	.	.	NOUN
bjos-8647123	159	10	10	10	NUM
bjos-8647123	159	11	.	.	PUNCT
bjos-8647123	160	1	mork	mork	PROPN
bjos-8647123	160	2	j	j	PROPN
bjos-8647123	160	3	,	,	PUNCT
bjos-8647123	160	4	lie	lie	VERB
bjos-8647123	160	5	a	a	DET
bjos-8647123	160	6	k	k	NOUN
bjos-8647123	160	7	,	,	PUNCT
bjos-8647123	160	8	glattre	glattre	NOUN
bjos-8647123	160	9	e	e	PROPN
bjos-8647123	160	10	,	,	PUNCT
bjos-8647123	160	11	hallmans	hallman	NOUN
bjos-8647123	160	12	g	g	NOUN
bjos-8647123	160	13	,	,	PUNCT
bjos-8647123	160	14	jellum	jellum	PROPN
bjos-8647123	160	15	e	e	PROPN
bjos-8647123	160	16	,	,	PUNCT
bjos-8647123	160	17	koskela	koskela	VERB
bjos-8647123	160	18	p	p	PRON
bjos-8647123	160	19	,	,	PUNCT
bjos-8647123	160	20	et	et	PROPN
bjos-8647123	160	21	al	al	PROPN
bjos-8647123	160	22	.	.	PROPN
bjos-8647123	160	23	human	human	ADJ
bjos-8647123	160	24	papillomavirus	papillomavirus	NOUN
bjos-8647123	160	25	infection	infection	NOUN
bjos-8647123	160	26	as	as	ADP
bjos-8647123	160	27	a	a	DET
bjos-8647123	160	28	risk	risk	NOUN
bjos-8647123	160	29	factor	factor	NOUN
bjos-8647123	160	30	for	for	ADP
bjos-8647123	160	31	squamous	squamous	ADJ
bjos-8647123	160	32	-	-	PUNCT
bjos-8647123	160	33	cell	cell	NOUN
bjos-8647123	160	34	carcinoma	carcinoma	NOUN
bjos-8647123	160	35	of	of	ADP
bjos-8647123	160	36	the	the	DET
bjos-8647123	160	37	head	head	NOUN
bjos-8647123	160	38	and	and	CCONJ
bjos-8647123	160	39	neck	neck	NOUN
bjos-8647123	160	40	.	.	PUNCT
bjos-8647123	161	1	n	n	PROPN
bjos-8647123	161	2	engl	engl	PROPN
bjos-8647123	161	3	j	j	PROPN
bjos-8647123	161	4	med	med	PROPN
bjos-8647123	161	5	.	.	PUNCT
bjos-8647123	162	1	2001	2001	NUM
bjos-8647123	162	2	apr	apr	NOUN
bjos-8647123	162	3	12;344(15):1125	12;344(15):1125	NUM
bjos-8647123	162	4	-	-	SYM
bjos-8647123	162	5	31	31	NUM
bjos-8647123	162	6	.	.	PUNCT
bjos-8647123	163	1	11	11	NUM
bjos-8647123	163	2	.	.	PUNCT
bjos-8647123	164	1	nishioka	nishioka	PROPN
bjos-8647123	164	2	s	s	PROPN
bjos-8647123	164	3	,	,	PUNCT
bjos-8647123	164	4	fukushima	fukushima	PROPN
bjos-8647123	164	5	k	k	PROPN
bjos-8647123	164	6	,	,	PUNCT
bjos-8647123	164	7	nishizaki	nishizaki	ADJ
bjos-8647123	164	8	k	k	PROPN
bjos-8647123	164	9	,	,	PUNCT
bjos-8647123	164	10	gunduz	gunduz	PROPN
bjos-8647123	164	11	m	m	PRON
bjos-8647123	164	12	,	,	PUNCT
bjos-8647123	164	13	tominaga	tominaga	NOUN
bjos-8647123	164	14	s	s	PART
bjos-8647123	164	15	,	,	PUNCT
bjos-8647123	164	16	fukazawa	fukazawa	PROPN
bjos-8647123	164	17	m	m	PROPN
bjos-8647123	164	18	,	,	PUNCT
bjos-8647123	164	19	et	et	PROPN
bjos-8647123	164	20	al	al	PROPN
bjos-8647123	164	21	.	.	PUNCT
bjos-8647123	165	1	human	human	ADJ
bjos-8647123	165	2	papillomavirus	papillomavirus	NOUN
bjos-8647123	165	3	as	as	ADP
bjos-8647123	165	4	a	a	DET
bjos-8647123	165	5	risk	risk	NOUN
bjos-8647123	165	6	factor	factor	NOUN
bjos-8647123	165	7	for	for	ADP
bjos-8647123	165	8	head	head	NOUN
bjos-8647123	165	9	and	and	CCONJ
bjos-8647123	165	10	neck	neck	NOUN
bjos-8647123	165	11	cancers	cancer	NOUN
bjos-8647123	165	12	:	:	PUNCT
bjos-8647123	165	13	a	a	DET
bjos-8647123	165	14	case	case	NOUN
bjos-8647123	165	15	-	-	PUNCT
bjos-8647123	165	16	control	control	NOUN
bjos-8647123	165	17	study	study	NOUN
bjos-8647123	165	18	.	.	PUNCT
bjos-8647123	166	1	acta	acta	PROPN
bjos-8647123	166	2	otolaryngol	otolaryngol	PROPN
bjos-8647123	166	3	.	.	PUNCT
bjos-8647123	167	1	suppl	suppl	PROPN
bjos-8647123	167	2	.	.	PUNCT
bjos-8647123	168	1	1999;540:77	1999;540:77	NUM
bjos-8647123	168	2	-	-	SYM
bjos-8647123	168	3	80	80	NUM
bjos-8647123	168	4	.	.	PUNCT
bjos-8647123	169	1	12	12	NUM
bjos-8647123	169	2	.	.	PUNCT
bjos-8647123	169	3	oda	oda	PROPN
bjos-8647123	170	1	d	d	NOUN
bjos-8647123	170	2	,	,	PUNCT
bjos-8647123	170	3	bigler	bigl	ADJ
bjos-8647123	170	4	l	l	PROPN
bjos-8647123	170	5	,	,	PUNCT
bjos-8647123	170	6	lee	lee	PROPN
bjos-8647123	170	7	p	p	PROPN
bjos-8647123	170	8	,	,	PUNCT
bjos-8647123	170	9	blanton	blanton	PROPN
bjos-8647123	170	10	r.	r.	PROPN
bjos-8647123	170	11	hpv	hpv	PROPN
bjos-8647123	170	12	immortalization	immortalization	NOUN
bjos-8647123	170	13	of	of	ADP
bjos-8647123	170	14	human	human	ADJ
bjos-8647123	170	15	oral	oral	ADJ
bjos-8647123	170	16	epithelial	epithelial	ADJ
bjos-8647123	170	17	cells	cell	NOUN
bjos-8647123	170	18	:	:	PUNCT
bjos-8647123	170	19	a	a	DET
bjos-8647123	170	20	model	model	NOUN
bjos-8647123	170	21	for	for	ADP
bjos-8647123	170	22	carcinogenesis	carcinogenesis	NOUN
bjos-8647123	170	23	.	.	PUNCT
bjos-8647123	171	1	exp	exp	NOUN
bjos-8647123	171	2	cell	cell	NOUN
bjos-8647123	171	3	res	re	NOUN
bjos-8647123	171	4	.	.	PUNCT
bjos-8647123	171	5	1996	1996	NUM
bjos-8647123	171	6	jul	jul	PROPN
bjos-8647123	171	7	10;226(1):164	10;226(1):164	PROPN
bjos-8647123	171	8	-	-	SYM
bjos-8647123	171	9	9	9	NUM
bjos-8647123	171	10	.	.	NOUN
bjos-8647123	171	11	13	13	NUM
bjos-8647123	171	12	.	.	PUNCT
bjos-8647123	172	1	miller	miller	PROPN
bjos-8647123	172	2	cs	cs	PROPN
bjos-8647123	172	3	,	,	PUNCT
bjos-8647123	172	4	johnstone	johnstone	PROPN
bjos-8647123	172	5	bm	bm	PROPN
bjos-8647123	172	6	.	.	PROPN
bjos-8647123	172	7	is	be	AUX
bjos-8647123	172	8	oral	oral	ADJ
bjos-8647123	172	9	infection	infection	NOUN
bjos-8647123	172	10	with	with	ADP
bjos-8647123	172	11	human	human	ADJ
bjos-8647123	172	12	papillomavirus	papillomavirus	NOUN
bjos-8647123	172	13	(	(	PUNCT
bjos-8647123	172	14	hpv	hpv	PROPN
bjos-8647123	172	15	)	)	PUNCT
bjos-8647123	172	16	a	a	DET
bjos-8647123	172	17	risk	risk	NOUN
bjos-8647123	172	18	factor	factor	NOUN
bjos-8647123	172	19	for	for	ADP
bjos-8647123	172	20	oral	oral	ADJ
bjos-8647123	172	21	squamous	squamous	ADJ
bjos-8647123	172	22	cell	cell	NOUN
bjos-8647123	172	23	carcinoma	carcinoma	NOUN
bjos-8647123	172	24	(	(	PUNCT
bjos-8647123	172	25	oscc	oscc	ADJ
bjos-8647123	172	26	)	)	PUNCT
bjos-8647123	172	27	?	?	PUNCT
bjos-8647123	173	1	evidencebased	evidencebase	VERB
bjos-8647123	173	2	dent	dent	NOUN
bjos-8647123	173	3	.	.	PUNCT
bjos-8647123	174	1	2003	2003	NUM
bjos-8647123	174	2	jun	jun	PROPN
bjos-8647123	174	3	28;4(2):29	28;4(2):29	NUM
bjos-8647123	174	4	.	.	PUNCT
bjos-8647123	175	1	doi:10.1038	doi:10.1038	NOUN
bjos-8647123	175	2	/	/	SYM
bjos-8647123	175	3	sj.ebd.6400171	sj.ebd.6400171	NOUN
bjos-8647123	175	4	.	.	PUNCT
bjos-8647123	176	1	14	14	NUM
bjos-8647123	176	2	.	.	PUNCT
bjos-8647123	177	1	syrjanen	syrjanen	PROPN
bjos-8647123	177	2	k	k	PROPN
bjos-8647123	177	3	,	,	PUNCT
bjos-8647123	177	4	syrjanen	syrjanen	PROPN
bjos-8647123	177	5	s	s	PROPN
bjos-8647123	177	6	,	,	PUNCT
bjos-8647123	177	7	lamberg	lamberg	PROPN
bjos-8647123	177	8	m	m	PROPN
bjos-8647123	177	9	,	,	PUNCT
bjos-8647123	177	10	pyrhonen	pyrhonen	PROPN
bjos-8647123	177	11	s	s	PROPN
bjos-8647123	177	12	,	,	PUNCT
bjos-8647123	177	13	nuutinen	nuutinen	PROPN
bjos-8647123	177	14	j.	j.	PROPN
bjos-8647123	177	15	morphological	morphological	ADJ
bjos-8647123	177	16	and	and	CCONJ
bjos-8647123	177	17	immunohistochemical	immunohistochemical	ADJ
bjos-8647123	177	18	evidence	evidence	NOUN
bjos-8647123	177	19	suggesting	suggest	VERB
bjos-8647123	177	20	human	human	ADJ
bjos-8647123	177	21	papillomavirus	papillomavirus	NOUN
bjos-8647123	177	22	(	(	PUNCT
bjos-8647123	177	23	hpv	hpv	NOUN
bjos-8647123	177	24	)	)	PUNCT
bjos-8647123	177	25	involvement	involvement	NOUN
bjos-8647123	177	26	in	in	ADP
bjos-8647123	177	27	oral	oral	ADJ
bjos-8647123	177	28	squamous	squamous	ADJ
bjos-8647123	177	29	cell	cell	NOUN
bjos-8647123	177	30	carcinogenesis	carcinogenesis	NOUN
bjos-8647123	177	31	.	.	PUNCT
bjos-8647123	178	1	int	int	NOUN
bjos-8647123	178	2	j	j	PROPN
bjos-8647123	178	3	oral	oral	ADJ
bjos-8647123	178	4	surg	surg	NOUN
bjos-8647123	178	5	.	.	PUNCT
bjos-8647123	179	1	1983	1983	NUM
bjos-8647123	179	2	dec;12(6):418	dec;12(6):418	PROPN
bjos-8647123	179	3	-	-	PROPN
bjos-8647123	179	4	24	24	NUM
bjos-8647123	179	5	.	.	PUNCT
bjos-8647123	180	1	15	15	NUM
bjos-8647123	180	2	.	.	PUNCT
bjos-8647123	181	1	moberg	moberg	PROPN
bjos-8647123	181	2	m	m	PROPN
bjos-8647123	181	3	,	,	PUNCT
bjos-8647123	181	4	gustavsson	gustavsson	PROPN
bjos-8647123	181	5	i	i	PRON
bjos-8647123	181	6	,	,	PUNCT
bjos-8647123	181	7	gyllensten	gyllensten	PROPN
bjos-8647123	181	8	u.	u.	PROPN
bjos-8647123	181	9	real	real	ADJ
bjos-8647123	181	10	-	-	PUNCT
bjos-8647123	181	11	time	time	NOUN
bjos-8647123	181	12	pcr	pcr	NOUN
bjos-8647123	181	13	-	-	PUNCT
bjos-8647123	181	14	based	base	VERB
bjos-8647123	181	15	system	system	NOUN
bjos-8647123	181	16	for	for	ADP
bjos-8647123	181	17	simultaneous	simultaneous	ADJ
bjos-8647123	181	18	quantification	quantification	NOUN
bjos-8647123	181	19	of	of	ADP
bjos-8647123	181	20	human	human	ADJ
bjos-8647123	181	21	papillomavirus	papillomavirus	NOUN
bjos-8647123	181	22	types	type	NOUN
bjos-8647123	181	23	associated	associate	VERB
bjos-8647123	181	24	with	with	ADP
bjos-8647123	181	25	high	high	ADJ
bjos-8647123	181	26	risk	risk	NOUN
bjos-8647123	181	27	of	of	ADP
bjos-8647123	181	28	cervical	cervical	ADJ
bjos-8647123	181	29	cancer	cancer	NOUN
bjos-8647123	181	30	.	.	PUNCT
bjos-8647123	182	1	j	j	PROPN
bjos-8647123	182	2	clin	clin	PROPN
bjos-8647123	182	3	microbiol	microbiol	PROPN
bjos-8647123	182	4	.	.	PUNCT
bjos-8647123	183	1	2003	2003	NUM
bjos-8647123	183	2	jul;41(7):3221	jul;41(7):3221	NOUN
bjos-8647123	183	3	-	-	PUNCT
bjos-8647123	183	4	8	8	NUM
bjos-8647123	183	5	.	.	PUNCT
bjos-8647123	183	6	16	16	NUM
bjos-8647123	183	7	.	.	PUNCT
bjos-8647123	184	1	akrish	akrish	PROPN
bjos-8647123	184	2	s	s	PROPN
bjos-8647123	184	3	,	,	PUNCT
bjos-8647123	184	4	ben	ben	PROPN
bjos-8647123	184	5	-	-	ADJ
bjos-8647123	184	6	izhak	izhak	PROPN
bjos-8647123	184	7	o	o	NOUN
bjos-8647123	184	8	,	,	PUNCT
bjos-8647123	184	9	sabo	sabo	NOUN
bjos-8647123	184	10	e	e	NOUN
bjos-8647123	184	11	,	,	PUNCT
bjos-8647123	184	12	rachmiel	rachmiel	PROPN
bjos-8647123	184	13	a.	a.	PROPN
bjos-8647123	184	14	oral	oral	PROPN
bjos-8647123	184	15	squamous	squamous	ADJ
bjos-8647123	184	16	cell	cell	NOUN
bjos-8647123	184	17	carcinoma	carcinoma	NOUN
bjos-8647123	184	18	associated	associate	VERB
bjos-8647123	184	19	with	with	ADP
bjos-8647123	184	20	proliferative	proliferative	ADJ
bjos-8647123	184	21	verrucous	verrucous	ADJ
bjos-8647123	184	22	leukoplakia	leukoplakia	NOUN
bjos-8647123	184	23	compared	compare	VERB
bjos-8647123	184	24	with	with	ADP
bjos-8647123	184	25	conventional	conventional	ADJ
bjos-8647123	184	26	squamous	squamous	ADJ
bjos-8647123	184	27	cell	cell	NOUN
bjos-8647123	184	28	carcinoma	carcinoma	NOUN
bjos-8647123	184	29	--	--	PUNCT
bjos-8647123	184	30	a	a	DET
bjos-8647123	184	31	clinical	clinical	ADJ
bjos-8647123	184	32	,	,	PUNCT
bjos-8647123	184	33	histologic	histologic	ADJ
bjos-8647123	184	34	and	and	CCONJ
bjos-8647123	184	35	immunohistochemical	immunohistochemical	ADJ
bjos-8647123	184	36	study	study	NOUN
bjos-8647123	184	37	.	.	PUNCT
bjos-8647123	185	1	oral	oral	ADJ
bjos-8647123	185	2	surg	surg	NOUN
bjos-8647123	185	3	oral	oral	ADJ
bjos-8647123	185	4	med	med	ADJ
bjos-8647123	185	5	oral	oral	ADJ
bjos-8647123	185	6	pathol	pathol	NOUN
bjos-8647123	185	7	oral	oral	ADJ
bjos-8647123	185	8	radiol	radiol	NOUN
bjos-8647123	185	9	.	.	PUNCT
bjos-8647123	186	1	2015	2015	NUM
bjos-8647123	186	2	mar;119(3):318	mar;119(3):318	NOUN
bjos-8647123	186	3	-	-	PUNCT
bjos-8647123	186	4	25	25	NUM
bjos-8647123	186	5	.	.	PUNCT
bjos-8647123	186	6	doi	doi	NOUN
bjos-8647123	186	7	:	:	PUNCT
bjos-8647123	186	8	10.1016	10.1016	NUM
bjos-8647123	186	9	/	/	SYM
bjos-8647123	186	10	j.oooo.2014.10.023	j.oooo.2014.10.023	PROPN
bjos-8647123	186	11	.	.	PROPN
bjos-8647123	187	1	17	17	NUM
bjos-8647123	187	2	.	.	PUNCT
bjos-8647123	187	3	stetler	stetler	NOUN
bjos-8647123	187	4	-	-	PUNCT
bjos-8647123	187	5	stevenson	stevenson	PROPN
bjos-8647123	187	6	wg	wg	PROPN
bjos-8647123	187	7	.	.	PUNCT
bjos-8647123	188	1	the	the	DET
bjos-8647123	188	2	tumor	tumor	NOUN
bjos-8647123	188	3	microenvironment	microenvironment	NOUN
bjos-8647123	188	4	:	:	PUNCT
bjos-8647123	188	5	regulation	regulation	NOUN
bjos-8647123	188	6	by	by	ADP
bjos-8647123	188	7	mmp	mmp	PROPN
bjos-8647123	188	8	-	-	PUNCT
bjos-8647123	188	9	independent	independent	ADJ
bjos-8647123	188	10	effects	effect	NOUN
bjos-8647123	188	11	of	of	ADP
bjos-8647123	188	12	tissue	tissue	NOUN
bjos-8647123	188	13	inhibitor	inhibitor	NOUN
bjos-8647123	188	14	of	of	ADP
bjos-8647123	188	15	metalloproteinases-2	metalloproteinases-2	PROPN
bjos-8647123	188	16	.	.	PUNCT
bjos-8647123	189	1	cancer	cancer	NOUN
bjos-8647123	189	2	metastasis	metastasis	NOUN
bjos-8647123	189	3	rev	rev	VERB
bjos-8647123	189	4	,	,	PUNCT
bjos-8647123	189	5	2008	2008	NUM
bjos-8647123	189	6	mar;27(1):57	mar;27(1):57	PROPN
bjos-8647123	189	7	-	-	PUNCT
bjos-8647123	189	8	66	66	NUM
bjos-8647123	189	9	.	.	PUNCT
bjos-8647123	190	1	18	18	NUM
bjos-8647123	190	2	.	.	X
bjos-8647123	190	3	görögh	görögh	PROPN
bjos-8647123	190	4	t	t	PROPN
bjos-8647123	190	5	,	,	PUNCT
bjos-8647123	190	6	beier	beier	VERB
bjos-8647123	190	7	u	u	PROPN
bjos-8647123	190	8	h	h	NOUN
bjos-8647123	190	9	,	,	PUNCT
bjos-8647123	190	10	bäumken	bäumken	VERB
bjos-8647123	190	11	j	j	PROPN
bjos-8647123	190	12	,	,	PUNCT
bjos-8647123	190	13	meyer	meyer	PROPN
bjos-8647123	190	14	je	je	PROPN
bjos-8647123	190	15	,	,	PUNCT
bjos-8647123	190	16	hoffmann	hoffmann	PROPN
bjos-8647123	190	17	m	m	PROPN
bjos-8647123	190	18	,	,	PUNCT
bjos-8647123	190	19	gottschlich	gottschlich	PROPN
bjos-8647123	190	20	s	s	PROPN
bjos-8647123	190	21	,	,	PUNCT
bjos-8647123	190	22	et	et	PROPN
bjos-8647123	190	23	al	al	PROPN
bjos-8647123	190	24	.	.	PROPN
bjos-8647123	191	1	metalloproteinases	metalloproteinase	NOUN
bjos-8647123	191	2	and	and	CCONJ
bjos-8647123	191	3	their	their	PRON
bjos-8647123	191	4	inhibitors	inhibitor	NOUN
bjos-8647123	191	5	:	:	PUNCT
bjos-8647123	191	6	influence	influence	NOUN
bjos-8647123	191	7	on	on	ADP
bjos-8647123	191	8	tumor	tumor	NOUN
bjos-8647123	191	9	invasiveness	invasiveness	NOUN
bjos-8647123	191	10	and	and	CCONJ
bjos-8647123	191	11	metastasis	metastasis	NOUN
bjos-8647123	191	12	formation	formation	NOUN
bjos-8647123	191	13	in	in	ADP
bjos-8647123	191	14	head	head	NOUN
bjos-8647123	191	15	and	and	CCONJ
bjos-8647123	191	16	neck	neck	VERB
bjos-8647123	191	17	squamous	squamous	ADJ
bjos-8647123	191	18	cell	cell	NOUN
bjos-8647123	191	19	carcinomas	carcinoma	NOUN
bjos-8647123	191	20	.	.	PUNCT
bjos-8647123	192	1	head	head	NOUN
bjos-8647123	192	2	neck	neck	NOUN
bjos-8647123	192	3	.	.	PUNCT
bjos-8647123	193	1	2006	2006	NUM
bjos-8647123	193	2	jan;28:31	jan;28:31	NOUN
bjos-8647123	193	3	-	-	PUNCT
bjos-8647123	193	4	9	9	NUM
bjos-8647123	193	5	.	.	NOUN
bjos-8647123	193	6	19	19	NUM
bjos-8647123	193	7	.	.	X
bjos-8647123	193	8	gillison	gillison	PROPN
bjos-8647123	193	9	ml	ml	PROPN
bjos-8647123	193	10	.	.	PUNCT
bjos-8647123	194	1	human	human	ADJ
bjos-8647123	194	2	papillomavirus	papillomavirus	NOUN
bjos-8647123	194	3	and	and	CCONJ
bjos-8647123	194	4	prognosis	prognosis	NOUN
bjos-8647123	194	5	of	of	ADP
bjos-8647123	194	6	oropharyngeal	oropharyngeal	ADJ
bjos-8647123	194	7	squamous	squamous	ADJ
bjos-8647123	194	8	cell	cell	NOUN
bjos-8647123	194	9	carcinoma	carcinoma	NOUN
bjos-8647123	194	10	:	:	PUNCT
bjos-8647123	194	11	implications	implication	NOUN
bjos-8647123	194	12	for	for	ADP
bjos-8647123	194	13	clinical	clinical	ADJ
bjos-8647123	194	14	research	research	NOUN
bjos-8647123	194	15	in	in	ADP
bjos-8647123	194	16	head	head	NOUN
bjos-8647123	194	17	and	and	CCONJ
bjos-8647123	194	18	neck	neck	NOUN
bjos-8647123	194	19	cancers	cancer	NOUN
bjos-8647123	194	20	.	.	PUNCT
bjos-8647123	195	1	j	j	PROPN
bjos-8647123	195	2	clin	clin	PROPN
bjos-8647123	195	3	oncol	oncol	PROPN
bjos-8647123	195	4	.	.	PUNCT
bjos-8647123	196	1	2006	2006	NUM
bjos-8647123	196	2	dec;24(36):5623	dec;24(36):5623	NOUN
bjos-8647123	196	3	-	-	PUNCT
bjos-8647123	196	4	5	5	NUM
bjos-8647123	196	5	.	.	NOUN
bjos-8647123	196	6	20	20	NUM
bjos-8647123	196	7	.	.	PUNCT
bjos-8647123	197	1	chandolia	chandolia	PROPN
bjos-8647123	197	2	b	b	PROPN
bjos-8647123	197	3	,	,	PUNCT
bjos-8647123	197	4	basu	basu	PROPN
bjos-8647123	197	5	sk	sk	PROPN
bjos-8647123	197	6	,	,	PUNCT
bjos-8647123	197	7	kumar	kumar	PROPN
bjos-8647123	197	8	m.	m.	PROPN
bjos-8647123	197	9	can	can	AUX
bjos-8647123	197	10	mmp-9	mmp-9	ADV
bjos-8647123	197	11	be	be	AUX
bjos-8647123	197	12	a	a	DET
bjos-8647123	197	13	prognosticator	prognosticator	NOUN
bjos-8647123	197	14	marker	marker	NOUN
bjos-8647123	197	15	for	for	ADP
bjos-8647123	197	16	oral	oral	ADJ
bjos-8647123	197	17	squamous	squamous	ADJ
bjos-8647123	197	18	cell	cell	NOUN
bjos-8647123	197	19	carcinoma	carcinoma	NOUN
bjos-8647123	197	20	?	?	PUNCT
bjos-8647123	198	1	j	j	PROPN
bjos-8647123	198	2	clin	clin	PROPN
bjos-8647123	198	3	diagn	diagn	PROPN
bjos-8647123	198	4	res	re	NOUN
bjos-8647123	198	5	.	.	PROPN
bjos-8647123	198	6	2016	2016	NUM
bjos-8647123	198	7	jan;10(1):zc09	jan;10(1):zc09	PROPN
bjos-8647123	198	8	-	-	PUNCT
bjos-8647123	198	9	13	13	NUM
bjos-8647123	198	10	.	.	PUNCT
bjos-8647123	199	1	doi	doi	NOUN
bjos-8647123	199	2	:	:	PUNCT
bjos-8647123	199	3	10.7860	10.7860	NUM
bjos-8647123	199	4	/	/	SYM
bjos-8647123	199	5	jcdr/2016/14128.7034	jcdr/2016/14128.7034	PROPN
bjos-8647123	199	6	.	.	PUNCT
bjos-8647123	200	1	21	21	NUM
bjos-8647123	200	2	.	.	PUNCT
bjos-8647123	200	3	ali	ali	PROPN
bjos-8647123	200	4	shm	shm	PROPN
bjos-8647123	200	5	,	,	PUNCT
bjos-8647123	200	6	al	al	PROPN
bjos-8647123	200	7	-	-	PUNCT
bjos-8647123	200	8	hijazi	hijazi	PROPN
bjos-8647123	200	9	ay	ay	PROPN
bjos-8647123	200	10	,	,	PUNCT
bjos-8647123	200	11	khashman	khashman	NOUN
bjos-8647123	200	12	bm	bm	PROPN
bjos-8647123	200	13	(	(	PUNCT
bjos-8647123	200	14	2011	2011	NUM
bjos-8647123	200	15	)	)	PUNCT
bjos-8647123	200	16	.	.	PUNCT
bjos-8647123	201	1	p53	p53	NOUN
bjos-8647123	201	2	-	-	PUNCT
bjos-8647123	201	3	tumor	tumor	NOUN
bjos-8647123	201	4	suppressor	suppressor	NOUN
bjos-8647123	201	5	gene	gene	NOUN
bjos-8647123	201	6	overexpression	overexpression	NOUN
bjos-8647123	201	7	in	in	ADP
bjos-8647123	201	8	huma	huma	PROPN
bjos-8647123	201	9	papilloma	papilloma	PROPN
bjos-8647123	201	10	virus	virus	NOUN
bjos-8647123	201	11	-	-	PUNCT
bjos-8647123	201	12	infected	infect	VERB
bjos-8647123	201	13	patients	patient	NOUN
bjos-8647123	201	14	with	with	ADP
bjos-8647123	201	15	oral	oral	ADJ
bjos-8647123	201	16	squamous	squamous	ADJ
bjos-8647123	201	17	cell	cell	NOUN
bjos-8647123	201	18	carcinoma	carcinoma	NOUN
bjos-8647123	201	19	.	.	PUNCT
bjos-8647123	202	1	j	j	PROPN
bjos-8647123	202	2	bagh	bagh	PROPN
bjos-8647123	202	3	college	college	PROPN
bjos-8647123	202	4	dentistry	dentistry	NOUN
bjos-8647123	202	5	.	.	PUNCT
bjos-8647123	203	1	2011;23	2011;23	X
bjos-8647123	203	2	(	(	PUNCT
bjos-8647123	203	3	spec	spec	PROPN
bjos-8647123	203	4	issue):70	issue):70	PROPN
bjos-8647123	203	5	-	-	PUNCT
bjos-8647123	203	6	6	6	NUM
bjos-8647123	203	7	.	.	NOUN
bjos-8647123	203	8	22	22	NUM
bjos-8647123	203	9	.	.	PUNCT
bjos-8647123	204	1	jabar	jabar	PROPN
bjos-8647123	204	2	s	s	PROPN
bjos-8647123	204	3	,	,	PUNCT
bjos-8647123	204	4	sarkis	sarkis	PROPN
bjos-8647123	204	5	s	s	PROPN
bjos-8647123	204	6	,	,	PUNCT
bjos-8647123	204	7	madjd	madjd	PROPN
bjos-8647123	204	8	z	z	PROPN
bjos-8647123	204	9	,	,	PUNCT
bjos-8647123	204	10	kalantari	kalantari	PROPN
bjos-8647123	204	11	e.	e.	PROPN
bjos-8647123	204	12	the	the	DET
bjos-8647123	204	13	expression	expression	NOUN
bjos-8647123	204	14	of	of	ADP
bjos-8647123	204	15	p53	p53	NOUN
bjos-8647123	204	16	and	and	CCONJ
bjos-8647123	204	17	mdm4	mdm4	PROPN
bjos-8647123	204	18	in	in	ADP
bjos-8647123	204	19	oral	oral	ADJ
bjos-8647123	204	20	,	,	PUNCT
bjos-8647123	204	21	laryngeal	laryngeal	ADJ
bjos-8647123	204	22	and	and	CCONJ
bjos-8647123	204	23	cutaneous	cutaneous	ADJ
bjos-8647123	204	24	squamous	squamous	ADJ
bjos-8647123	204	25	cell	cell	NOUN
bjos-8647123	204	26	carcinoma	carcinoma	NOUN
bjos-8647123	204	27	;	;	PUNCT
bjos-8647123	204	28	a	a	DET
bjos-8647123	204	29	comparative	comparative	ADJ
bjos-8647123	204	30	study	study	NOUN
bjos-8647123	204	31	by	by	ADP
bjos-8647123	204	32	tissue	tissue	NOUN
bjos-8647123	204	33	microarray	microarray	NOUN
bjos-8647123	204	34	.	.	PUNCT
bjos-8647123	205	1	eur	eur	PROPN
bjos-8647123	205	2	scientif	scientif	PROPN
bjos-8647123	205	3	j	j	PROPN
bjos-8647123	205	4	,	,	PUNCT
bjos-8647123	205	5	2013	2013	NUM
bjos-8647123	205	6	dec;9(36):56	dec;9(36):56	PROPN
bjos-8647123	205	7	-	-	PUNCT
bjos-8647123	205	8	73	73	NUM
bjos-8647123	205	9	.	.	PUNCT
bjos-8647123	206	1	23	23	NUM
bjos-8647123	206	2	.	.	PUNCT
bjos-8647123	207	1	katayama	katayama	PROPN
bjos-8647123	207	2	a	a	PRON
bjos-8647123	207	3	,	,	PUNCT
bjos-8647123	207	4	bandoh	bandoh	PROPN
bjos-8647123	207	5	n	n	CCONJ
bjos-8647123	207	6	,	,	PUNCT
bjos-8647123	207	7	kishibe	kishibe	VERB
bjos-8647123	207	8	k	k	NOUN
bjos-8647123	207	9	,	,	PUNCT
bjos-8647123	207	10	takahara	takahara	NOUN
bjos-8647123	207	11	m	m	PROPN
bjos-8647123	207	12	,	,	PUNCT
bjos-8647123	207	13	ogino	ogino	PROPN
bjos-8647123	207	14	t	t	PROPN
bjos-8647123	207	15	,	,	PUNCT
bjos-8647123	207	16	nonaka	nonaka	PROPN
bjos-8647123	207	17	s	s	PROPN
bjos-8647123	207	18	,	,	PUNCT
bjos-8647123	207	19	et	et	PROPN
bjos-8647123	207	20	al	al	PROPN
bjos-8647123	207	21	.	.	PUNCT
bjos-8647123	207	22	expressions	expression	NOUN
bjos-8647123	207	23	of	of	ADP
bjos-8647123	207	24	matrix	matrix	NOUN
bjos-8647123	207	25	metalloproteinases	metalloproteinase	NOUN
bjos-8647123	207	26	in	in	ADP
bjos-8647123	207	27	early	early	ADJ
bjos-8647123	207	28	-	-	PUNCT
bjos-8647123	207	29	stage	stage	NOUN
bjos-8647123	207	30	oral	oral	ADJ
bjos-8647123	207	31	squamous	squamous	ADJ
bjos-8647123	207	32	cell	cell	NOUN
bjos-8647123	207	33	carcinoma	carcinoma	NOUN
bjos-8647123	207	34	as	as	ADP
bjos-8647123	207	35	predictive	predictive	ADJ
bjos-8647123	207	36	indicators	indicator	NOUN
bjos-8647123	207	37	for	for	ADP
bjos-8647123	207	38	tumor	tumor	NOUN
bjos-8647123	207	39	metastases	metastasis	NOUN
bjos-8647123	207	40	and	and	CCONJ
bjos-8647123	207	41	prognosis	prognosis	NOUN
bjos-8647123	207	42	.	.	PUNCT
bjos-8647123	208	1	clin	clin	PROPN
bjos-8647123	208	2	cancer	cancer	NOUN
bjos-8647123	208	3	res	re	NOUN
bjos-8647123	208	4	.	.	PUNCT
bjos-8647123	209	1	2004	2004	NUM
bjos-8647123	209	2	jan	jan	PROPN
bjos-8647123	209	3	15;10(2):634	15;10(2):634	NUM
bjos-8647123	209	4	-	-	SYM
bjos-8647123	209	5	40	40	NUM
bjos-8647123	209	6	.	.	PUNCT
bjos-8647123	210	1	24	24	NUM
bjos-8647123	210	2	.	.	PUNCT
bjos-8647123	211	1	lee	lee	PROPN
bjos-8647123	211	2	sy	sy	PROPN
bjos-8647123	211	3	,	,	PUNCT
bjos-8647123	211	4	park	park	NOUN
bjos-8647123	211	5	sy	sy	PROPN
bjos-8647123	211	6	,	,	PUNCT
bjos-8647123	211	7	kim	kim	PROPN
bjos-8647123	211	8	sh	sh	PROPN
bjos-8647123	211	9	,	,	PUNCT
bjos-8647123	211	10	choi	choi	PROPN
bjos-8647123	211	11	ec	ec	PROPN
bjos-8647123	211	12	.	.	PUNCT
bjos-8647123	212	1	expression	expression	NOUN
bjos-8647123	212	2	of	of	ADP
bjos-8647123	212	3	matrix	matrix	NOUN
bjos-8647123	212	4	metalloproteinases	metalloproteinase	NOUN
bjos-8647123	212	5	and	and	CCONJ
bjos-8647123	212	6	their	their	PRON
bjos-8647123	212	7	inhibitors	inhibitor	NOUN
bjos-8647123	212	8	in	in	ADP
bjos-8647123	212	9	squamous	squamous	ADJ
bjos-8647123	212	10	cell	cell	NOUN
bjos-8647123	212	11	carcinoma	carcinoma	NOUN
bjos-8647123	212	12	of	of	ADP
bjos-8647123	212	13	the	the	DET
bjos-8647123	212	14	tonsil	tonsil	NOUN
bjos-8647123	212	15	and	and	CCONJ
bjos-8647123	212	16	their	their	PRON
bjos-8647123	212	17	clinical	clinical	ADJ
bjos-8647123	212	18	significance	significance	NOUN
bjos-8647123	212	19	.	.	PUNCT
bjos-8647123	213	1	clin	clin	PROPN
bjos-8647123	213	2	exp	exp	NOUN
bjos-8647123	213	3	otorhinolaryngol	otorhinolaryngol	NOUN
bjos-8647123	213	4	.	.	PUNCT
bjos-8647123	214	1	2011	2011	NUM
bjos-8647123	214	2	jun;4(2):88	jun;4(2):88	PROPN
bjos-8647123	214	3	-	-	PUNCT
bjos-8647123	214	4	94	94	NUM
bjos-8647123	214	5	.	.	PUNCT
bjos-8647123	215	1	25	25	NUM
bjos-8647123	215	2	.	.	PUNCT
bjos-8647123	216	1	al	al	PROPN
bjos-8647123	216	2	-	-	PUNCT
bjos-8647123	216	3	salihi	salihi	PROPN
bjos-8647123	216	4	ka	ka	PROPN
bjos-8647123	216	5	,	,	PUNCT
bjos-8647123	216	6	ang	ang	PROPN
bjos-8647123	216	7	sl	sl	PROPN
bjos-8647123	216	8	,	,	PUNCT
bjos-8647123	216	9	azlina	azlina	VERB
bjos-8647123	216	10	a	a	NOUN
bjos-8647123	216	11	,	,	PUNCT
bjos-8647123	216	12	farini	farini	PROPN
bjos-8647123	216	13	ms	ms	PROPN
bjos-8647123	216	14	,	,	PUNCT
bjos-8647123	216	15	jaffar	jaffar	PROPN
bjos-8647123	216	16	h.	h.	PROPN
bjos-8647123	216	17	immunohistochemical	immunohistochemical	ADJ
bjos-8647123	216	18	and	and	CCONJ
bjos-8647123	216	19	molecular	molecular	ADJ
bjos-8647123	216	20	genetic	genetic	ADJ
bjos-8647123	216	21	analysis	analysis	NOUN
bjos-8647123	216	22	of	of	ADP
bjos-8647123	216	23	p	p	NOUN
bjos-8647123	216	24	53	53	NUM
bjos-8647123	216	25	in	in	ADP
bjos-8647123	216	26	oral	oral	ADJ
bjos-8647123	216	27	squamous	squamous	ADJ
bjos-8647123	216	28	cell	cell	NOUN
bjos-8647123	216	29	carcinoma	carcinoma	NOUN
bjos-8647123	216	30	(	(	PUNCT
bjos-8647123	216	31	scc	scc	NOUN
bjos-8647123	216	32	)	)	PUNCT
bjos-8647123	216	33	in	in	ADP
bjos-8647123	216	34	hospital	hospital	NOUN
bjos-8647123	216	35	university	university	PROPN
bjos-8647123	216	36	science	science	NOUN
bjos-8647123	216	37	malaysia	malaysia	PROPN
bjos-8647123	216	38	:	:	PUNCT
bjos-8647123	216	39	a	a	DET
bjos-8647123	216	40	preliminary	preliminary	ADJ
bjos-8647123	216	41	study	study	NOUN
bjos-8647123	216	42	.	.	PUNCT
bjos-8647123	217	1	braz	braz	PROPN
bjos-8647123	217	2	j	j	PROPN
bjos-8647123	217	3	oral	oral	PROPN
bjos-8647123	217	4	sci	sci	PROPN
bjos-8647123	217	5	.	.	PROPN
bjos-8647123	217	6	2008	2008	NUM
bjos-8647123	217	7	jan	jan	PROPN
bjos-8647123	217	8	-	-	PUNCT
bjos-8647123	217	9	mar;7(24):1476	mar;7(24):1476	NOUN
bjos-8647123	217	10	-	-	PUNCT
bjos-8647123	217	11	83	83	NUM
bjos-8647123	217	12	.	.	PUNCT
bjos-8647123	217	13	26	26	NUM
bjos-8647123	217	14	.	.	PUNCT
bjos-8647123	218	1	mashhadiabbas	mashhadiabbas	PROPN
bjos-8647123	218	2	f	f	PROPN
bjos-8647123	218	3	,	,	PUNCT
bjos-8647123	218	4	mahjour	mahjour	PROPN
bjos-8647123	218	5	f	f	PROPN
bjos-8647123	218	6	,	,	PUNCT
bjos-8647123	218	7	mahjour	mahjour	PROPN
bjos-8647123	218	8	sb	sb	PROPN
bjos-8647123	218	9	,	,	PUNCT
bjos-8647123	218	10	fereidooni	fereidooni	PROPN
bjos-8647123	218	11	f	f	X
bjos-8647123	218	12	,	,	PUNCT
bjos-8647123	218	13	hosseini	hosseini	PROPN
bjos-8647123	218	14	fs	fs	PROPN
bjos-8647123	218	15	.	.	PUNCT
bjos-8647123	219	1	the	the	DET
bjos-8647123	219	2	immunohistochemical	immunohistochemical	ADJ
bjos-8647123	219	3	characterization	characterization	NOUN
bjos-8647123	219	4	of	of	ADP
bjos-8647123	219	5	mmp-2	mmp-2	PRON
bjos-8647123	219	6	,	,	PUNCT
bjos-8647123	219	7	mmp-10	mmp-10	ADJ
bjos-8647123	219	8	,	,	PUNCT
bjos-8647123	219	9	timp-1	timp-1	NUM
bjos-8647123	219	10	,	,	PUNCT
bjos-8647123	219	11	timp-2	timp-2	NOUN
bjos-8647123	219	12	,	,	PUNCT
bjos-8647123	219	13	and	and	CCONJ
bjos-8647123	219	14	podoplanin	podoplanin	PROPN
bjos-8647123	219	15	in	in	ADP
bjos-8647123	219	16	oral	oral	ADJ
bjos-8647123	219	17	squamous	squamous	ADJ
bjos-8647123	219	18	cell	cell	NOUN
bjos-8647123	219	19	carcinoma	carcinoma	NOUN
bjos-8647123	219	20	.	.	PUNCT
bjos-8647123	220	1	oral	oral	ADJ
bjos-8647123	220	2	surg	surg	NOUN
bjos-8647123	220	3	oral	oral	ADJ
bjos-8647123	220	4	med	med	ADJ
bjos-8647123	220	5	oral	oral	ADJ
bjos-8647123	220	6	pathol	pathol	NOUN
bjos-8647123	220	7	oral	oral	ADJ
bjos-8647123	220	8	radiol	radiol	NOUN
bjos-8647123	220	9	.	.	PUNCT
bjos-8647123	221	1	2012	2012	NUM
bjos-8647123	221	2	aug;114(2):240	aug;114(2):240	NOUN
bjos-8647123	221	3	-	-	PUNCT
bjos-8647123	221	4	50	50	NUM
bjos-8647123	221	5	.	.	PUNCT
bjos-8647123	222	1	doi	doi	NOUN
bjos-8647123	222	2	:	:	PUNCT
bjos-8647123	222	3	10.1016	10.1016	NUM
bjos-8647123	222	4	/	/	SYM
bjos-8647123	222	5	j.oooo.2012.04.009	j.oooo.2012.04.009	PROPN
bjos-8647123	222	6	.	.	PUNCT
bjos-8647123	223	1	27	27	NUM
bjos-8647123	223	2	.	.	PUNCT
bjos-8647123	224	1	maheshwari	maheshwari	PROPN
bjos-8647123	224	2	v	v	PROPN
bjos-8647123	224	3	,	,	PUNCT
bjos-8647123	224	4	sharma	sharma	PROPN
bjos-8647123	224	5	sc	sc	PROPN
bjos-8647123	224	6	,	,	PUNCT
bjos-8647123	224	7	narula	narula	NOUN
bjos-8647123	224	8	v	v	ADP
bjos-8647123	224	9	,	,	PUNCT
bjos-8647123	224	10	verma	verma	PROPN
bjos-8647123	224	11	s	s	PROPN
bjos-8647123	224	12	,	,	PUNCT
bjos-8647123	224	13	jain	jain	PROPN
bjos-8647123	224	14	a	a	PRON
bjos-8647123	224	15	,	,	PUNCT
bjos-8647123	224	16	alam	alam	PROPN
bjos-8647123	224	17	k.	k.	PROPN
bjos-8647123	224	18	prognostic	prognostic	PROPN
bjos-8647123	224	19	and	and	CCONJ
bjos-8647123	224	20	predictive	predictive	ADJ
bjos-8647123	224	21	impact	impact	NOUN
bjos-8647123	224	22	of	of	ADP
bjos-8647123	224	23	ki67	ki67	PROPN
bjos-8647123	224	24	in	in	ADP
bjos-8647123	224	25	premalignant	premalignant	ADJ
bjos-8647123	224	26	and	and	CCONJ
bjos-8647123	224	27	malignant	malignant	ADJ
bjos-8647123	224	28	squamous	squamous	ADJ
bjos-8647123	224	29	cell	cell	NOUN
bjos-8647123	224	30	lesion	lesion	NOUN
bjos-8647123	224	31	of	of	ADP
bjos-8647123	224	32	oral	oral	ADJ
bjos-8647123	224	33	cavity	cavity	NOUN
bjos-8647123	224	34	.	.	PUNCT
bjos-8647123	225	1	int	int	PROPN
bjos-8647123	225	2	j	j	PROPN
bjos-8647123	225	3	head	head	NOUN
bjos-8647123	225	4	neck	neck	NOUN
bjos-8647123	225	5	surg	surg	NOUN
bjos-8647123	225	6	.	.	PUNCT
bjos-8647123	226	1	2013	2013	NUM
bjos-8647123	226	2	mayaug;4(2):61	mayaug;4(2):61	NOUN
bjos-8647123	226	3	-	-	SYM
bjos-8647123	226	4	5	5	NUM
bjos-8647123	226	5	.	.	NOUN
bjos-8647123	226	6	28	28	NUM
bjos-8647123	226	7	.	.	PUNCT
bjos-8647123	227	1	ree	ree	VERB
bjos-8647123	227	2	ah	ah	INTJ
bjos-8647123	227	3	,	,	PUNCT
bjos-8647123	227	4	florenes	florenes	PROPN
bjos-8647123	227	5	va	va	PROPN
bjos-8647123	227	6	,	,	PUNCT
bjos-8647123	227	7	berg	berg	PROPN
bjos-8647123	227	8	jp	jp	PROPN
bjos-8647123	227	9	,	,	PUNCT
bjos-8647123	227	10	maelandsmo	maelandsmo	PROPN
bjos-8647123	227	11	gm	gm	PROPN
bjos-8647123	227	12	,	,	PUNCT
bjos-8647123	227	13	nesland	nesland	PROPN
bjos-8647123	227	14	jm	jm	PROPN
bjos-8647123	227	15	,	,	PUNCT
bjos-8647123	227	16	fodstad	fodstad	PROPN
bjos-8647123	227	17	o.	o.	PROPN
bjos-8647123	227	18	high	high	ADJ
bjos-8647123	227	19	levels	level	NOUN
bjos-8647123	227	20	of	of	ADP
bjos-8647123	227	21	messenger	messenger	NOUN
bjos-8647123	227	22	rnas	rna	NOUN
bjos-8647123	227	23	for	for	ADP
bjos-8647123	227	24	tissue	tissue	NOUN
bjos-8647123	227	25	inhibitors	inhibitor	NOUN
bjos-8647123	227	26	of	of	ADP
bjos-8647123	227	27	metalloproteinases	metalloproteinase	NOUN
bjos-8647123	227	28	(	(	PUNCT
bjos-8647123	227	29	timp-1	timp-1	NUM
bjos-8647123	227	30	and	and	CCONJ
bjos-8647123	227	31	timp-2	timp-2	NUM
bjos-8647123	227	32	)	)	PUNCT
bjos-8647123	227	33	in	in	ADP
bjos-8647123	227	34	primary	primary	ADJ
bjos-8647123	227	35	breast	breast	NOUN
bjos-8647123	227	36	carcinomas	carcinoma	NOUN
bjos-8647123	227	37	are	be	AUX
bjos-8647123	227	38	associated	associate	VERB
bjos-8647123	227	39	with	with	ADP
bjos-8647123	227	40	development	development	NOUN
bjos-8647123	227	41	of	of	ADP
bjos-8647123	227	42	distant	distant	ADJ
bjos-8647123	227	43	metastases	metastasis	NOUN
bjos-8647123	227	44	.	.	PUNCT
bjos-8647123	228	1	clin	clin	PROPN
bjos-8647123	228	2	cancer	cancer	NOUN
bjos-8647123	228	3	res	re	NOUN
bjos-8647123	228	4	.	.	PUNCT
bjos-8647123	228	5	1997	1997	NUM
bjos-8647123	228	6	sep;3(9):1623	sep;3(9):1623	NOUN
bjos-8647123	228	7	-	-	PUNCT
bjos-8647123	228	8	8	8	NUM
bjos-8647123	228	9	.	.	NOUN
bjos-8647123	228	10	29	29	NUM
bjos-8647123	228	11	.	.	PUNCT
bjos-8647123	229	1	grimminger	grimminger	PROPN
bjos-8647123	229	2	cm	cm	PROPN
bjos-8647123	229	3	,	,	PUNCT
bjos-8647123	229	4	danenberg	danenberg	PROPN
bjos-8647123	229	5	pv	pv	NOUN
bjos-8647123	229	6	.	.	PUNCT
bjos-8647123	230	1	update	update	NOUN
bjos-8647123	230	2	of	of	ADP
bjos-8647123	230	3	prognostic	prognostic	ADJ
bjos-8647123	230	4	and	and	CCONJ
bjos-8647123	230	5	predictive	predictive	ADJ
bjos-8647123	230	6	biomarkers	biomarker	NOUN
bjos-8647123	230	7	in	in	ADP
bjos-8647123	230	8	oropharyngeal	oropharyngeal	ADJ
bjos-8647123	230	9	squamous	squamous	ADJ
bjos-8647123	230	10	cell	cell	NOUN
bjos-8647123	230	11	carcinoma	carcinoma	NOUN
bjos-8647123	230	12	:	:	PUNCT
bjos-8647123	230	13	a	a	DET
bjos-8647123	230	14	review	review	NOUN
bjos-8647123	230	15	.	.	PUNCT
bjos-8647123	231	1	eur	eur	PROPN
bjos-8647123	231	2	arch	arch	ADJ
bjos-8647123	231	3	otorhinolaryngol	otorhinolaryngol	NOUN
bjos-8647123	231	4	.	.	PUNCT
bjos-8647123	232	1	2011	2011	NUM
bjos-8647123	233	1	jan;268(1):5	jan;268(1):5	NUM
bjos-8647123	233	2	-	-	PUNCT
bjos-8647123	233	3	16	16	NUM
bjos-8647123	233	4	.	.	PUNCT
bjos-8647123	234	1	doi	doi	NOUN
bjos-8647123	234	2	:	:	PUNCT
bjos-8647123	234	3	10.1007	10.1007	NUM
bjos-8647123	234	4	/	/	SYM
bjos-8647123	234	5	s00405010	s00405010	NOUN
bjos-8647123	234	6	-	-	PUNCT
bjos-8647123	234	7	1369	1369	NUM
bjos-8647123	234	8	-	-	PUNCT
bjos-8647123	234	9	x.	x.	NOUN
bjos-8647123	234	10	30	30	NUM
bjos-8647123	234	11	.	.	PUNCT
bjos-8647123	235	1	cardeal	cardeal	ADJ
bjos-8647123	235	2	lb	lb	NOUN
bjos-8647123	235	3	,	,	PUNCT
bjos-8647123	235	4	boccardo	boccardo	NOUN
bjos-8647123	235	5	e	e	NOUN
bjos-8647123	235	6	,	,	PUNCT
bjos-8647123	235	7	termini	termini	NOUN
bjos-8647123	235	8	l	l	NOUN
bjos-8647123	235	9	,	,	PUNCT
bjos-8647123	235	10	rabachini	rabachini	PROPN
bjos-8647123	235	11	t	t	PROPN
bjos-8647123	235	12	,	,	PUNCT
bjos-8647123	235	13	andreoli	andreoli	PROPN
bjos-8647123	235	14	ma	ma	PROPN
bjos-8647123	235	15	,	,	PUNCT
bjos-8647123	235	16	di	di	X
bjos-8647123	235	17	loreto	loreto	PROPN
bjos-8647123	235	18	c	c	PROPN
bjos-8647123	235	19	,	,	PUNCT
bjos-8647123	235	20	et	et	PROPN
bjos-8647123	235	21	al	al	PROPN
bjos-8647123	235	22	.	.	PUNCT
bjos-8647123	236	1	hpv16	hpv16	NOUN
bjos-8647123	236	2	oncoproteins	oncoprotein	NOUN
bjos-8647123	236	3	induce	induce	VERB
bjos-8647123	236	4	mmps	mmp	NOUN
bjos-8647123	236	5	/	/	SYM
bjos-8647123	236	6	reck	reck	NOUN
bjos-8647123	236	7	-	-	PUNCT
bjos-8647123	236	8	timp-2	timp-2	NUM
bjos-8647123	236	9	imbalance	imbalance	NOUN
bjos-8647123	236	10	in	in	ADP
bjos-8647123	236	11	primary	primary	ADJ
bjos-8647123	236	12	keratinocytes	keratinocyte	NOUN
bjos-8647123	236	13	:	:	PUNCT
bjos-8647123	236	14	possible	possible	ADJ
bjos-8647123	236	15	implications	implication	NOUN
bjos-8647123	236	16	in	in	ADP
bjos-8647123	236	17	cervical	cervical	ADJ
bjos-8647123	236	18	carcinogenesis	carcinogenesis	NOUN
bjos-8647123	236	19	.	.	PUNCT
bjos-8647123	237	1	plos	plos	PROPN
bjos-8647123	237	2	one	one	NUM
bjos-8647123	237	3	.	.	PUNCT
bjos-8647123	238	1	2012;7(3):e33585	2012;7(3):e33585	NUM
bjos-8647123	238	2	.	.	PUNCT
bjos-8647123	238	3	doi	doi	NOUN
bjos-8647123	238	4	:	:	PUNCT
bjos-8647123	238	5	10.1371	10.1371	NUM
bjos-8647123	238	6	/	/	SYM
bjos-8647123	238	7	journal.pone.0033585	journal.pone.0033585	NOUN
bjos-8647123	238	8	.	.	PROPN
bjos-8647123	238	9	31	31	NUM
bjos-8647123	238	10	.	.	PUNCT
bjos-8647123	239	1	yoshizaki	yoshizaki	PROPN
bjos-8647123	239	2	t	t	PROPN
bjos-8647123	239	3	,	,	PUNCT
bjos-8647123	239	4	maruyama	maruyama	PROPN
bjos-8647123	239	5	y	y	PROPN
bjos-8647123	239	6	,	,	PUNCT
bjos-8647123	239	7	sato	sato	PROPN
bjos-8647123	239	8	h	h	NOUN
bjos-8647123	239	9	,	,	PUNCT
bjos-8647123	239	10	furukawa	furukawa	PROPN
bjos-8647123	239	11	m.	m.	NOUN
bjos-8647123	239	12	expression	expression	NOUN
bjos-8647123	239	13	of	of	ADP
bjos-8647123	239	14	tissue	tissue	NOUN
bjos-8647123	239	15	inhibitor	inhibitor	NOUN
bjos-8647123	239	16	of	of	ADP
bjos-8647123	239	17	matrix	matrix	NOUN
bjos-8647123	239	18	metalloproteinase-2	metalloproteinase-2	NUM
bjos-8647123	239	19	correlates	correlate	VERB
bjos-8647123	239	20	with	with	ADP
bjos-8647123	239	21	activation	activation	NOUN
bjos-8647123	239	22	of	of	ADP
bjos-8647123	239	23	matrix	matrix	NOUN
bjos-8647123	239	24	metalloproteinase-2	metalloproteinase-2	NUM
bjos-8647123	239	25	and	and	CCONJ
bjos-8647123	239	26	predicts	predict	VERB
bjos-8647123	239	27	poor	poor	ADJ
bjos-8647123	239	28	prognosis	prognosis	NOUN
bjos-8647123	239	29	in	in	ADP
bjos-8647123	239	30	tongue	tongue	NOUN
bjos-8647123	239	31	squamous	squamous	ADJ
bjos-8647123	239	32	cell	cell	NOUN
bjos-8647123	239	33	carcinoma	carcinoma	NOUN
bjos-8647123	239	34	.	.	PUNCT
bjos-8647123	240	1	int	int	NOUN
bjos-8647123	240	2	j	j	PROPN
bjos-8647123	240	3	cancer	cancer	NOUN
bjos-8647123	240	4	.	.	PUNCT
bjos-8647123	241	1	2001	2001	NUM
bjos-8647123	241	2	jan	jan	PROPN
bjos-8647123	241	3	20;95(1):44	20;95(1):44	NUM
bjos-8647123	241	4	-	-	SYM
bjos-8647123	241	5	50	50	NUM
bjos-8647123	241	6	.	.	PUNCT
bjos-8647123	241	7	32	32	NUM
bjos-8647123	241	8	.	.	PUNCT
bjos-8647123	241	9	pérez	pérez	NOUN
bjos-8647123	241	10	-	-	PUNCT
bjos-8647123	241	11	sayáns	sayáns	NOUN
bjos-8647123	241	12	garcía	garcía	PROPN
bjos-8647123	241	13	m	m	PROPN
bjos-8647123	241	14	,	,	PUNCT
bjos-8647123	241	15	suárez	suárez	NOUN
bjos-8647123	241	16	-	-	PUNCT
bjos-8647123	241	17	peñaranda	peñaranda	NOUN
bjos-8647123	241	18	jm	jm	PROPN
bjos-8647123	241	19	,	,	PUNCT
bjos-8647123	241	20	gayoso	gayoso	PROPN
bjos-8647123	241	21	-	-	PUNCT
bjos-8647123	241	22	diz	diz	PROPN
bjos-8647123	241	23	p	p	PROPN
bjos-8647123	241	24	,	,	PUNCT
bjos-8647123	241	25	barros	barros	PROPN
bjos-8647123	241	26	-	-	PUNCT
bjos-8647123	241	27	angueira	angueira	PROPN
bjos-8647123	241	28	f	f	PROPN
bjos-8647123	241	29	,	,	PUNCT
bjos-8647123	241	30	gándara	gándara	NOUN
bjos-8647123	241	31	-	-	PUNCT
bjos-8647123	241	32	rey	rey	PROPN
bjos-8647123	241	33	jm	jm	PROPN
bjos-8647123	241	34	,	,	PUNCT
bjos-8647123	241	35	garcía	garcía	NOUN
bjos-8647123	241	36	-	-	PUNCT
bjos-8647123	241	37	garcía	garcía	ADJ
bjos-8647123	241	38	a	a	DET
bjos-8647123	241	39	(	(	PUNCT
bjos-8647123	241	40	2012	2012	NUM
bjos-8647123	241	41	)	)	PUNCT
bjos-8647123	241	42	.	.	PUNCT
bjos-8647123	242	1	tissue	tissue	NOUN
bjos-8647123	242	2	inhibitor	inhibitor	NOUN
bjos-8647123	242	3	of	of	ADP
bjos-8647123	242	4	metalloproteinases	metalloproteinase	NOUN
bjos-8647123	242	5	in	in	ADP
bjos-8647123	242	6	oral	oral	ADJ
bjos-8647123	242	7	squamous	squamous	ADJ
bjos-8647123	242	8	cell	cell	NOUN
bjos-8647123	242	9	carcinomas	carcinoma	VERB
bjos-8647123	242	10	a	a	DET
bjos-8647123	242	11	therapeutic	therapeutic	ADJ
bjos-8647123	242	12	target	target	NOUN
bjos-8647123	242	13	?	?	PUNCT
bjos-8647123	243	1	cancer	cancer	NOUN
bjos-8647123	243	2	lett	lett	PROPN
bjos-8647123	243	3	.	.	PUNCT
bjos-8647123	244	1	2012	2012	NUM
bjos-8647123	244	2	oct	oct	PROPN
bjos-8647123	244	3	1;323(1):11	1;323(1):11	PROPN
bjos-8647123	244	4	-	-	SYM
bjos-8647123	244	5	9	9	NUM
bjos-8647123	244	6	.	.	PUNCT
bjos-8647123	244	7	doi	doi	NOUN
bjos-8647123	244	8	:	:	PUNCT
bjos-8647123	244	9	10.1016	10.1016	NUM
bjos-8647123	244	10	/	/	SYM
bjos-8647123	244	11	j.	j.	PROPN
bjos-8647123	244	12	canlet.2012.03.040	canlet.2012.03.040	PROPN
bjos-8647123	244	13	.	.	PROPN
bjos-8647123	244	14	33	33	NUM
bjos-8647123	244	15	.	.	PUNCT
bjos-8647123	244	16	dürst	dürst	NUM
bjos-8647123	244	17	m	m	PROPN
bjos-8647123	244	18	,	,	PUNCT
bjos-8647123	244	19	dzarlieva	dzarlieva	NOUN
bjos-8647123	244	20	-	-	PUNCT
bjos-8647123	244	21	petrusevska	petrusevska	PROPN
bjos-8647123	244	22	rt	rt	PROPN
bjos-8647123	244	23	,	,	PUNCT
bjos-8647123	244	24	boukamp	boukamp	PROPN
bjos-8647123	244	25	p	p	X
bjos-8647123	244	26	,	,	PUNCT
bjos-8647123	244	27	fusenig	fusenig	PROPN
bjos-8647123	244	28	ne	ne	PROPN
bjos-8647123	244	29	,	,	PUNCT
bjos-8647123	244	30	gissmann	gissmann	PROPN
bjos-8647123	244	31	l.	l.	PROPN
bjos-8647123	244	32	molecular	molecular	ADJ
bjos-8647123	244	33	and	and	CCONJ
bjos-8647123	244	34	cytogenetic	cytogenetic	ADJ
bjos-8647123	244	35	analysis	analysis	NOUN
bjos-8647123	244	36	of	of	ADP
bjos-8647123	244	37	immortalized	immortalized	ADJ
bjos-8647123	244	38	human	human	ADJ
bjos-8647123	244	39	primary	primary	ADJ
bjos-8647123	244	40	keratinocytes	keratinocyte	NOUN
bjos-8647123	244	41	obtained	obtain	VERB
bjos-8647123	244	42	after	after	ADP
bjos-8647123	244	43	transfection	transfection	NOUN
bjos-8647123	244	44	with	with	ADP
bjos-8647123	244	45	human	human	ADJ
bjos-8647123	244	46	papillomavirus	papillomavirus	NOUN
bjos-8647123	244	47	type	type	NOUN
bjos-8647123	244	48	16	16	NUM
bjos-8647123	244	49	dna	dna	NOUN
bjos-8647123	244	50	.	.	PUNCT
bjos-8647123	245	1	oncogene	oncogene	NOUN
bjos-8647123	245	2	.	.	PUNCT
bjos-8647123	246	1	1987;1:(3):251	1987;1:(3):251	NUM
bjos-8647123	246	2	-	-	SYM
bjos-8647123	246	3	6	6	NUM
bjos-8647123	246	4	.	.	NOUN
bjos-8647123	246	5	34	34	NUM
bjos-8647123	246	6	.	.	PUNCT
bjos-8647123	246	7	feller	feller	NOUN
bjos-8647123	246	8	l	l	NOUN
bjos-8647123	246	9	,	,	PUNCT
bjos-8647123	246	10	wood	wood	PROPN
bjos-8647123	246	11	nh	nh	PROPN
bjos-8647123	246	12	,	,	PUNCT
bjos-8647123	246	13	khammissa	khammissa	ADJ
bjos-8647123	246	14	ra	ra	PROPN
bjos-8647123	246	15	,	,	PUNCT
bjos-8647123	246	16	lemmer	lemmer	NOUN
bjos-8647123	246	17	j.	j.	PROPN
bjos-8647123	246	18	human	human	PROPN
bjos-8647123	246	19	papillomavirusmediated	papillomavirusmediate	VERB
bjos-8647123	246	20	carcinogenesis	carcinogenesis	NOUN
bjos-8647123	246	21	and	and	CCONJ
bjos-8647123	246	22	hpv	hpv	NOUN
bjos-8647123	246	23	-	-	PUNCT
bjos-8647123	246	24	associated	associate	VERB
bjos-8647123	246	25	oral	oral	ADJ
bjos-8647123	246	26	and	and	CCONJ
bjos-8647123	246	27	oropharyngeal	oropharyngeal	ADJ
bjos-8647123	246	28	squamous	squamous	ADJ
bjos-8647123	246	29	cell	cell	NOUN
bjos-8647123	246	30	carcinoma	carcinoma	NOUN
bjos-8647123	246	31	.	.	PUNCT
bjos-8647123	247	1	part	part	NOUN
bjos-8647123	247	2	2	2	NUM
bjos-8647123	247	3	:	:	PUNCT
bjos-8647123	247	4	human	human	ADJ
bjos-8647123	247	5	papillomavirus	papillomavirus	NOUN
bjos-8647123	247	6	associated	associate	VERB
bjos-8647123	247	7	oral	oral	ADJ
bjos-8647123	247	8	and	and	CCONJ
bjos-8647123	247	9	oropharyngeal	oropharyngeal	ADJ
bjos-8647123	247	10	squamous	squamous	ADJ
bjos-8647123	247	11	cell	cell	NOUN
bjos-8647123	247	12	carcinoma	carcinoma	NOUN
bjos-8647123	247	13	.	.	PUNCT
bjos-8647123	248	1	head	head	NOUN
bjos-8647123	248	2	face	face	VERB
bjos-8647123	248	3	med.n	med.n	NOUN
bjos-8647123	248	4	2010	2010	NUM
bjos-8647123	248	5	jul	jul	PROPN
bjos-8647123	248	6	15;6:15	15;6:15	NUM
bjos-8647123	248	7	.	.	PUNCT
bjos-8647123	249	1	doi	doi	NOUN
bjos-8647123	249	2	:	:	PUNCT
bjos-8647123	249	3	10.1186/1746	10.1186/1746	NUM
bjos-8647123	249	4	-	-	SYM
bjos-8647123	249	5	160x-6	160x-6	NUM
bjos-8647123	249	6	-	-	SYM
bjos-8647123	249	7	15	15	NUM
bjos-8647123	249	8	.	.	NOUN
bjos-8647123	249	9	35	35	NUM
bjos-8647123	249	10	.	.	PUNCT
bjos-8647123	250	1	zhu	zhu	PROPN
bjos-8647123	250	2	c	c	X
bjos-8647123	250	3	,	,	PUNCT
bjos-8647123	250	4	ling	ling	PROPN
bjos-8647123	250	5	y	y	PROPN
bjos-8647123	250	6	,	,	PUNCT
bjos-8647123	250	7	dong	dong	PROPN
bjos-8647123	250	8	c	c	PROPN
bjos-8647123	250	9	,	,	PUNCT
bjos-8647123	250	10	zhou	zhou	PROPN
bjos-8647123	250	11	x	x	PROPN
bjos-8647123	250	12	,	,	PUNCT
bjos-8647123	250	13	wang	wang	PROPN
bjos-8647123	250	14	f.	f.	PROPN
bjos-8647123	250	15	the	the	DET
bjos-8647123	250	16	relationship	relationship	NOUN
bjos-8647123	250	17	between	between	ADP
bjos-8647123	250	18	oral	oral	ADJ
bjos-8647123	250	19	squamous	squamous	ADJ
bjos-8647123	250	20	cell	cell	NOUN
bjos-8647123	250	21	carcinoma	carcinoma	NOUN
bjos-8647123	250	22	and	and	CCONJ
bjos-8647123	250	23	human	human	ADJ
bjos-8647123	250	24	papillomavirus	papillomavirus	NOUN
bjos-8647123	250	25	:	:	PUNCT
bjos-8647123	250	26	a	a	DET
bjos-8647123	250	27	meta	meta	ADJ
bjos-8647123	250	28	-	-	PUNCT
bjos-8647123	250	29	analysis	analysis	NOUN
bjos-8647123	250	30	of	of	ADP
bjos-8647123	250	31	a	a	DET
bjos-8647123	250	32	chinese	chinese	ADJ
bjos-8647123	250	33	population	population	NOUN
bjos-8647123	250	34	(	(	PUNCT
bjos-8647123	250	35	1994–2011	1994–2011	NUM
bjos-8647123	250	36	)	)	PUNCT
bjos-8647123	250	37	.	.	PUNCT
bjos-8647123	251	1	plos	plos	PROPN
bjos-8647123	251	2	one	one	NUM
bjos-8647123	251	3	.	.	PUNCT
bjos-8647123	252	1	2012;7(5):e36294	2012;7(5):e36294	NOUN
bjos-8647123	252	2	.	.	PUNCT
bjos-8647123	253	1	doi	doi	NOUN
bjos-8647123	253	2	:	:	PUNCT
bjos-8647123	253	3	10.1371	10.1371	NUM
bjos-8647123	253	4	/	/	SYM
bjos-8647123	253	5	journal.pone.0036294	journal.pone.0036294	PROPN
bjos-8647123	253	6	.	.	PROPN
bjos-8647123	254	1	36	36	NUM
bjos-8647123	254	2	.	.	PUNCT
bjos-8647123	255	1	mclaughlin	mclaughlin	PROPN
bjos-8647123	255	2	-	-	PUNCT
bjos-8647123	255	3	drubin	drubin	PROPN
bjos-8647123	255	4	me	i	PRON
bjos-8647123	255	5	,	,	PUNCT
bjos-8647123	255	6	münger	münger	ADV
bjos-8647123	255	7	k	k	X
bjos-8647123	255	8	(	(	PUNCT
bjos-8647123	255	9	2009	2009	NUM
bjos-8647123	255	10	)	)	PUNCT
bjos-8647123	255	11	.	.	PUNCT
bjos-8647123	256	1	oncogenic	oncogenic	ADJ
bjos-8647123	256	2	activities	activity	NOUN
bjos-8647123	256	3	of	of	ADP
bjos-8647123	256	4	human	human	ADJ
bjos-8647123	256	5	papillomaviruses	papillomaviruse	NOUN
bjos-8647123	256	6	.	.	PUNCT
bjos-8647123	257	1	virus	virus	NOUN
bjos-8647123	257	2	res	re	NOUN
bjos-8647123	257	3	.	.	PUNCT
bjos-8647123	257	4	2009	2009	NUM
bjos-8647123	257	5	aug;143(2):195	aug;143(2):195	NOUN
bjos-8647123	257	6	-	-	PUNCT
bjos-8647123	257	7	208	208	NUM
bjos-8647123	257	8	.	.	PUNCT
bjos-8647123	258	1	doi	doi	NOUN
bjos-8647123	258	2	:	:	PUNCT
bjos-8647123	258	3	10.1016	10.1016	NUM
bjos-8647123	258	4	/	/	SYM
bjos-8647123	258	5	j.virusres.2009.06.008	j.virusres.2009.06.008	NOUN
bjos-8647123	258	6	.	.	PUNCT
bjos-8647123	259	1	expression	expression	NOUN
bjos-8647123	259	2	of	of	ADP
bjos-8647123	259	3	timp-2	timp-2	PROPN
bjos-8647123	259	4	in	in	ADP
bjos-8647123	259	5	hpv-16	hpv-16	NUM
bjos-8647123	259	6	infected	infect	VERB
bjos-8647123	259	7	oral	oral	ADJ
bjos-8647123	259	8	squamous	squamous	ADJ
bjos-8647123	259	9	cell	cell	NOUN
bjos-8647123	259	10	carcinoma	carcinoma	NOUN
bjos-8647123	259	11	in	in	ADP
bjos-8647123	259	12	patients	patient	NOUN
bjos-8647123	259	13	in	in	ADP
bjos-8647123	259	14	iraq	iraq	PROPN
bjos-8647123	259	15	braz	braz	PROPN
bjos-8647123	259	16	j	j	PROPN
bjos-8647123	259	17	oral	oral	PROPN
bjos-8647123	259	18	sci	sci	PROPN
bjos-8647123	259	19	.	.	PUNCT
bjos-8647123	260	1	15(1):51	15(1):51	NUM
bjos-8647123	260	2	-	-	SYM
bjos-8647123	260	3	56	56	NUM
bjos-8647123	260	4	56	56	NUM
bjos-8647123	260	5	braz	braz	PROPN
bjos-8647123	260	6	j	j	PROPN
bjos-8647123	260	7	oral	oral	PROPN
bjos-8647123	260	8	sci	sci	PROPN
bjos-8647123	260	9	.	.	PUNCT
bjos-8647123	261	1	15(1):51	15(1):51	NUM
bjos-8647123	261	2	-	-	SYM
bjos-8647123	261	3	56	56	NUM
bjos-8647123	261	4	37	37	NUM
bjos-8647123	261	5	.	.	PUNCT
bjos-8647123	262	1	ikebe	ikebe	PROPN
bjos-8647123	262	2	t	t	PROPN
bjos-8647123	262	3	,	,	PUNCT
bjos-8647123	262	4	shinohara	shinohara	PROPN
bjos-8647123	262	5	m	m	PROPN
bjos-8647123	262	6	,	,	PUNCT
bjos-8647123	262	7	takeuchi	takeuchi	PROPN
bjos-8647123	262	8	h	h	PROPN
bjos-8647123	262	9	,	,	PUNCT
bjos-8647123	262	10	beppu	beppu	PROPN
bjos-8647123	262	11	m	m	PROPN
bjos-8647123	262	12	,	,	PUNCT
bjos-8647123	262	13	kurahara	kurahara	PROPN
bjos-8647123	262	14	s	s	PROPN
bjos-8647123	262	15	,	,	PUNCT
bjos-8647123	262	16	nakamura	nakamura	PROPN
bjos-8647123	262	17	s	s	PROPN
bjos-8647123	262	18	,	,	PUNCT
bjos-8647123	262	19	et	et	PROPN
bjos-8647123	262	20	al	al	PROPN
bjos-8647123	262	21	.	.	PROPN
bjos-8647123	262	22	gelatinolytic	gelatinolytic	ADJ
bjos-8647123	262	23	activity	activity	NOUN
bjos-8647123	262	24	of	of	ADP
bjos-8647123	262	25	matrix	matrix	NOUN
bjos-8647123	262	26	metalloproteinase	metalloproteinase	NOUN
bjos-8647123	262	27	in	in	ADP
bjos-8647123	262	28	tumor	tumor	NOUN
bjos-8647123	262	29	tissues	tissue	NOUN
bjos-8647123	262	30	correlates	correlate	VERB
bjos-8647123	262	31	with	with	ADP
bjos-8647123	262	32	the	the	DET
bjos-8647123	262	33	invasiveness	invasiveness	NOUN
bjos-8647123	262	34	of	of	ADP
bjos-8647123	262	35	oral	oral	ADJ
bjos-8647123	262	36	cancer	cancer	NOUN
bjos-8647123	262	37	.	.	PUNCT
bjos-8647123	263	1	clin	clin	PROPN
bjos-8647123	263	2	exp	exp	NOUN
bjos-8647123	263	3	metastasis	metastasis	NOUN
bjos-8647123	263	4	.	.	PUNCT
bjos-8647123	263	5	1999	1999	NUM
bjos-8647123	263	6	jun;17(4):315	jun;17(4):315	PROPN
bjos-8647123	263	7	-	-	PUNCT
bjos-8647123	263	8	23	23	NUM
bjos-8647123	263	9	.	.	PUNCT
bjos-8647123	264	1	38	38	NUM
bjos-8647123	264	2	.	.	PUNCT
bjos-8647123	265	1	o	o	X
bjos-8647123	265	2	-	-	NOUN
bjos-8647123	265	3	charoenrat	charoenrat	NOUN
bjos-8647123	265	4	p	p	NOUN
bjos-8647123	265	5	,	,	PUNCT
bjos-8647123	265	6	rhys	rhys	PROPN
bjos-8647123	265	7	-	-	PUNCT
bjos-8647123	265	8	evans	evans	PROPN
bjos-8647123	265	9	p	p	X
bjos-8647123	265	10	,	,	PUNCT
bjos-8647123	265	11	eccles	eccles	PROPN
bjos-8647123	265	12	sa	sa	PROPN
bjos-8647123	265	13	.	.	PUNCT
bjos-8647123	265	14	expression	expression	NOUN
bjos-8647123	265	15	of	of	ADP
bjos-8647123	265	16	matrix	matrix	NOUN
bjos-8647123	265	17	metalloproteinases	metalloproteinase	NOUN
bjos-8647123	265	18	and	and	CCONJ
bjos-8647123	265	19	their	their	PRON
bjos-8647123	265	20	inhibitors	inhibitor	NOUN
bjos-8647123	265	21	correlates	correlate	VERB
bjos-8647123	265	22	with	with	ADP
bjos-8647123	265	23	invasion	invasion	NOUN
bjos-8647123	265	24	and	and	CCONJ
bjos-8647123	265	25	metastasis	metastasis	NOUN
bjos-8647123	265	26	in	in	ADP
bjos-8647123	265	27	squamous	squamous	ADJ
bjos-8647123	265	28	cell	cell	NOUN
bjos-8647123	265	29	carcinoma	carcinoma	NOUN
bjos-8647123	265	30	of	of	ADP
bjos-8647123	265	31	the	the	DET
bjos-8647123	265	32	head	head	NOUN
bjos-8647123	265	33	and	and	CCONJ
bjos-8647123	265	34	neck	neck	NOUN
bjos-8647123	265	35	.	.	PUNCT
bjos-8647123	266	1	arch	arch	ADJ
bjos-8647123	266	2	otolaryngol	otolaryngol	PROPN
bjos-8647123	266	3	head	head	NOUN
bjos-8647123	266	4	neck	neck	NOUN
bjos-8647123	266	5	surg	surg	NOUN
bjos-8647123	266	6	.	.	PUNCT
bjos-8647123	267	1	2001	2001	NUM
bjos-8647123	267	2	jul;127(7):813	jul;127(7):813	PROPN
bjos-8647123	267	3	-	-	PUNCT
bjos-8647123	267	4	20	20	NUM
bjos-8647123	267	5	.	.	NOUN
bjos-8647123	267	6	39	39	NUM
bjos-8647123	267	7	.	.	PUNCT
bjos-8647123	268	1	grignon	grignon	PROPN
bjos-8647123	268	2	dj	dj	PROPN
bjos-8647123	268	3	,	,	PUNCT
bjos-8647123	268	4	sakr	sakr	PROPN
bjos-8647123	268	5	w	w	PROPN
bjos-8647123	268	6	,	,	PUNCT
bjos-8647123	268	7	toth	toth	PROPN
bjos-8647123	268	8	m	m	PROPN
bjos-8647123	268	9	,	,	PUNCT
bjos-8647123	268	10	ravery	ravery	PROPN
bjos-8647123	268	11	v	v	PROPN
bjos-8647123	268	12	,	,	PUNCT
bjos-8647123	268	13	angulo	angulo	PROPN
bjos-8647123	268	14	j	j	PROPN
bjos-8647123	268	15	,	,	PUNCT
bjos-8647123	268	16	shamsa	shamsa	NOUN
bjos-8647123	268	17	f	f	NOUN
bjos-8647123	268	18	,	,	PUNCT
bjos-8647123	268	19	et	et	PROPN
bjos-8647123	268	20	al	al	PROPN
bjos-8647123	268	21	.	.	PROPN
bjos-8647123	268	22	high	high	ADJ
bjos-8647123	268	23	levels	level	NOUN
bjos-8647123	268	24	of	of	ADP
bjos-8647123	268	25	tissue	tissue	NOUN
bjos-8647123	268	26	inhibitor	inhibitor	NOUN
bjos-8647123	268	27	of	of	ADP
bjos-8647123	268	28	metalloproteinase-2	metalloproteinase-2	PROPN
bjos-8647123	268	29	(	(	PUNCT
bjos-8647123	268	30	timp-2	timp-2	NOUN
bjos-8647123	268	31	)	)	PUNCT
bjos-8647123	268	32	expression	expression	NOUN
bjos-8647123	268	33	are	be	AUX
bjos-8647123	268	34	associated	associate	VERB
bjos-8647123	268	35	with	with	ADP
bjos-8647123	268	36	poor	poor	ADJ
bjos-8647123	268	37	outcome	outcome	NOUN
bjos-8647123	268	38	in	in	ADP
bjos-8647123	268	39	invasive	invasive	ADJ
bjos-8647123	268	40	bladder	bladder	NOUN
bjos-8647123	268	41	cancer	cancer	NOUN
bjos-8647123	268	42	.	.	PUNCT
bjos-8647123	269	1	cancer	cancer	NOUN
bjos-8647123	269	2	res	re	NOUN
bjos-8647123	269	3	.	.	PUNCT
bjos-8647123	269	4	1996	1996	NUM
bjos-8647123	269	5	apr	apr	VERB
bjos-8647123	269	6	1;56(7):1654	1;56(7):1654	NUM
bjos-8647123	269	7	-	-	SYM
bjos-8647123	269	8	9	9	NUM
bjos-8647123	269	9	.	.	NUM
bjos-8647123	269	10	40	40	NUM
bjos-8647123	269	11	.	.	PUNCT
bjos-8647123	270	1	ondruschka	ondruschka	PROPN
bjos-8647123	270	2	c	c	PROPN
bjos-8647123	270	3	,	,	PUNCT
bjos-8647123	270	4	buhtz	buhtz	ADV
bjos-8647123	270	5	p	p	X
bjos-8647123	270	6	,	,	PUNCT
bjos-8647123	270	7	motsch	motsch	NOUN
bjos-8647123	270	8	c	c	NOUN
bjos-8647123	270	9	,	,	PUNCT
bjos-8647123	270	10	freigang	freigang	PROPN
bjos-8647123	270	11	b	b	PROPN
bjos-8647123	270	12	,	,	PUNCT
bjos-8647123	270	13	schneider	schneider	NOUN
bjos-8647123	270	14	-	-	PUNCT
bjos-8647123	270	15	stock	stock	NOUN
bjos-8647123	270	16	r	r	NOUN
bjos-8647123	270	17	,	,	PUNCT
bjos-8647123	270	18	roessner	roessner	NOUN
bjos-8647123	270	19	a	a	NOUN
bjos-8647123	270	20	,	,	PUNCT
bjos-8647123	270	21	et	et	PROPN
bjos-8647123	270	22	al	al	PROPN
bjos-8647123	270	23	.	.	PROPN
bjos-8647123	271	1	prognostic	prognostic	ADJ
bjos-8647123	271	2	value	value	NOUN
bjos-8647123	271	3	of	of	ADP
bjos-8647123	271	4	mmp-2	mmp-2	NUM
bjos-8647123	271	5	,	,	PUNCT
bjos-8647123	271	6	-9	-9	PROPN
bjos-8647123	271	7	and	and	CCONJ
bjos-8647123	271	8	timp1	timp1	NOUN
bjos-8647123	271	9	,	,	PUNCT
bjos-8647123	271	10	-2	-2	X
bjos-8647123	271	11	immunoreactive	immunoreactive	ADJ
bjos-8647123	271	12	protein	protein	NOUN
bjos-8647123	271	13	at	at	ADP
bjos-8647123	271	14	the	the	DET
bjos-8647123	271	15	invasive	invasive	ADJ
bjos-8647123	271	16	front	front	NOUN
bjos-8647123	271	17	in	in	ADP
bjos-8647123	271	18	advanced	advanced	ADJ
bjos-8647123	271	19	head	head	NOUN
bjos-8647123	271	20	and	and	CCONJ
bjos-8647123	271	21	neck	neck	VERB
bjos-8647123	271	22	squamous	squamous	ADJ
bjos-8647123	271	23	cell	cell	NOUN
bjos-8647123	271	24	carcinomas	carcinoma	NOUN
bjos-8647123	271	25	.	.	PUNCT
bjos-8647123	272	1	pathol	pathol	VERB
bjos-8647123	272	2	res	re	NOUN
bjos-8647123	272	3	pract	pract	NOUN
bjos-8647123	272	4	.	.	PUNCT
bjos-8647123	273	1	2002;198(8):509	2002;198(8):509	NUM
bjos-8647123	273	2	-	-	SYM
bjos-8647123	273	3	15	15	NUM
bjos-8647123	273	4	.	.	NOUN
bjos-8647123	274	1	41	41	NUM
bjos-8647123	274	2	.	.	PUNCT
bjos-8647123	275	1	sternlicht	sternlicht	PROPN
bjos-8647123	275	2	md	md	PROPN
bjos-8647123	275	3	,	,	PUNCT
bjos-8647123	275	4	bissell	bissell	PROPN
bjos-8647123	275	5	mj	mj	PROPN
bjos-8647123	275	6	,	,	PUNCT
bjos-8647123	275	7	werb	werb	NOUN
bjos-8647123	275	8	z.	z.	PROPN
bjos-8647123	276	1	the	the	DET
bjos-8647123	276	2	matrix	matrix	NOUN
bjos-8647123	276	3	metalloproteinase	metalloproteinase	NOUN
bjos-8647123	276	4	stromelysin-1	stromelysin-1	PROPN
bjos-8647123	276	5	acts	act	NOUN
bjos-8647123	276	6	as	as	ADP
bjos-8647123	276	7	a	a	DET
bjos-8647123	276	8	natural	natural	ADJ
bjos-8647123	276	9	mammary	mammary	ADJ
bjos-8647123	276	10	tumor	tumor	NOUN
bjos-8647123	276	11	promoter	promoter	NOUN
bjos-8647123	276	12	.	.	PUNCT
bjos-8647123	277	1	oncogene	oncogene	NOUN
bjos-8647123	277	2	.	.	PUNCT
bjos-8647123	278	1	2000	2000	NUM
bjos-8647123	278	2	feb	feb	NOUN
bjos-8647123	278	3	21;19(8):1102	21;19(8):1102	NUM
bjos-8647123	278	4	-	-	SYM
bjos-8647123	278	5	13	13	NUM
bjos-8647123	278	6	.	.	PUNCT
bjos-8647123	278	7	42	42	NUM
bjos-8647123	278	8	.	.	PUNCT
bjos-8647123	279	1	lee	lee	PROPN
bjos-8647123	279	2	ji	ji	PROPN
bjos-8647123	279	3	,	,	PUNCT
bjos-8647123	279	4	jin	jin	PROPN
bjos-8647123	279	5	bh	bh	PROPN
bjos-8647123	279	6	,	,	PUNCT
bjos-8647123	279	7	kim	kim	PROPN
bjos-8647123	279	8	ma	ma	PROPN
bjos-8647123	279	9	,	,	PUNCT
bjos-8647123	279	10	yoon	yoon	PROPN
bjos-8647123	279	11	hj	hj	PROPN
bjos-8647123	279	12	,	,	PUNCT
bjos-8647123	279	13	hong	hong	PROPN
bjos-8647123	279	14	sp	sp	PROPN
bjos-8647123	279	15	,	,	PUNCT
bjos-8647123	279	16	hong	hong	PROPN
bjos-8647123	279	17	sd	sd	NOUN
bjos-8647123	279	18	.	.	PUNCT
bjos-8647123	280	1	prognostic	prognostic	ADJ
bjos-8647123	280	2	significance	significance	NOUN
bjos-8647123	280	3	of	of	ADP
bjos-8647123	280	4	cxcr-4	cxcr-4	NUM
bjos-8647123	280	5	expression	expression	NOUN
bjos-8647123	280	6	in	in	ADP
bjos-8647123	280	7	oral	oral	ADJ
bjos-8647123	280	8	squamous	squamous	ADJ
bjos-8647123	280	9	cell	cell	NOUN
bjos-8647123	280	10	carcinoma	carcinoma	NOUN
bjos-8647123	280	11	.	.	PUNCT
bjos-8647123	281	1	oral	oral	ADJ
bjos-8647123	281	2	surg	surg	NOUN
bjos-8647123	281	3	oral	oral	ADJ
bjos-8647123	281	4	med	med	ADJ
bjos-8647123	281	5	oral	oral	ADJ
bjos-8647123	281	6	pathol	pathol	NOUN
bjos-8647123	281	7	oral	oral	ADJ
bjos-8647123	281	8	radiol	radiol	NOUN
bjos-8647123	281	9	endod	endod	PROPN
bjos-8647123	281	10	.	.	PUNCT
bjos-8647123	282	1	2009	2009	NUM
bjos-8647123	282	2	may;107(5):678	may;107(5):678	NOUN
bjos-8647123	282	3	-	-	SYM
bjos-8647123	282	4	84	84	NUM
bjos-8647123	282	5	.	.	PUNCT
bjos-8647123	283	1	doi	doi	NOUN
bjos-8647123	283	2	:	:	PUNCT
bjos-8647123	283	3	10.1016	10.1016	NUM
bjos-8647123	283	4	/	/	SYM
bjos-8647123	283	5	j.tripleo.2008.12.047	j.tripleo.2008.12.047	PROPN
bjos-8647123	283	6	.	.	PUNCT
bjos-8647123	284	1	43	43	NUM
bjos-8647123	284	2	.	.	PUNCT
bjos-8647123	285	1	qu	qu	PROPN
bjos-8647123	285	2	h	h	PROPN
bjos-8647123	285	3	,	,	PUNCT
bjos-8647123	285	4	xin	xin	PROPN
bjos-8647123	285	5	ze	ze	PROPN
bjos-8647123	285	6	,	,	PUNCT
bjos-8647123	285	7	jing	jing	ADJ
bjos-8647123	285	8	x.	x.	NOUN
bjos-8647123	285	9	expression	expression	NOUN
bjos-8647123	285	10	and	and	CCONJ
bjos-8647123	285	11	correlation	correlation	NOUN
bjos-8647123	285	12	of	of	ADP
bjos-8647123	285	13	mmp-2	mmp-2	NUM
bjos-8647123	285	14	.	.	PUNCT
bjos-8647123	286	1	timp-2	timp-2	NUM
bjos-8647123	286	2	in	in	ADP
bjos-8647123	286	3	oral	oral	ADJ
bjos-8647123	286	4	squamous	squamous	ADJ
bjos-8647123	286	5	cell	cell	NOUN
bjos-8647123	286	6	cancer	cancer	NOUN
bjos-8647123	286	7	.	.	PUNCT
bjos-8647123	287	1	j	j	PROPN
bjos-8647123	287	2	hard	hard	ADJ
bjos-8647123	287	3	tissue	tissue	NOUN
bjos-8647123	287	4	biol	biol	NOUN
bjos-8647123	287	5	.	.	PUNCT
bjos-8647123	288	1	2005;14(2):311	2005;14(2):311	NUM
bjos-8647123	288	2	-	-	SYM
bjos-8647123	288	3	2	2	NUM
bjos-8647123	288	4	.	.	NUM
bjos-8647123	288	5	44	44	NUM
bjos-8647123	288	6	.	.	PUNCT
bjos-8647123	289	1	singh	singh	PROPN
bjos-8647123	289	2	rd	rd	PROPN
bjos-8647123	289	3	,	,	PUNCT
bjos-8647123	289	4	haridas	haridas	PROPN
bjos-8647123	289	5	n	n	PART
bjos-8647123	289	6	,	,	PUNCT
bjos-8647123	289	7	patel	patel	PROPN
bjos-8647123	289	8	jb	jb	PROPN
bjos-8647123	289	9	,	,	PUNCT
bjos-8647123	289	10	shah	shah	PROPN
bjos-8647123	289	11	fd	fd	PROPN
bjos-8647123	289	12	,	,	PUNCT
bjos-8647123	289	13	shukla	shukla	PROPN
bjos-8647123	289	14	sn	sn	PROPN
bjos-8647123	289	15	,	,	PUNCT
bjos-8647123	289	16	shah	shah	PROPN
bjos-8647123	289	17	pm	pm	PROPN
bjos-8647123	289	18	,	,	PUNCT
bjos-8647123	289	19	et	et	PROPN
bjos-8647123	289	20	al	al	PROPN
bjos-8647123	289	21	.	.	PROPN
bjos-8647123	289	22	matrix	matrix	NOUN
bjos-8647123	289	23	metalloproteinases	metalloproteinase	NOUN
bjos-8647123	289	24	and	and	CCONJ
bjos-8647123	289	25	their	their	PRON
bjos-8647123	289	26	inhibitors	inhibitor	NOUN
bjos-8647123	289	27	:	:	PUNCT
bjos-8647123	289	28	correlation	correlation	NOUN
bjos-8647123	289	29	with	with	ADP
bjos-8647123	289	30	invasion	invasion	NOUN
bjos-8647123	289	31	and	and	CCONJ
bjos-8647123	289	32	metastasis	metastasis	NOUN
bjos-8647123	289	33	in	in	ADP
bjos-8647123	289	34	oral	oral	ADJ
bjos-8647123	289	35	cancer	cancer	NOUN
bjos-8647123	289	36	.	.	PUNCT
bjos-8647123	290	1	2010	2010	NUM
bjos-8647123	290	2	jul;25(3):250	jul;25(3):250	PROPN
bjos-8647123	291	1	-	-	PUNCT
bjos-8647123	291	2	9	9	NUM
bjos-8647123	291	3	.	.	PUNCT
bjos-8647123	291	4	doi	doi	NOUN
bjos-8647123	291	5	:	:	PUNCT
bjos-8647123	291	6	10.1007/	10.1007/	NUM
bjos-8647123	291	7	s12291	s12291	PROPN
bjos-8647123	291	8	-	-	PUNCT
bjos-8647123	291	9	010	010	NUM
bjos-8647123	291	10	-	-	PUNCT
bjos-8647123	291	11	0060	0060	NUM
bjos-8647123	291	12	-	-	PUNCT
bjos-8647123	291	13	8	8	NUM
bjos-8647123	291	14	.	.	X
bjos-8647123	292	1	45	45	NUM
bjos-8647123	292	2	.	.	PUNCT
bjos-8647123	293	1	blancato	blancato	PROPN
bjos-8647123	293	2	j	j	PROPN
bjos-8647123	293	3	,	,	PUNCT
bjos-8647123	293	4	singh	singh	PROPN
bjos-8647123	293	5	b	b	PROPN
bjos-8647123	293	6	,	,	PUNCT
bjos-8647123	293	7	liu	liu	PROPN
bjos-8647123	293	8	a	a	PROPN
bjos-8647123	293	9	,	,	PUNCT
bjos-8647123	293	10	liao	liao	PROPN
bjos-8647123	293	11	dj	dj	PROPN
bjos-8647123	293	12	,	,	PUNCT
bjos-8647123	293	13	dickson	dickson	PROPN
bjos-8647123	293	14	rb	rb	PROPN
bjos-8647123	293	15	.	.	PUNCT
bjos-8647123	293	16	correlation	correlation	NOUN
bjos-8647123	293	17	of	of	ADP
bjos-8647123	293	18	amplification	amplification	NOUN
bjos-8647123	293	19	and	and	CCONJ
bjos-8647123	293	20	overexpression	overexpression	NOUN
bjos-8647123	293	21	of	of	ADP
bjos-8647123	293	22	the	the	DET
bjos-8647123	293	23	c	c	PROPN
bjos-8647123	293	24	-	-	PUNCT
bjos-8647123	293	25	myc	myc	NOUN
bjos-8647123	293	26	oncogene	oncogene	NOUN
bjos-8647123	293	27	in	in	ADP
bjos-8647123	293	28	high	high	ADJ
bjos-8647123	293	29	–	–	PUNCT
bjos-8647123	293	30	grade	grade	NOUN
bjos-8647123	293	31	breast	breast	NOUN
bjos-8647123	293	32	cancer	cancer	NOUN
bjos-8647123	293	33	:	:	PUNCT
bjos-8647123	293	34	fish	fish	NOUN
bjos-8647123	293	35	,	,	PUNCT
bjos-8647123	293	36	ish	ish	VERB
bjos-8647123	293	37	and	and	CCONJ
bjos-8647123	293	38	immunohistochemical	immunohistochemical	ADJ
bjos-8647123	293	39	analysis	analysis	NOUN
bjos-8647123	293	40	.	.	PUNCT
bjos-8647123	294	1	br	br	PROPN
bjos-8647123	294	2	j	j	PROPN
bjos-8647123	294	3	cancer	cancer	NOUN
bjos-8647123	294	4	2004	2004	NUM
bjos-8647123	294	5	apr	apr	VERB
bjos-8647123	294	6	19;90(8):1612	19;90(8):1612	NUM
bjos-8647123	294	7	-	-	SYM
bjos-8647123	294	8	9	9	NUM
bjos-8647123	294	9	.	.	PUNCT
bjos-8647123	294	10	expression	expression	NOUN
bjos-8647123	294	11	of	of	ADP
bjos-8647123	294	12	timp-2	timp-2	NUM
bjos-8647123	294	13	in	in	ADP
bjos-8647123	294	14	hpv-16	hpv-16	NUM
bjos-8647123	294	15	infected	infect	VERB
bjos-8647123	294	16	oral	oral	ADJ
bjos-8647123	294	17	squamous	squamous	ADJ
bjos-8647123	294	18	cell	cell	NOUN
bjos-8647123	294	19	carcinoma	carcinoma	NOUN
bjos-8647123	294	20	in	in	ADP
bjos-8647123	294	21	patients	patient	NOUN
bjos-8647123	294	22	in	in	ADP
bjos-8647123	294	23	iraq	iraq	PROPN